<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://www.nal.usda.gov/exhibits/speccoll/items/browse?advanced%5B0%5D%5Belement_id%5D=49&amp;advanced%5B0%5D%5Btype%5D=is+exactly&amp;advanced%5B0%5D%5Bterms%5D=state-funded+Vietnam+veterans+study&amp;output=omeka-xml" accessDate="2026-07-20T07:15:14+00:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>15</perPage>
      <totalResults>13</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="3293" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24364">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24365">
              <text>1869</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24367">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24363">
                <text>Bender, Gerald C, Jr.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24366">
                <text>Memorandum: to Interested Persons from Gerald C. Bender, Jr., regarding Wisconsin Mortality Study, July 23, 1985</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24368">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24369">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24370">
                <text>cancer risk assessment</text>
              </elementText>
              <elementText elementTextId="24371">
                <text>alcohol use</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3292" public="1" featured="0">
    <fileContainer>
      <file fileId="1702">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/b677371336f0a60017b46af9dd5a1d6f.pdf</src>
        <authentication>a3e56005c1947ba2597cabb4591043d8</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63651">
                    <text>Item ID Number

01868

Author

Shepard, Barclay M.

Corporate Author
ROpOTt/ArUdO TltlB Critique of West Virginia Mortality Study

Journal/Book Title
Year

1986

Month/Day

February 4

Color

a

Number of Images

36

UOSCrtytOn NOtBS

ltem inlcudes

critique, as well as attached 1) M. L.
Neighbors Diversified Maritime Services, Inc.
advertisement and 2) Vietnam-Era Veterans Mortality
Study, West Virginia Residents 1968-1983, Preliminary
Report, January 1986.

Wednesday, July 11, 2001

Page 1869 of 1870

�FEB 04 1986
Critique of West Virginia Mortality Study

The West Virginia Department of Health has recently completed a
mortality study (copy attached) of Vietnam-era veterans based on the
recipients of a state bonus. The State offered a differential bonus
to all West Virginia residents who served in the military during the
Vietnam era with a larger amount going to those who served "incountry". 41,059 in-country (Vietnam veterans) and 41,782 non-incountry (non-Vietnam) veterans received the bonus. The list of bonus
recipients was matched against state vital statistic records
resulting in 1225 male Vietnam-era veterans who had died between 1968
and 1983. For each deceased male veteran a copy of the Report of
Separation From Active Duty (DD 214) was reviewed to determine dates
and place of service. The latter was determined by receipt of at
least one of the three medals awarded for service in the Southeast
Asia theater of operations. In addition, cause of death information
was obtained on each deceased veteran. Of the 1225 deceased
veterans, 615 were in the group of Vietnam veterans and the remaining
610 were non-Vietnam veterans, i.e., veterans who served elsewhere
during the same period of time. When comparing causes of death
between all veterans in the group and non-veterans of similar age
only those classified as accidents, poisoning, and violence were
elevated among the veteran group. Deaths due to cancer were
statistically the same in both groups. Other causes of death were
lower in the veteran group, a commonly observed phenomenon known as
the "healthy veteran effect".
A stated by the authors, the study has a number of limitations which
must be kept in mind when interpreting the results:
"In spite of the intense publicity given to the bonus campaign,
it is likely that many veterans or their survivors never applied
for the bonus. Thus, those veterans who did qualify for a bonus
represent an unknown proportion of the actual number of West
Virginia males'who served in the military during the Vietnam
era. It cannot be assumed that the proportion was similar for
both [groups]. Furthermore, because the mortality tape
identified only residents of West Virginia who died during the
study period, deaths in that period among veterans who no longer
resided in West Virginia at the time of their demise would not
have been counted among the 1,225 veterans deaths ascertained.
. . With respect to a comparison between in-country and era
.
veterans, it cannot be assumed that similar proportions of the
respective candidate population qualified for the bonus or that
the death rates among in-country veterans who were no longer
West Virginia residents were similar to those among era veterans
who were no longer residents."

�There were 145 cancer deaths of which 71 were in the group of
Vietnam veterans and 74 were among the non-Vietnam veterans. In
comparing specific types of cancers between these two veteran
groups, only Hodgkin's disease, testicular cancer, and soft tissue
sarcoma were elevated in the Vietnam veteran group. In each
instance, however, the number of actual cases was small, i.e., 5
cases of Hodgkin's disease, 3 testicular cancers and 3 soft tissue
sarcomas. As the authors state: "These findings must be
interpreted cautiously ... since ... the site- specific cancer
deaths were derived from a relatively small number . . and would
.
therefore be subject to ... large random fluctuations".
In addition to the stated limitations of the study, as pointed out
by the authors, there has been no systematic review of military
personnel records, except for the DD 214 reviews as noted above, to
validate the Vietnam service status of the study subjects. Because
of the interest and concern over the relationship between soft
tissue sarcoma and exposure to the phenoxy herbicides, the authors
have now requested a review of the personnel records of the 3
veterans recorded as having this diagnosis. All.three of these were
reported to have occurred in the in-country veteran group. The
first of these is now known to have served in Thailand, not Vietnam,
and would not have been exposed to Agent Orange. This is an example
of the serious effect of misclassification especially when dealing
with small numbers of subjects. In addition, there has been no
systematic review of hospital or other clinical records to validate
cause of death information or confirm the specific cancer diagnosis.
Again, when dealing with relatively small numbers, a few errors in
diagnosis can significantly alter the conclusions.
In summary, this study appears to have been well designed and well
conducted as far as it goes. As noted by the authors, however, it
has inherent limitations and additional data are needed to validate
some of the conclusions.

BARCLAY M. SHEPARD, M.D.

Director, Agent Orange Projects Office

�«J£.

tLAet&amp;Ad&amp;Ht-

1 January 1986
ANNOUNCEMENT
M. L. NEIGHBORS, DIVERSIFIED MARITIME SERVICES, INC., announces
that it is now able to offer part time consultative service or
representation in the Washington, DC area to additional firms or
persons that are engaged or have an interest in maritime related
business ventures or business involving the disposal of chemical
waste. Such work may also be arranged for in locations other than
the Washington DC area as mutually agreed, and on either a prime or
sub-contract basis.
Among services offered are:
A. Maintaining continuous contact with federal agencies
having jurisdiction or control over maritime or chemical waste
disposal ventures, and submittal of reports on matters of client
interest. Rapid "feed-back" on specific information of more
urgent interest can also be provided.
B. Projection of U.S. chemical waste disposal requirements,
in general or with specificity.
C. Assisting in the initiation of either a maritime project
or a project involving chemical waste disposal (except services
involving the disposal of chemical waste by incineration at sea
cannot be provided until after 30 November, 1986).
CORPORATE EXPERIENCE INCLUDES:
Nineteen years involvement with Department of Defense vessel
charters and military cargo movement contracts.
Thirteen years involvement with various offices of the
Environmental Protection Agency that are responsible for
regulating chemical waste disposal. This work included interaction with other federal agencies and with commercial firms
offering alternative types of chemical waste disposal service.
Written inquiries should be addressed to M. L. Neighbors, DMS
Inc., 777 Fourteenth St., Suite 747, Washington, DC, 20005.
Further information may also be obtained from Mr. Neighbors at
phone number 564 1568 (area code 301 if calling from outside
metro area).

�WEST VIRGINIA HEALTH DEPARTMENT

�VIETNAM-ERA VETERANS MORTALITY STUDY
WEST VIRGINIA RESIDENTS

1968 - 1983

Preliminary Report

January 1986

Arch A. Moore, Jr.
Governor

David K. Heydinger, M.D.
Director, Department of Health

�Alan P. Holmes, B.S.E.E., M.B.A.
Principal Investigator

WEST VIRGINIA DEPARTMENT OF HEALTH
VIETNAM-ERA VETERANS MORTALITY STUDY COMMITTEE

Charles Bailey
Assistant Director, Health Statistics Center
Roy C. Baron, M.D., M.P.H.
Medical Epidemiologist
Edward Bosanac, Ph.D.
Research Consultant
John Brough, Dr. P.H.
Director, Preventive Health Services
Charles Conroy, M.A.
Agent Orange Program Coordinator
Acting Director, Community Health Services
Loretta Haddy, M.A., M.S.
State Epidemiologist
Alan P. Holmes, M.B.A.
Director, Health Statistics Center

ACKNOWLEDGEMENTS

Sandra Y. Pope, Administrative Assistant, Agent Orange Program
Eugenia Thoenen, Publications Coordinator, Health Statistics Center
Thomas N. Leonard, Programmer/Analyst, Health Statistics Center
Betty Jo Berry, Secretary, Health Statistics Center
We would also like to thank Col. John W. Moon and the staff of
, the West Virginia Department of Veterans' Affairs for their
invaluable assistance in providing data used in this study.

For further information, contact
Charles Conroy, Agent Orange Program Coordinator
1800 Washington Street, East
Charleston, WV 25305
Telephone: (304) 348-3210

�Vietnam-Era Veterans Mortality Study
West Virginia Residents 1968-1983

The Agent Orange Assistance Program, established in 1982 by
the West Virginia legislature, requested the Health Statistics
Center of the Department of Health to conduct a study of the
causes of death among state Vietnam veterans from 1968 through
1983.*

The purpose of the study was to compare the mortality

pattern among veterans with that of nonveterans

in order to

generate hypotheses regarding any differences in the causes of
death among the former. A comparison of the causes of death among
veterans who served in Vietnam with those among veterans who did
not serve in Vietnam was also undertaken in order to speculate
whether

the Vietnam

experience

might

be

associated

with a

distinct mortality pattern.

METHODS

Identification of West Virginia Veterans

West Virginia residents who served in the military during
the years of the Vietnam Conflict were identified from the list

*The Vietnam era is generally defined as extending from 1964
until 1973. For the purposes of this study, however, only those
deaths from 1968 were considered because of the small number of
deaths occurring before that year, in addition to difficulties
imposed by cause-of-death coding changes over the longer
interval.

�of applicants for a military service bonus offered by the state
Department of Veterans' Affairs in 1974.

To qualify for a bonus,

veterans had to meet the following criteria:
1) they must have rendered active service in the armed
forces at some time between August 1, 1964, and March
28, 1973, inclusive, or have been recipients of the
Vietnam armed forces expeditionary medal if they saw
active service prior to August 1;
2) they must have been residents of West Virginia for at
least six months prior to entry into active service;
3) they must have actively served for a period of at least
ninety days unless discharged because of a servicerelated disability, and
4) they must have been honorably discharged.
Efforts to notify eligible veterans or their survivors about
the bonus program included one national public awareness campaign
conducted in November 1975 and one conducted in July 1976.
Public service announcements were issued over the television
networks, and notices were posted in every major newspaper in the
country

and

organizations

on

service

advertised

networks

the

bonus

overseas.
legislation

Veterans'
in

their

publications, and some offered assistance in filing for the bonus
as a promotional device in their membership campaigns.

Three different bonuses were offered. Veterans who did not
serve in Vietnam

("out-of-country" or era veterans) were to

receive up to $300 (Type 3 bonus); Vietnam veterans ("in-country"
veterans) were

to receive

up to $400

(Type 4 bonus), and

surviving relatives of veterans who died while in the service
during the period designated by the legislature were to receive

�$500 (Type 5 bonus).

In West Virginia,

the Department

of Veterans'

reported a total of 86,247 initial applicants.

Affairs

Of those who

applied for the bonus, 83,730 veterans or survivors (97%) were
eligible (Figure 1).

Of these, 41,782 qualified for the Type 3

(Vietnam-era) bonus, 41,059 qualified for the Type 4 (Vietnam)
bonus, and 889 qualified for the Type 5 bonus.

Since this was to

be a study of mortality following discharge from the service, the
Type 5 bonus recipients were excluded from subsequent analyses.
Names of the Type 3 and Type 4 qualifiers were, entered onto a
computer tape, referred to as the "bonus tape."

Identification of Veteran and Nonveteran Deaths

A complete listing of West Virginia resident deaths from
1968 through 1983 was prepared from records maintained by the
Health Statistics Center and entered onto a "mortality tape."
The

names

on

this

list were then compared with those on the

bonus tape in order to identify veterans who died during this
period.

For deaths from 1968 through 1978, the information had

to be matched by name since social security numbers were not
included on the mortality tape for these years.

Any possible

match generated in this manner was searched by hand and confirmed
by comparing the social security number on the death certificate
with that on the veteran application.

From 1979 through 1983, it

was possible to match by social security number.

�FIGURE 1
WV VIETNAM VETERAN MORTALITY STUDY
SELECTION OF STUDY POPULATION
1968-83

Bonus Tape
83,730

1

1

1
In -Country
Vietnam
41,059

Not-in-Country
Era
41,782

No-Match
Death File
41,169

Females

Era
3

Nonwhite
Males
Era
30

MatchedDeath File
Era
613

Males
Era
610

White
Males
Era
580

No-Match
Death File
40,444

Died in
Service
889

MatchedDeath File
Vietnam
615

Females
Vietnam
0

Males
Vietnam
615

Nonwhite
Males
Vietnam
36

White
Males
Vietnam
579

�There were 1,234 initial matches between the bonus tape and
the mortality tape, 614 Vietnam-era (Type 3) veterans and 620
in-country

(Type

4) veterans.

The veterans' discharge forms

(DD-214s) were then manually checked to verify their in-country
status.*

This

review

reclassification

of

resulted

several

in

records,

the

deletion

leaving

1,228

and/or
deceased

veterans who qualified, 613 for the Type 3 bonus and 615 for the
Type 4 bonus.

Three of the deceased veterans, all Type 3 bonus

recipients, were female.

They were excluded from the final tape;

the subsequent analyses included only deceased male veterans.

Of the 1,225 male veterans who died (Table 1), 1,159 were
white and 66 were nonwhite (65 black and 1 Hawaiian).
nonwhite veterans were Type 3 (5%) and 36 were Type 4

Thirty
(6%).

Because nonwhite veterans constituted a small percentage of those
who died, the study combined the mortality patterns of white and
nonwhite veterans.

For

nonveteran males,

deaths were

identified

from the

mortality tape by deleting the records of all remaining female
deaths and those of the 1,225 male veteran deaths.
thus four groups defined for analysis:
died; (2) male

Vietnam-era-only

There were

(1) all male veterans who

(Type 3)

veterans

who

died;

*In-country status was determined by the receipt by the
veteran of one of three service medals (the Vietnam service medal,
the Vietnam campaign medal, or the Vietnam expeditionary medal) as
noted on the DD-214. These medals were awarded to military
personnel who served in the Southeast Asia theater of operations.

�TABLE 1
TYPE 3 AND TYPE 4
MATCHES BETWEEN BONUS TAPE AND MORTALITY TAPE
BY YEAR
1968-83

YEAR

VIETNAM-ERA
(Type 3)

IN-COUNTRY
(Type 4)

TOTAL

1968

4

13

17

1969

14

16

30

1970

17

22

39

1971

16

33

49

1972

26

31

57

1973

33

22

55

1974

25

29

54

1975

50

47

97

1976

47

46

93

1977

50

40

90

1978

54

35

89

1979

53

44

97

1980

58

51

109

1981

53

70

123

1982

55

59

114

1983

56

56

112

TOTAL

610

615

1,225

�(3) male in-country (Type 4) Vietnam veterans who died, and (4)
all

other West

Virginia

males

(nonveterans) who

died

from

1968-83.

DEMOGRAPHIC PROFILE OF DECEASED VETERANS

Age Distribution

The average age at death was 35.3 for all veterans, 35.1 for
era veterans and 35.4 for in-country veterans.

Table 2 shows

that the distribution of deaths by age for Type 3 and Type 4
veterans was similar.

Tables 3 and 4 present the distributions of age at death by
race for Vietnam-era and Vietnam veterans, respectively.

Among

white Type 3 veterans, the average age at death was 35.3, among
nonwhites 31.3. For Type 4 veterans, the mean age at death for
whites was 35.5, with 33.5 that for nonwhites.

�TABLE 2
ALL VIETNAM-ERA VETERANS
Age Distribution by Type of Service

VIETNAM-ERA
(Type 3)

TOTAL

IN- COUNTRY
(Type 4)

AGE GROUP

f

%

%

*

4

I

15-19

4

0.7

1

0.2

5

0.4

20-24

82

13.4

92

14.9

174

14.2

25-29

139

22.8

125

20.3

264

21.5

30-34

137

22.4

143

23.2

280

22.9

35-39

83

13.6

61

9.9

144

11.7

40-44

42

6.9

53

8.6

95

7.7

45-49

36

5.9

60

9.8

96

7.8

50-54

40

6.6

33

5.4

73

6.0

55-59

24

3.9

32

5.2

56

4.6

60-64

12

2.0

12

2.0

24

2.0

65-69

9

1.5

3

0.5

12

1.0

70-74

2

0.3

0

0.0

2

0.2

TOTAL

610

100.0

615

100.0

1,225

100.0

Average Age
at Death

35.4

35.1

8

35.3

�TABLE 3
VIETNAM-ERA VETERANS (TYPE 3)
Age Distribution by Race

WHITE

TOTAL

NONWHITE

AGE GROUPS

%

#

%

#

%

1

19

4

0.7

0

0.0

4

0.7

20-24

77

13.3

5

16.7

82

13.4

25-29

131

22.6

8

26.7

139

22.8

30-34

127

21.9

10

33.3

137

22.4

35-39

79

13.6

4

13.3

83

13.6

40-44

42

7.2

0

0.0

42

6.9

45-49

33

5.7

3

10.0

36

5.9

50-54

40

6.8

0

0.0

40

6.6

55-59

24

4.2

0

0.0

24

3.9

60-64

12

2.1

0

0.0

12

2.0

65-69

9

1.6

0

0.0

9

1.5

70-74

2

0.3

0

0.0

2

0.3

TOTAL

580

100.0

30

100.0

610

100.0

Average Age
at Death

35.3

31.3

35.1

�TABLE 4
IN-COUNTRY VIETNAM VETERANS (TYPE 4)
Age Distribution by Race

NONWHITE

WHITE

TOTAL

AGE GROUPS

%

#

#

%

t

Z

19

0

0.0

1

2.8

1

0.2

20-24

87

15.0

5

13.8

92

14.9

25-29

114

19.7

11

30.5

125

20.3

30-34

135

23.3

8

22.2

143

23.2

35-39

59

10.2

2

5.6

61

9.9

40-44

51

8.8

2

5.6

53

8.6

45-49

59

10.2

1

2.8

60

9.8

50-54

29

5.0

4

11.1

33

5.4

55-59

30

5.2

2

5.6

32

5.2

60-64

12

2.1

0

0.0

12

2.0

65-69

3

0.5

0

0.0

3

0.5

70-74

0

0.0

0

0.0

0

0.0

TOTAL

579

100.0

36

100.0

615

100.0

Average Age
at Death

35.5

33.5

10

35.4

�Branch of Service

Review of the DD-214 forms showed that 718 (59%) of the
deceased veterans had served in the army, 210 (17%) had served in
the air force, 167* (14%) had served in the navy, and 120 (10%)
had served in the marines (Table 5).

Seventy-five percent of the

in-country veterans who died had been in either the army or the
marines, in contrast to 62% of the era veterans.

Twenty-five

percent of in-country veterans had served in either the air force
or the navy, in contrast to 37% of, the era veterans.

For 10

veterans, the branch of service was not recorded on the discharge
forms.

*Includes 3 coast guard veterans.

11

�TABLE 5
ALL VIETNAM-ERA VETERANS
Branch of Service by Type of Service
VIETNAM-ERA
(Type 3)

IN-COUNTRY
(Type 4)

TOTAL

BRANCH OF SERVICE

%

*

t

%

*

%

Army

340

55.7

378

61.5

718

58.6

Air Force

127

20.8

83

13.5

210

17.2

16.1

69

11.2

167

13.6

Navy

98*

Marines

39

6.4

81

13.2

120

9.8

Unknown

6

1.0

4

0.6

10

0.8

610

100.0

615

100.0

TOTAL

*Includes
3 coast
guard
veterans

12

1,225

100.0

�ANALYTIC METHODS

In

spite

of

the

intense publicity

given to the bonus

campaign, it is likely that many veterans or their
never

applied

for the bonus.

survivors

Thus, those veterans

who did

qualify for a bonus represent an unknown proportion of the actual
number of West Virginia males who served in the military during
the Vietnam era.

It cannot be assumed that the proportion was

similar for both Type 3 (era) and Type 4 (in-country) qualifiers.
Furthermore, because the mortality tape identified only residents
of West Virginia who died during the study period, deaths in that
period among veterans who no longer resided in West Virginia at
the time of their demise would not have been counted among the
1,225 veteran deaths ascertained.

Because of these limitations, the records provide neither
complete information about the total candidate population nor a
comprehensive

estimate

of the force

veterans who did qualify.
the

veteran

and

the

of mortality

among

the

With respect to a comparison between
nonveteran

groups,

the

data

would

underestimate the relative force of mortality among the veterans,
if such a comparison were made.

With respect to a comparison

between in-country and era veterans, it cannot be assumed that
similar

proportions

of

the

respective

candidate population

qualified for the bonus or that the death rates among in-country
veterans who were no longer West Virginia residents were similar
to those among era veterans who were no longer residents.

13

�The method of choice for a study of mortality when there is
incomplete data on the population at risk is a proportionate
mortality analysis.

In this type of study the proportion of all

deaths due to the disease(s) of interest in the study population
is

compared with

the proportion of all deaths due to the

disease(s) of interest in the comparison (referent) population.
Such proportional rates do not express the risk of dying from a
disease since the incidence is not measured against a population
base.

They simply suggest that there may be a difference worth

investigating further.

The validity of such a study rests on the

assumption that there is no association between the study factor,
i.e.,

veteran

status, and the occurrence of other diseases.

Since we cannot make this assumption, such an analysis is used to
generate hypotheses or to conduct preliminary tests of etiologic
hypotheses without collecting much additional data.

The relationship between the proportion of deaths due to a
specified cause in a study population and the proportion derived
from the referent population is expressed as a proportionate
mortality ratio (PMR).

The PMRs in this study are standardized

to adjust for selected confounding variables.

When the veteran

group and its subgroups were compared with the nonveteran group,
adjustments were made by stratifying on age at death by 5-year
intervals (15-19, 20-24, . . . etc.) and on year of death by
2-year intervals
stratum,

(1968-69, 1970-71,

expected deaths were

. . . 1982-83).

For each

calculated by determining

the

percentage the cause of death of interest contributed to all

14

�causes in the referent population and multiplying this result by
the total deaths from all causes in the study population.

The

standardized PMR statistic (sPMR) is the ratio of the number of
deaths of interest observed in the study population summed over
all strata, multiplied by 100, and then divided by the expected
values summed over all strata.

Stratification by age only and

not by year of death was done when the in-country (study) group
of veterans was compared to the era (referent) group.

This was

done in order to avoid losing data from the study group when
respective strata in the referent group had no deaths.

An sPMR

greater than 100 indicates that the cause of interest contributes
a greater percentage of all deaths in the study population than
in the referent population; an sPMR less than 100 indicates that
the cause contributes a smaller percentage of all deaths in the
study population than in the referent population, and an sPMR of
100 indicates that the cause of interest contributes the same
percentage of all deaths in both groups.
expected frequencies
against

confidence
p-value

for each cause of interest were tested

the null hypothesis, i.e.,

proportionate

mortality

interval

expressing

The observed and

structure,

around
the

each

each

exact

sPMR

by

group has the same
calculating

a

95%

and also a one-tailed

probability

of

finding

the

difference between the observed and expected frequencies.
RESULTS

In the period 1968 through 1983, there were 1,225 deaths
among males who had served in the military during the Vietnam

15

�Conflict.

Six hundred fifteen of the men served at least a

portion of their duty in Vietnam (in-country, Type 4 veterans)
and 610 had no experience in Vietnam (era, Type 3 veterans). For
both groups combined, 716 deaths (58%) were from external causes
(injury from accidents, poisoning, or violence), 237 (19%) were
from

cardiovascular

neoplasms,

48

(4%)

disease,
were

145

from

(12%)

were

nonmalignant

from
diseases

malignant
of the

gastrointestinal system, 24 (2%) were from nonmalignant diseases
of

the

respiratory

system,

5

(-=1%) were

from allergic,

metabolic, and endocrine disorders, and 50 (4%) were from all
other causes.

With nonveteran West Virginia male deaths from 1968 through
1983 as a reference, Table 6 demonstrates the number of observed
and

expected

deaths

in

each

cause-of-death category for all

veterans together and for in-country and era veterans separately.
For all veterans, the observed distribution of deaths over these
categories was significantly different from the expected (Chi
square

Goodness

of

Fit •» 50.2

with

6 degrees of

freedom,

p&lt;10~8).

Accidents,
significantly

poisoning,

greater

and

proportion

violence
of

accounted

all veteran

for

a

deaths than

expected (sPMR excess), while deaths from allergic, metabolic,
and endocrine conditions and from all other causes accounted for
significantly smaller-than-expected
deaths

(sPMR

deficits).

For

16

proportions of all veteran

cardiovascular, digestive, and

�TABLE 6
ALL CAUSES OF MORTALITY
Vietnam Veterans vs. Nonveterans
West Virginia, 1968-83
ALL VETERANS
vs.
NONVETERANS

IN- COUNTRY VETERANS
vs.
NONVETERANS

ALL CAUSES

°/.
Accidents, Poisoning,
and Violence
(80E9)
E0-99

716,
'626.74

Cardiovascular Disease
(9-5)
3049

237,
'251.5

Malignant Neoplasms
(140-209)

sPMR

(95Z CI)

°/
'E

sPMR

ERA VETERANS
vs.
NONVETERANS

(95Z CI)

°
/

sPMR

(95Z CI)

(106-130)

354,
'318.1

111*

(100-124)

'E

(106-123)

362.
'308.6

117**

94

(83-107)

114,
'129.1

88

(73-106)

123,
'122.4

100

(84-120)

145,
'142.4

102

(86-120)

71,
'73.6

96

(75-122)

74,
'88
6.

108

(85-136)

Diseases of the
Digestive System
(520-577)

48,
'56.7

85

(62-112)

29,
'29.0

100

(67-144)

19,
'27.8

68

(41-107)

Diseases of the
Respiratory System
(460-519)

24.
'29
3.

73

(47-108)

12,
'16.7

72

(37-125)

12,
'16.2

74

(38-129)

38*

(10-96)

52**

(33-77)

114**

y

Allergic, Metabolic,
and Endocrine Diseases
(240-279)
All Other Causes
(Residual)

'19
2.

50.
'29
9.

23**

(7-53)

'll.2

9**

(-=1-47)

'06
1.

54**

(40-71)

26.
'68
4.

56**

(36-81)

24,
'61
4.

Goodness of Fit X2. -50.2
odt
p- 1 '
08
*polsson p value*.05
**poisson p value£.001

�respiratory diseases, the standardized proportionate mortality
ratios were less than unity when all veterans were compared with
nonveterans,

but

the

observed

numbers

of

deaths

in these

categories were not significantly lower than the expected.
proportion of veteran

The

deaths due to malignant neoplasms was

similar to that of nonveterans.

The pattern

of death

for

in-country

and era

veterans

evaluated separately relative to the nonveteran population was
similar in both instances to the pattern observed for the groups
combined.

In a separate contrast with era veteran deaths as the

standard (not shown), no difference was. observed in the overall
mortality pattern between in-country and era veterans (Chi square
Goodness of

Fit = 7.0 with

5 degrees

of

freedom, p - .22).

In order to evaluate more specific causes of death within
the leading categories, the contrasts were repeated to obtain
standardized proportionate category-specific mortality ratios for
external causes (injury), cardiovascular diseases, and malignant
neoplasms separately.

Table 7 shows the distribution of injury

deaths for veterans contrasted with nonveterans over five causes:
motor vehicle accidents, non-motor-vehicle accidents, suicide,
homicide, and all other external causes.

Homicide accounted for

a significantly smaller-than-expected proportion of the injury
deaths among veterans.

The standardized proportionate injury

mortality ratio for motor-vehicle-related deaths among veterans
was greater than 100 but was not a statistically significant

18

�TABLE 7
INJURY MORTALITY
Vietnam Veterans vs. Nonveterans
West Virginia, 1968-83
ALL VETERANS
vs.
NONVETERANS
°
/

sPMR

(95Z CD

315,
'9.
206

108

(97-121)

201,
'0.
293

96

(83-110)

104

(85-125)

ACCIDENTS. POISONING,
AND VIOLENCE
(E800-999)
Motor Vehicle
(E810-E825)
Ron-Motor Vehicle
(E800-E809,
E826-E949)
Suicide
(E9SO-E9S9)
HoBiclde
(E960-E969)
All Other Causes
(E970-E999)

IN-COUNTRY VETERANS
vs.
NONVETERANS

'E

111

'107.2
63.
'81.5

77*

(59-99)

26.
'74
2.

95

(62-139)

Goodness of Fit X^.--6.78

P-.15
*poisson p value-=.05

sPMR

107

(115
9-2)

100,
'105.1

95

(77-116)

111

(85-144)

sPMR

(95Z CI)

154.
'4.
105

110

(318
9-2)

101,
'0.
142

97

(79-118)

/
'54.2

96

(72-126)

35,
'14
4.

85

(59-118)

87

(45-152)

(95Z CI)

161,
'5.
101

ERA VETERANS
vs.
NONVETERANS

°'E
/

5
9

/
'53.0

28.
'02
4.
1
4

/
'13.6

70*

103

(46-101)

(56-173)

Goodness of Fit XJ^-5.43

P-.25

°'E
/

5
2

12

/
'38
1.

Goodness of Fit X2df-2.71

p-,61

�excess.

For non-motor-vehicle fatalities, suicide, and all other

causes, the expected numbers were similar to the observed.

The

overall pattern for veterans was not significantly different from
nonveterans (Chi square Goodness of Fit » 6.78 with 4 degrees of
freedom, p =.15).

Separate comparisons of the in-country and era

veteran populations

with

nonveterans

similarly

overall difference in the distribution

reflected no

of injury deaths; the

ratios in each of these contrasts were similar to those observed
for the combined veteran group.

Among the cardiovascular causes of mortality
there

were

no

veteran

deaths

from

either

(Table 8),

hypertension or

rheumatic heart disease (p-=.005), fewer-than-expected veteran
deaths from cerebrovascular disease (difference not significant),
and

more-than-expected veteran deaths due to ischemic heart

disease

(difference

standardized

not

significant).

proportionate

cardiovascular

The

individual

disease

mortality

ratios for in-country and era veterans were similar to the
corresponding mortality ratios derived for the combined group.

Proportionate cancer mortality ratios comparing veterans to
nonveterans are shown in Table 9.
veterans

and

respiratory

the
system

nonveteran

excess

contributed

population,

accounted

proportion of veteran cancer
by

In the comparison between all

for

deaths

in-country

identical to that contributed by

20

a

era

neoplasms

significantly
than

of

greater

expected.

veterans
veterans.

was

the

The

virtually

Melanoma of

�TABLE 8
CARDIOVASCULAR DISEASE MORTALITY
Vietnam Veterans vs. Nonveterans
West Virginia, 1968-83
ALL VETERANS
vs.
NONVETERANS
CARDIOVASCULAR DISEASES
(390-459)
Ischemic Heart Disease
(410-414)

Cerebrovascular Disease
(430-438)

°/.

sPMR

(95Z CI)

158.
'141.5

112

(95-131)

18,
'50
2.

72

(43-114)

Hypertension
(400-405)

°65
'.

Rheumatic Heart Disease
(390-398)

°/5.4

All Other
Cardiovascular Diseases
(415-429, 440-459)

IN-COUNTRY VETERANS
vs.
NONVETERANS

61

'86
5.

0**

0**

104

*poisson p valuer .05
**poisson p value «.005

°/

'E

sPMR

(95Z CI)

°'E
/

sPMR

(952 CI)

/
'67.7

111

(87-139)

83,
'40
7.

112

(89-139)

73

(32-144)

10,
'40
1.

71

(34-131)

75

8

/
'09
1.

-

°/3.4

0*

-

°&gt;1.9

0

/
'30.2

103

(80-134)

ERA VETERANS
vs.
NONVETERANS

31

-

°/3.0

0*

-

°/3.5

0*

(70-146)

30

'84
2.

106

-

(71-151)

�TABLH. »
CANCER MORTALITY

Vietnam Veteran* vs. Nonveterans
West Virginia. 1968-83
IN-COUNTRY VETERANS
vs.
NONVETERANS

ALL VETERANS
vs.
NONVETERANS
MALIGNANT NEOPLASMS
(140-209)

sPHR

(951 CD

135*

(102-174)

123

(91-162)

462*

(6-9)
1897

21,
'69
2.

78

(819
4-1)

12,
'.
66

182*

(94-318)

79

(38-145)

6

128

(46-276)

7

123

(50-254)

°&gt;E

Respiratory System
"4.
'31
(160-163)
Trachea, Bronchus, 50
and Lung
'07
4.
(162)
Larynx
(161)
Digestive Organs
and Peritoneum
(150-159)

to
to

Malignant Melanoma
of the Skin
(172)
Lymphoms
(200-203, 208-209)

'13
'.

10

/
'12.7

Hodgklns Disease
(201)

/4.7

Hale Genital Organs
(185-187)
Leukemia
(204-207)

&gt;,.7

6

/13.1

3

/0.7

%

sPHR

(951 CD

131*

(87-187)

29,
'09
2.

139*

(93-199)

118

(76-174)

25.
'19.5

128

(83-189)

49
2*

(95-1349)

49
2*

(95-1349)

77

(37-142)

% 7
.

4

148

(40-378)

%9
.

205*

(89-406)

7

&gt;6.2

113

(45-233)

% 4
.

47

(10-136)

% 4
.

208

(69-497)

&gt;/2.4

42

(1-233)

4

182

(49-461)

%*
.

83

(18-254)

(17-100)

3

48

(10-139)

V.

44

(9-129)

(36-334)

2

/1.4

143

(17-508)

2

118

(5-435)

(11-102)

'41
/.

24

(-1-137)

3

51

(10-148)

250

(52-731)

% 7
.

429*

(90-1271)

200

(5-1071)

46*

129

*/10

Soft and Connective
Tissue
(171)

3

Bone
(170)

2

/K4

143

(18-531)

Urinary Organs
(188-189)

2

/5.6

36

(4-129)

/15.6

103

(59-166)

16

/
'21.2

(951 CD

10,
'13.0

Brain i Nervous System
(191-192)

All Other Halfgnancle.

25

sPNR

(911
3-4)

4

/1.2

29,
'22.2

NONVETERANS

79

Oral Cavity
(140-149)

&gt;3.1

°&gt;E

ERA VETERANS

40*

•polaaon p value*.05

11,
'14.0

/2.7

/2.2

/6.3

'05
'.

V,

'77
'.

0*

78

/1.7
/5.9

°OS
'.

V
.
2

-

(29-170)

'.
27

' ,
V

0

-

125

(3-663)

74

(10-305)

127

360-231)

�TABLE 10
CANCER MORTALITY FOR VIETNAM VETERANS

In-Country Veterans vs. Era Veterans
West Virginia, 1968-83

OBSERVED,
'EXPECTED
Respiratory System
(160-163)

(95Z CI)

93

(63-134)

NS

110

(55-197)

NS

7

280

(113-577)

0.014

5

833

(271-1945)

0.0004

222

(62-579)

NS

500

(103-1461)

0.023

(12-118)

0.066

-

-

29,
'31.0

n
Digestive Organs and Peritoneum
(150-159)
Lymphoma
(200-203. 208-209)

to

Hodgklns Disease
(201)

POISSON p VALUE
(Fisher's exact)

sPMR

/
'10.0
'2.5

'.
06

U)

Male Genital Organs
(185-187)

*!.
/.

Cancer of the Testls
(186)

V
.

Malignant Melanoma of the Skin
(172)

VT

46

Soft and Connective Tissue
(171)

\

oo

Leukerolas
(204-207)

3

Oral Cavity
(140-149)

2
/

All Others

/1.9

2.4

8

/
'12.7

158

(33-461)

NS

83

(10-301)

NS

63

(27-124)

NS

�the skin also accounted for a significantly greater-than-expected
proportion

of

cancer

deaths

among

all

veterans,

but

the

contribution of in-country veterans to this excess was trivial in
comparison with that of era veterans.

Deaths from leukemias and

malignant neoplasms of the nervous system each occurred less
frequently than expected among both veteran groups.
tissue tumors,

For soft

a significant difference between observed and

expected deaths was not found for all veterans combined.

These

tumors occurred only among in-country veterans and not among era
veterans,

however.

When

in-country

veterans

alone

were

contrasted with nonveterans, they had a significantly elevated
standardized proportionate cancer mortality .ratio for soft tissue
tumors.

The

contrast between

in-country and era veteran cancer

deaths shows the difference in the observed (3) and expected (0)
soft

tissue

tumors

for

in-country

veterans

(Table

10).

In-country veterans also have significantly elevated standardized
proportionate
contrasted

cancer

with

era

mortality

ratios

veterans.

The

for

lymphoma

difference

is

when
more

specifically attributable to Hodgkin's disease, for which there
were five deaths in this group, compared with an expected 0.6.
Finally, there was a statistically significant excess in the sPMR
from testicular cancer among the in-country veterans.
Discussion
The present study demonstrates that the mortality experience

24

�among persons who served in the military during the Vietnam
Conflict differs substantially from that of nonveterans.

It also

suggests that there may be important differences between the
veterans who served in Vietnam and those who did not with respect
to their cancer mortality experience.

Differences in the mortality experience between veteran and
nonveteran groups are influenced by a selection bias initiated at
the time of induction to the military service.
assure

that healthy

individuals

In order to

serve in the military,

the

preinduction screening process excludes persons with preexisting
conditions

such

as

diabetes and

allergies, asthma, hypertension,

have

substantially

metabolic

disorders,

rheumatic heart disease, and

clinically apparent malignancies.
veterans

other

lower

Because of this selection,
mortality

rates

than the

nonveteran population for many years following their induction.
This is known as the "healthy veteran effect."

In the present

study, this selection bias is the most plausible hypothesis to
account for the significant sPMR deficits observed among veterans
for mortality from allergic, metabolic, and endocrine disorders,
all

other causes, rheumatic heart disease, and hypertension.

Moreover, it may also have contributed to the less prominently
diminished sPMRs among veterans for cardiovascular,

digestive,

and respiratory diseases.

While

real

differences

in the mortality

rates

between

veteran and nonveteran groups for selected causes are reflected

25

�in

the

sPMRs,

proportionate

they

also

mortality

complicate the
for

other

interpretation

causes.

Since

of
the

proportionate contribution from all separate causes must sum to
100, the proportionate contributions

among "healthy" veterans

from causes that are not screened by the induction process become
artificially inflated relative to their contribution among the
"unhealthy" population.

Injury, the leading cause of death for both veterans and
nonveterans, played a significantly greater role among veterans,
accounting for 58% of their deaths as opposed to an expected 51%.
Since the study did not adjust for discrepancies in the health
status between veterans and nonveterans, part of the excess in
injury among veterans must be due to the relative absence of
deaths from conditions that would exclude persons from military
service.

While an excess of these deaths araong nonveterans

reciprocally

diminishes

the

proportion

of

their mortality

attributable to injury, there may be a real difference in life
style

and

the

propensity

veterans and nonveterans.

for

risk-taking

behavior

between

An evaluation of injury mortality

alone, performed to eliminate distortion from the healthy veteran
bias, showed only that homicide was significantly less important
as

a

cause

nonveterans.

of

injury

death

among

veterans

than

On the other hand, while not significant,

among
the

difference between the observed and expected number of veteran
deaths from motor-vehicle accidents would suggest that this is at
least one area where veterans may be at a substantially greater

26

�risk

of death than nonveterans.

This

issue, however,

and

previous assertions that veterans are at greater risk of death
from suicide cannot be adequately addressed by this analysis in
the absence of more complete data on the populations at risk.

While

malignancies

as

a

group

accounted

for

similar

proportions of veteran and nonveteran deaths, deaths from tumors
of the respiratory system were a significantly more prominent
cause of cancer death among veterans than among nonveterans.
probable

explanation

for

this

finding

would

be

A

a greater

prevalence of smoking among military as compared with nonmilitary
personnel, but this cannot be substantiated from the limited
information available on death certificates.

In general, the pattern of death among in-country veterans
from all causes, and within the subcategories of "accidents,
poisoning, and violence" and "cardiovascular diseases," were
similar to those observed for all veterans combined, and there
were no substantial differences in the mortality patterns between
in-country and era veterans for these categories.

Among cancer

deaths, however, there was strong statistical evidence to suggest
that .Hodgkin's disease, cancer of the testis, and soft tissue
tumors were more common among veterans who served in Vietnam than
among veterans who did not.
cautiously,

however,

These findings must be interpreted

since

the

expected

proportions

of

site-specific cancer deaths for in-country veterans were derived
from a relatively small number (74) of cancer deaths among era
27

�veterans and would therefore be subject to considerably large
random fluctuations.

At the same time, the difference between

the observed and expected numbers of soft tissue tumors among
in-country

veterans

supports similar

proportionate mortality

findings

study conducted

in a previous

by the Massachusetts

Department of Public Health. Neither the Wisconsin study nor the
New York study found significant differences between in-country
and era veterans in the occurrence

of soft tissue

sarcomas.

These studies, however, and the present one are limited by the
absence of precise exposure data, unknown sizes of the candidate
populations at risk, and insufficient follow-up time to account
for

latency

from

in-country veterans.

exposures

that might have been unique to

Also, by including deaths from as early as

1968, the present study may have been biased against finding an
excess occurrence of cancers with long latency periods.

This study only suggests the possibility that the risk of
death

from

soft

tissue

sarcomas,

Hodgkin's

disease,

and

testicular cancer are elevated among veterans who served in
Vietnam.

We are currently awaiting the records of the in-country

veterans who died from these tumors in order to speculate about
possible exposure histories and to generate hypotheses that may
have some biologic plausibility.

To take advantage of latency

periods, cancer-specific proportionate mortality studies could be
repeated

in several years.

Also, by excluding

deaths

that

occurred in the late-Vietnam and early post-Vietnam period, and
by improving ascertainment of exposure histories, studies can

28

�focus more sharply on etiologic hypotheses relating to possible
exposures in Vietnam.

On the other hand, since proportionate

mortality studies are more useful to explore than to confirm
hypotheses, it is recommended that more precise risk-assessment
studies of Vietnam cohorts be performed using national data to
further test the hypothesis that Hodgkin's disease, testicular
malignancies, and soft tissue tumors may be important causes of
cancer mortality among veterans who served in Vietnam.

29

�BIBLIOGRAPHY

Dienstfrey, Stephen J., and James J. Bryne.
Veterans in the
United States; A Statistical Portrait from the 1980" Gensus.
Washington, D.C.: Veterans Administration, 1985.
"Final Toll for U.S. in Indb-China."
(Sept. 24, 1973): 73.

U.S. News £ World Report

Kogan, Michael D., and Clapp, Richard W. Mortality among Vietnam
Veterans in Mas sachuse t1s, 1972-1983. Boston: Massachusetts
Department of Public Health, 1985.
Lawrence, Charles E. et al. "Mortality Patterns of New York
State Vietnam Veterans." American Journal of Public Health
75 (March 1985): 277-79.
'
Shottenfeld, David, and Joseph F. Fraumeni, Jr., Cancer
Epidemiology and Prevention.
Philadelphia: W.B. Saunders
Company, 1982.

30

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24354">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24355">
              <text>1868</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24358">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24353">
                <text>Shepard, Barclay M.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24356">
                <text>February 4 1986</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24357">
                <text>Critique of West Virginia Mortality Study</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24359">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24360">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24361">
                <text>study criticism</text>
              </elementText>
              <elementText elementTextId="24362">
                <text>study protocol</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3291" public="1" featured="0">
    <fileContainer>
      <file fileId="1701">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/beed241e785b94fc9bd023e5a06109dc.pdf</src>
        <authentication>3523666342d3d5bb26133cf78991dd4d</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63650">
                    <text>ItomlDNunber

°1867

Author

Anderson, Ron J.

Corporate Author

Texas Veterans Agent Orange Assistance Program, Tex

Report/Article Title Annual Report

Journal/Book Title
Year

1985

Month/Day

Au ust

Color

n

Number of Images

91

9

Descrlpton Notes

Wednesday, July 11, 2001

Page 1868 of 1870

�TEXAS VETERANS AGENT ORANGE
ASSISTANCE PROGRAM

TEXAS DEPARTMENT OF HEALTH
AUSTIN, TEXAS

A N N U A L
August

Ron J. Anderson, M.D.
Chairman
Texas Board of Health

R E P O R T
1985

Robert Bernstein, M.D., F.A.C.P.
Commissioner of Health
Texas Department of Health

�1036-1986

Texas Department of Health
Robert Bernstein, M.D., F.A.C.P.
Commissioner
Robert A. Maclean, M.D.
Deputy Commissioner
Professional Services
Hermas L. Miller
Deputy Commissioner
Management and Administration

1100 West 49th Street
Austin, Texas 78756-3199
(512)458-7111

August 23, 1985

Members of the Board
Ron J. Anderson, M.D., Chairman
Laurance N. Mickey, M.D., F.A.A.P., ViceChairman
Bob D. Glaze, D.C., Secretary
Johnnie M. Benson, F.A.C.N.H.A.
Sister Bernard Marie Borgmeyer, R.N., F.A.CH.A.
Frank Bryant, Jr., M.D., F.A.A.F.P.
Joaquin C. Cigarroa, Jr., M.O.
Barry D. Cunningham, D.O.S.
Ben M. Durr, M.H.A.
Dennis K. Mclntosh, O.V.M.
Robert D. Moreton, M.D., F.A.C.R.
Joe N. Pyle, P.E.
Arthur L. Raines, M.D.
Isadore Roosth
Barbara T. Slover, R.Ph.
Max M. Stettner, D.O.
Edward H. Zunker, O.D.

The Honorable Mark W. White
Governor of Texas
State Capitol
Austin, Texas 78711
Dear Governor White:
Enclosed is the Annual Report of the T e x a s V e t e r a n s Agent Orange A s s i s t a n c e
Program.
Pursuant to Section 3 of Article U447w, VTCS, this report is being
distributed to the Legislature, V e t e r a n s Administration, T e x a s V e t e r a n s
Affairs Commission, veterans' organizations, and interested individuals.
It
reflects the work of the Texas Department of Health Agent Orange Program to
date.
The report contains research findings on the effects of exposure to chemical
defoliants or herbicides or other causative agents, including Agent Orange,
and statistical information compiled from reports submitted by physicans,
hospitals, and veterans.
I hope you find this report both useful and informative.
Sincerely,

Commissioner of Health
Enclosure

�18J6-I986

Texas Department of Health
Robert Bernstein, M.D., F.A.C.P.
Commissioner
Robert A. Maclean, M.D.
Deputy Commissioner
Professional Services

1100 West 49th Street
Austin, Texas 78756-3199
(512)458-7111

Members of the Board
Ron \. Anderson, M.D., Chairman
Laurance N. Nickey, M.D., F.A.A.P., Vice-Chairman

Bob D. Glaze, D.C., Secretary
Johnnie M. Benson, F.A.C.N.H.A.

Sister Bernard Marie Borgmeyer, R.N., F.A.C.H.A.

Hermas L. Miller
Deputy Commissioner
Management and Administration

Frank Bryant, Jr., M.D., F.A.A.F.P.
Joaquin C. Cigarroa, Jr., M.D.
Barry D. Cunningham, O.D.S.
Ben M. Durr, M.H.A.
Dennis K. Mclntosh, D.V.M.
Robert D. Moreton, M.O., F.A.C.R.
Joe N. Pyle, P.E.
Arthur L. Raines, M.O.

Isadore Roosth
PREFACE

Barbara T. Slover, R.Ph.
Max M. Stettner, D.O.
Edward H. Zunker, O.D.

From 1962 to 1971 during the Vietnam conflict, 152,000 Texans serving in the
m i l i t a r y forces were exposed to v a r y i n g amounts of herbicides used to kill or
d e f o l i a t e plants. Since t h a t t i m e v e t e r a n s have a t t r i b u t e d a n u m b e r of
illnesses to Agent Orange which c o n t a i n e d a c o n t a m i n a t i n g chemical (TCCD);
known to be highly toxic to animals, yet not well understood in its effects on
humans.
The T e x a s V e t e r a n s A g e n t O r a n g e A s s i s t a n c e P r o g r a m set into m o t i o n a
cooperative program between the Texas Department of Health and the U n i v e r s i t y
of Texas System to assist these veterans in establishing claims through pilot
clinical studies designed to establish the cause and effect relationship of
exposed v e t e r a n s and s u b s e q u e n t h e a l t h p r o b l e m s . The U n i v e r s i t y of Texas
Agent Orange Project has selected 248 for study from whom 927 specimens have
been a n a l y s e d in the v a r i o u s protocols. To date no f i n a l r e s u l t s of the
s t u d i e s have been released since i n t e r p r e t a t i o n of the i n d i v i d u a l s t u d y
reports requires correlation with controls and the results of the project as a
whole.
Activities at the federal level have increased, as evidenced by the activities
of the Agent Orange Epidemiological Study at the Centers for Disease Control,
the VA Chloracne Task force and completion of the morbidity study phase of the
Air Force R a n c h H a n d Study, and the r e l e a s e of the B i r t h D e f e c t S t u d y in
Atlanta by the Centers for Disease Control.

Robert Bernstein
Commissioner of Health

�TABLE OF CONTENTS
TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH
.

ANNUAL REPORT
August
1985

Status Report and Data Sheet, July 31, 1985
Summary of Pilot Studies Protocols (FY 84-85 studies)
Report on "Development and Preliminary Results of Pilot Clinical
Studies, March 26, 1984 (FY 82, 83, 84 studies)
Analysis of Major Demographic Statistics, May 3, 1985 (FY 82, 83, 84 studies)
Herbicide Status Report by Department of the Army
Veterans Health Survey—Report on Agent Orange studies conducted by the
Centers for Disease Control, July 1985

�Texas Department of Health

1836-1986

Robert Bernstein, M.D., F.A.C.P.
Commissioner

1100 West 49th Street
Austin, Texas 78756
(512) 458-Trtr 7251

Robert A. Mac Lean, M.D.
Deputy Commissioner
Professional Services
Hermas L. Miller
Deputy Commissioner
Management and Administration

DATE:
TO:
FROM:

RE:

August 5, 1985
INTERESTED INDIVIDUALS AND ORGANIZATIONS
HARRIET FRANSON, Program Manager
Agent Orange Program
TEXAS AGENT ORANGE PROGRAM STATUS REPORT FOR PERIOD
ENDING JULY 31, 1985

Enclosed is the Texas Agent Orange Program Status Report
for period ending July 31, 1985. This report is cumulative
and reflects program activities since the inception of the
program on September 1, 1981.
As you may be aware, the Texas Legislature this year did
not approve continued funding for the Agent Orange Program.
Therefore, funding will expire on August 31, 1985 with resulting curtailment of program activities. Program data
analyses are anticipated and study results published.
It is our understanding that a nationwide search is
underway for individuals to assist in the distribution plan
for the $180 million settlement fund approved by the New
York State Court in the class action suit against the seven
chemical companies. Appointments will be made to an Advisory
Group for the payment program, an Executive Director, and a
Board of Directors for the Foundation. Names with resumes
can be forwarded to Kenneth R. Feinberg, Suite 1150, 1575 Eye
Street, N.W., Washington, D.C. 20005. The resumes should
reflect relevant background and experience (see attached
request).

�^•-KAYE, SCHOLER, FIERMAN, HAYS &amp; HANDLER
1575 EYE STREET, N.W.
NEW YORK OFFICE
4«« PARK AVENUE
NEW YORK. N.Y. IOOJI
(til) 4 O 7 - 8 O O O

FLORIDA OFFICE
125 WORTH AVCNUC
PALM BEACH. FLA. J34*

WASHINGTON, D.C. 2 O O O 5

CA1LE ADDRESSES
KAYEMACLCR

WASHINGTON

KAYEMACLER NCW YORK

(2O2) 783-I2OO

TELEX HUMIERS
WASHINGTON

a»'*S8

NEW YORK DOMESTIC 128911
NEW YORK INTX
234860
HOMO KONG
62818
•AY NX

(3O5) 8 J J - 5 I B I
MONO KONO OFFICt
CDINCUROH TOweft
«OYH FLOOR
IB OUCCN'S ROAO CENTRl
HOMO KONO

For Release:

June 7, 1985

PRESS RELEASE

Kenneth R. Feinberg, the Special Master reappointed by
the Court in the Agent Orange litigation to help develop a
distribution plan for the Settlement Fund, announced today that a
nationwide search for individuals to assist in implementing the
distribution plan approved by the Court would be undertaken as
the first step in the distribution of the $180 million Fund.
The settlement is between the seven defendant chemical
companies and the plaintiff class, which consists of those
veterans who served in or near Vietnam from 1961 to 1972, who
were exposed to Agent Orange and have injuries allegedly related
to that exposure. The class also includes spouses and children
of the veterans. Over 240,000 claims have been filed with the
Court by class members seeking to participate in the settlement
distribution.
The Court order requires a $150 million cash compensation program for veterans exposed to Agent Orange who are longterm totally disabled or to the families of those who have died,
and a $45 million foundation to provide grants for services to
the class, including those children of the class members
suffering from birth defects.
The Court ordered that members of the class play a
significant role in the governance of all aspects of the
distribution plan. To that end, the Court ordered the Special
Master to take appropriate steps leading to the recommendation of
names to the Court for appointment to an Advisory Group for the
payment program and a Board of Directors of the foundation. Both
the Advisory Group and the Board of Directors are to be comprised
primarily, but not exclusively, of class members.

�KAYE,SCHOLER. FIERMAN, HAYS &amp; HANDLER
- 2 -

June 7, 1985

The Special Master announced today that he is soliciting names from all interested groups or individuals who would be
willing to serve either as an Advisory Group member or on the
Board of Directors. The names will then be submitted to the
Court for final review and appointment. All Advisors and Board
members will serve without compensation, other than reimbursement
of reasonable travel and other per diem expenses. The Advisory
Group and the Board will be as representative of the class as
possible, cutting across economic, social, racial, gender,
geographic and occupational lines. Persons with management,
investment, budget and foundation experience would be particularly desirable as members. Resumes showing relevant background
and experience should be included with any suggestions of persons
for consideration.
In another aspect of the outreach effort, Mr. Peinberg
announced that a nationwide search would begin for an experienced
professional to serve as Executive Director of the foundation.
The Executive Director would administer the day-to-day operations
of the foundation and would be compensated from the Fund. The
Court will initially appoint the Executive Director, who will
then serve at the pleasure of the Board of Directors. All
inquiries or suggestions for the Advisory Group, the Board of
Directors or the Executive Director should be directed, in
writing with supporting data, to Kenneth R. Peinberg, Suite 1150,
1575 Eye Street, N.W., Washington, DC 20005.
The final outreach effort announced by the Special
Master*is the solicitation of insurance companies or other
parties interested in bidding on contracts to implement the $150
million payment program. Contracts .for claims processing,
investment consulting, claims adjudication, and auditing will be
finalized by the Court within the next few months. Contractors
interested in receiving bid specifications or in obtaining
information concerning the payment program should contact, in
writing, Lawrence B. Novey, consultant to the Special Master, who
can be reached at the same address as Mr. Feinberg.

�IfcAAbUtPAKIMtlN I Uh HtALI H
AUSTIN
THROUGH: CHIEF, BUREAU OF EPIDEMIOLOGY
THROUGH: ASSOCIATE COMMISSIONER FOR
PREVENTABLE DISEASES

FROM

TEXAS
INTER-OFFICE THROUGH: DEPUTY COMMISSIONER FOR
PROFESSIONAL SERVICES

GEORGE R. ANDERSON, M.D.
OCCUPATIONAL MEDICINE AND TOXICOLOGY/
AGENT ORANGE PROGRAM

Robert Bernstein, M.D., F.A.C.P.
Commissioner of Health

TO

Page 1

SUBJECT TEXAS VETERANS AGENT_ORANGE ASSISTANCE PROGRAM
STATUS REPORT FOR 2 MONTH PERIOD ENDING JULY 31, 1985

REFERRALS
No. of veterans referred into the program
this reporting period
(No.-of deceased veterans—1: TOTAL 22)

TOTAL
TO DATE
(6/1/85-7/31/85)
1,962
29

Military and medical records have been requested
for all referred veterans:
Medical records reviewed to date:
(Include VA and civilian records—
105 reviewed this reporting period)

2,073

Military records reviewed to date:
(include combat history, DD211,
and/or medical—205 reviewed this
reporting period)

1,795

No. of veterans referred into program
and not in compliance with residency
requirements—ineligible

18

CONTACTS
Direct contacts from veterans this reporting
period

1,352

39

By phone—31 (total to date: 981)
By letter—6 (total to date: 326)
By visit—2 (total to date: 51)
Contact from News Media:
Channel 7 TV (Austin)
Bryan Eagle (Bryan)

114

Boston Globe

Contact from or with other states/countries:
Massachusetts (1)
Orgeon (1)
Washington (1)

287

West Virginia (1)
Wisconsin (3)

StCNB&gt;
DATi _

-CONTINUEDAugust 2, 1985
FORM NO. AG-2-A

�TEXAS DEPARTMENI Oh HEALIH
AUSTIN

TEXAS

INTER-OFFICE

FROM

George R. Anderson, M.D.

TO

Robert Bernstein, M.D., F.A.C.P.
Pa

8e 2

TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
STATUS REPORT FOR 2 MONTH PERIOD ENDING JULY 31, 1983

Continuing contact with Legislative offices (State Representatives Larry
Don Shaw 4 Jerry Yost) Office of the Governor, Office of the Attorney
General, State Auditor, Congressman J.J. Pickle, Texas Department of
Corrections, Texas Veterans Affairs Commission, Texas Land Commission,
U n i v e r s i t y of Texas System, V e t e r a n ' s A d m i n i s t r a t i o n , Vet Centers,
Military Personnel Records Center, County Veteran Services Officers,
Local Health D e p a r t m e n t s / C l i n i c s , Other State Agent Orange offices,
counseling services/physicians/hospitals, veterans' organizations,
Dow Chemical Company, law firms, and students
9 f o l l o w u p letters were sent this reporting period to veterans who
p r e v i o u s l y inquired about the program but not yet participating.
(TOTAL TO DATE: 684)
Made/mailed 112 followup phone calls/letters to check on military/medical
records requested but not yet received. (TOTAL TO DATE: 1,851)
One feedback letter was sent this reporting period to v e t e r a n in our
program to apprise him of the status of his case ( m i l i t a r y / m e d i c a l
records received, pending, etc.). (TOTAL TO DATE: 540)
10 veterans in the program requested or were placed on inactive status
this r e p o r t i n g period, p r i m a r i l y due to i n d i v i d u a l s m o v i n g w i t h no
forwarding addressess available (TOTAL TO DATE: 127) Inactive veterans
resuming participation in the program. (TOTAL TO DATE: 6)
In response to our m a i l i n g to Texas v e t e r a n s on the VA Agent Orange
Registry received 0 completed questionnaire (TOTAL TO DATE: 1,511) of
which 0 asked to be registered with the Texas Agent Orange Program
(TOTAL TO DATE: 1,217).
5 veterans requested and were sent copies of case file records, in
preparation for filing a claim: (TOTAL TO DATE: 27)

SIGNED
DATE

-CONTINUEDAugust 2, 1985
FORM NO. AG-2-A

�UtrAKIMtIN I Oh HtALI M
AUSTIN

TEXAS
INTER-OFFICE

HIOM

George R. Anderson, JJ.JK

TO

Robert Bernstein, M.D., F.A.C.P.

SUBJECT TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
STATUS REPORT FOR 2 MONTH PERIOD ENDING JULY"31,1985

Page 3

PROTOCOL STUDIES
The second phase of the clinical studies has begun, with the following
studies conducted this fiscal year:
Cytogenetics at UTS CANCER CENTER, Houston, by Dr. Hsu
Bleomycin Test at UTS, CANCER CENTER, Houston, by Dr. Hsu
Immune Profile at UT HEALTH SCIENCE CENTER, Houston, by
Dr. Kerman
Uroporphyrins at UT HEALTH SCIENCE CENTER, Houston, by
Dr. Kerman
Aryl Hydrocarbon Hydroxylase Induction at UT MEDICAL BRANCH,
Galveston, by Dr. Ward
The protocols were published in summary and complete format.
Questionnaires received from selected veterans and proposed controls
continue to be reviewed to establish proper matching of veterans with
controls.
17

volunteer control questionnaires for the Agent Orange clinical
studies were received. (TOTAL TO DATE: 148, of which 1 is TDH
employee.

Contacts made with selected veterans and controls to make appointments
for the collection of specimens.
Contacts made with the clinics/laboratories where specimens
collected/delivered.

are to be

53 appointments arranged for the collection of specimens (TOTAL TO DATE:
304). Total specimens collected for the 2nd/3rd collection of
specimens for the Sperm Study (TOTAL TO DATE: 232). No reminder
letters were sent re. collection of specimens (TOTAL TO DATE: 31).
Collection of specimens for the Sperm Study is now completed.

SIGNED
DATE

-CONTINUEDAugust 2. 1985
FORM NO. AG-2-A

�ItAAS LJtrAKIMtlNI UMItALIH
AUSTIN

TEXAS

INTER-OFFICE

George R. Anderson. M.D.

reOM

SUBJECT

TO

Robert Bernstein, M.D., F.A.C.P.
Pa

8e 4

TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
STATUS REPORT FOR 2 MONTH PERIOD ENDING~TULY 31, 1985

111 letters were mailed to veterans concerning their participation in the
clinical studies (TOTAL TO DATE: 159) and 55 to proposed controls
(TOTAL TO DATE: 226).
Number of specimens collected and shipped to UTS:
(6/1/85-7/31/85)

TOTAL TO DATE
"

CYTOGENETICS STUDY

23

238

IMMUNE SUPPRESSION STUDY
UROPORPHYRIN
AHH (Enzymes)
SPERM STUDY
SPECIMEN N O . 2
SPECIMEN N O . 3

23
23
13
0

237
72
58
126

FAT TISSUE SPECIMEN

0
0

9
9

0

9
5

2

Two v e t e r a n / c o n t r o l s requested and were given results of i n d i v i d u a l
study specimens analyses. (TOTAL TO DATE: 156)
SELECTION PROCESS FOR REFERRAL TO THE UTS SYSTEM

Review of cases is an ongoing process for eventual referral to the Agent
Orange Selection Committee—700 were reviewed this period for referral
to the committee.
To d a t e the Selection C o m m i t t e e has r e v i e w e d 1,103 cases (117 being
r e v i e w e d more than once), of w h i c h 2U8 have been selected for the
clinical studies (of which 126 are for inclusion in the second study
phase). 95 v e t e r a n s have also been selected as possible low-risk
controls.
BROCHURES/POSTERS

To date a p p r o x i m a t e l y 35,500 brochures and 7,726 posters have been
mailed. In addition to individual requests, brochures and posters have
been p r o v i d e d to v e t e r a n s ' o r g a n i z a t i o n s , c o u n t y service o f f i c e r s ,
clinics/hospitals, and other states.

SIGNED
DATE

-CONTINUEDAugust 2. 1985
FORM NO A&lt;-,-•&gt;. A

�UtrAK I /VltIN I Ur MtALI M
AUSTIN
TEXAS

INTER-OFFICE

FROM

George R. Anderson^J1.JK

____

TO

Robert Bernstein, M.D., F.A.C.P.

SUBJtCT _ J^MO^l^liy^AGjra^
____
STATUS REPORT FOR 2 MONTH PERIOD ENDING JULY 31,

Page 5

MAINTAINING STATISTICAL INFORMATION

I n f o r m a t i o n is compiled each m o n t h from case files concerning the
following medical conditions reported and substantiated by medical
records. This information is provided to the Agent Orange Selection
Committee and becomes part of our data information.
Such information
will be compiled for other medical conditions as the need arises.
Cancer in Veterans Under Age 36
Cancer in Veterans Over Age 36
Tingling/Numbness in Extremities
Post Traumatic Stress Disorder (PTSD)

Current Rashes
Children with Leg Deformities
Miscarriages/Stillbirths
Schizophrenia

Diagnoses continue to be coded w i t h I n t e r n a t i o n a l Code for c o m p u t e r
entry.
AGENT ORANGE ADVISORY COMMITEE

No meetings were held during this reporting period.
SPECIAL ACTIVITIES
Continue review of available literature for research on Agent Orange and
related topics.
Continue to purchase publications for reference library.
E x t r a c t i o n of statistical data from case files concerning specific
military data and medical conditions, etc.
Utilize word processor for the storage/retrieval of data and for
multiple reproduction of originally-typed letters when form letters
are not warranted.
In-house t r a i n i n g on use of computer equipment for R i c h a r d Smith and
Harriet Franson (d-Base and Software Users Group)
continues.

SIGNED
DATE

-CONTINUEDAugust 2. 1985
FORM NO. AG-2-A

�i CA/\a i&gt;cr/m i IVICIN i isrncs\Lin
AUSTIN

TEXAS

INTER-OFFICE

FROM

George R. Anderson. M.D. _________ TO Robert Bernstein, M.D. , F.A.C.P.

SUBJECT TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
STATUS REPORT FOR 2 MONTH PERIOD ENDING JULY 31, 1985

_
Pa

8e

_____

6

Received "Wisconsin Vietnam Veteran Mortality Study" for review
Ongoing communication with other state Agent Orange Commissions/Programs
as their representative on the VA Advisory Committee on Health-Related
Effects of Herbicides.
One summer employee is assisting with coding and data entry for the
Epidemiological Study. A senior citizen volunteer is also assisting
the program on a limited basis.
MAJOR ACCOMPLISHMENTS

1.

Number of veterans in the program has increased to 1,962 — an
increase of 1,565 since the beginning of FY 84.

2.

To date 1,243 cases have been reviewed by the Subject Selection
Committee, of which over 248 have been selected for referral to
the U n i v e r s i t y of Texas clinical studies. A total of 906
blood/sperm specimens have been collected and shipped to the
U n i v e r s i t y of Texas System laboratories and one fat tissue
shipped for analysis in the V.A./E.P.A. Study of Dioxin Levels in
Human Adipose Tissue.

MEETINGS ATTENDED

None attended or scheduled.

Attachment — Data Sheet
cc:

Agent Orange Selection Committee
Agent Orange Advisory Committee
Veterans' Organizations and other
•
interested individuals

SIGNED
DATE

August 2, 1985
FORM NO. AG-2-A

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH

DATA SHEET
(as of July 31, 1985)
NOTE: Variation in totals is due to receipt
of only questionnaires to date and/or
lack of medical/military information.
\
In some instances, the initial complaint
and those listed under "Other Medical
Problems" were supplied by the veteran
rather than a physician.
BY (When entering
AGE program)
29
30

2
7

32
33
34
35
36
37
38
39
40

II
74
117
134
169
120
97
72
56

BY SEX
MALE

BY SERVICE
Army

FEMALE

4

791

Air Force

1958

118

Marines

193

BY RACE
WHITE
BLACK

244

HISPANIC

NaVy

733

277

41

31

42
43
44
45
46
47
48
49
50

36
20
30
25
17
17
16
20
20

51
52

23
20

NO. OF DECEASED VETERANS
REPORTED INTO THE PROGRAM

53
54
55
56
57
58
5 9
60
61

20
15
9
11
7
9
8
3
1

'

OTHER

9

NO. REPORTED INTO THE
PROGRAM AND DETERMINED
NOT TO BE ELIGIBLE
'
'
'

62

5

1
1
2
3
1
1
1

PROGRAM AND RESIDING
IN ANOTHER STATE

18

NO. REPORTED INTO THE

63
64
65
66
68
70
72

22

I

26

5?

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)
BYjCOUNTY
Anderson
5
Andrews
1
Angelina
1
Aransas
3
Bandera
3
Bastrop
14
Bee
3
Bell
50
Bexar
101
Bosque
3
Bowie
9
Brazoria
12
Brazos
8
Brooks
1
Brown
1
Burleson
3
Burnet
5
Calhoun
2
Callahan
2
Cameron
13
Cass
5
Castro
2
Chambers
1
Cherokee
5
Collin
7
Collingworth 2
Comal
3
Concho
1
Cooke
4
Coryell

Crockett
Dallas
Deaf Smith
Denton
Dewitt
Dimmit
Donley
Duval
Ector
Ellis
El Paso
Falls
Far-.nin
Fayette
Fisher
Fort Bend
Gaines
Galveston

10

1
104
1
6
1
1
2
1
6
3
109
3
2
2
1
7
2
21

Goliad
Grayson
Gregg
Guadalupe
Hale
Hamilton
Hardeman
Hardin
Harris
Harrison
Haskell
Hays
Henderson
Hidalgo
Hill
Hockley
Hood
Hopkins
Howard
Hunt
Hutchinson
Jackson
Jasper
Jefferson
Jim Wells
Johnson
Karnes
Kaufman
Kendall
Kerr
Kimble
Kleberg
Lamar
Lamb
Lampasas
Lavaca
Leon
Liberty
Llano
Lubbock
Lynn
Marion
Matagorda
Maverick
McCullock
McLennan
Medina
Midland

2
11
3
2
1
1
1
2
118
3
1
2
2
26
2
1
2
2
4
6
1
1
1
15
5
5
1
7
2
5
1
3
2
1
3
3
1
6
2
12
1
2
2
1
1
9
2
6

Milam
Montague
Montgomery
Moore
Morris
Nacogdoches
Navarro
Newton
Nueces
Ochiltree
Orange
Palo Pinto
Parker
Parmer
Potter
Randall
Reeves
Richmond
Robertson
Rusk
San Jacinto
San Patricio
Shelby
Smith
Starr
Tarrant
Taylor
Tom Green
Travis
Tyler
Upshur
Uvalde
Val Verde
Van Zandt
Victoria
Walker
Ward
Webb
Wharton
Wichita
Wilbarger
Willacy
Williamson
Wilson
Winkler
Wise
Wood
Young
Zapata

2
1
8
1
1
1
2
'I
53
1
9
1
3
1
10
5
1
1
1
3
2
12
1
6
1
71
3
5
82
1
6
3
6
4
7
38
4
6
1
11
1
1
14
2
1
5
2
1
1

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)

DUTY PERFORMED

DUTY PERFORMED

Accounting Specialist
Administrative Specialist
Administrative &amp; Supply
ADP Officer
Aerial Photo Interpretator
Airborne Infantry
Aircraft Technician
Air Crew
Air Frame Repair Specialist
Air Mobile
Air policeman
Air Operation Supervisor/Spec.
Air Traffic Control
Ammunition
Ammo Cargo Handler
Armor Unit
Artillery
Base Maintenance
Battalion Clerk
Boatswain Mate
Calibration Team Technician
Career Counselor
Cargo Handler
Carpenter
Chaplain
Chemical Operations
Combat Cook
Combat Engineer
Combat Military Police
Combat News Correspondent
Communications Specialist
Construction
Controller
Convoy Escort
Corpsman
Counterinsurgency Specialist
Courier
Coxswain
Crane Operator
Crew Chief
Deck Force
Demolition Expert
Dining Facility Manager
Engineering
Equipment Repair
Explosives
Finance
Firefighter

Food Service
Forward Air Control
Freight Handler
Grave Registration
Ground Crew
Guard
Gunfire Spotter

1
10
5
1
2
3
42
71
1
2
1
1
2
6
2
12
62
1
2
5
1
2
6
3
3
11
20
22
1
1
30
10
1
4
7
1
1
1
1
5
2
3
2
15
4
2
3
2

Gunner's Mate
Harbor Defense
Infantry
Inspector General
Intelligence
Interrogator
Investigator, Narcotic
Journalist
Lineman
Machinist
Maintenance

Mechanic
Medic
Medical Advisor
Medical Clerk
Medical Corps
Mess Steward
Meteorologist
Military Advisor
Military Police

Musician
NCO
Neuropsy Specialist
Nurse
Operator, Heavy Equipment
Paratrooper
Personnel Officer
Petroleum Storage Supply
Photographer
Pilot
Platoon Leader
Plumber
Polelinetnan

Powerlineman
Printer Guard
Psychological Operations
Radar Operator
Radio Operator
Radio Repair (field)
Recon. Infantry
Recon. Forward Observer
River Rat

3

6
2
1
4
6
1
1
7
1
456
1
18
2
1
1
4
1
20
32
24
4
1
2
1
1

2
17
1
1
1
3
11
3
4
4
2
16
6
3
1
2
1
3
4
9
3
5
11
3

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS.DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DUTY PERFORMED

Sea Bees
Security Guard
Sergeant/Clerk
Ship Crew
Ship Engine Man
Signal Corps
Small Missile Repairman
Social Worker Physical Specialist
Special Forces Advisory Group
Supply Sergeant
Supply Specialist
Support Battalion
Switchboard Operator
Tank Crewman
Telephone Repair
Translator/Interpreter
Transportation
Truck Driver
Tunnel Rat
Warehouseman
Watercraft Operator
Weapons Mechanic
Wireman

3
5
2
2
1
9
1
1
6
21
36
11
1
9
2
1
23
33
1
4
1
2
5

NO OF VETERANS REPORTING MISCARRIAGES/STILLBIRTHS

329

NO OF VETERANS REPORTING CHILDREN WITH BIRTH DEFECTS '
AND/OR MEDICAL PROBLEMS PRESENT SINCE BIRTH

307

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
CURRENT OCCUPATION
CURRENT ^OCCUPATION

Accountant
Active Duty
.
Administrative
Aircraft
Air Conditioning/Refrig.
Contractor
Apartment Manager
Applied Research Lab
Army Depot
Attorney
Automotive
Banking
Barber
Bellman
Biomedical Engineering
Technician
Border Patrol
Building Inspector
Cable Company
Carpenter
Carpet Installer
Cement Company
Chemical Company
Child Care
Chrome Plater
City Employee
Civil Service
Clergy
Clerical
Computers
Construction
Consultant
Cook
Correctional Institution
Counselor
Cowboy
Custodian
Disability Examiner
Disabled, medically
unemployed
Draftsman
Editor, publication
Education Specialist
Electrical Supply
Electrician
Electrician, Naval Aviation

11
3
34
13
4
2
1
4
3
1
2
3
1
2
1
1
4
18
1
1
6
2
1
8
8
3
8
6
28
5
5
1
2
2
11
1
96
3
1
1
1
14
1

Electric Technician
Electronics Technician
Employment Interviewer

Engineering
Environmentalist
Equipment Operator

Executive
Executive, Oil Field
Fence Builder
Firebrick Company
Fire Dept.
Fisherman
Floor Finisher
Food Service
Funeral Home
Furniture Restoration
Gas pipeline operator
Glazier
Grocer
Hair Stylist
Helicopter Technician
Highway Dept.
Inmate
Inspector Quality Control
Insurance Claims/Agent
Investigator, State
Ironworker
IRS
Laborer
Laundry
Lawman
Legal Assistant
Library
Lineman
Lumber Mill Worker

3
14
1

6
1
15

3
1
1
1
9
2
1
7
2
1
1
2
1
1
1
1
46
2
8
5
4
1
14
2
27
1
1
4
2

Machinist

18

Maintenance
Management Analyst
Meat Packer
Mechanic
Medical Assistant
Medical Lab Tech.
Military Base
Millwright
Mobile Court Owner
Musician
Newspaper Carrier

19
1
1
52
1
1
1
3
1
1
1

Nurse

2

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31 • 1985)
CURRENT OCCUPATION

CURRENT OCCUPATION
&lt;;ti short Oil
Oilfield
Operating Room Technician
Optometry
Oxygen Plant
Painter
Parks Service
Pest Control
Pharmacy Tech.
Photographer
Physical Therapist
Physician
Pipefitter
Planner Estimator
Plant Operator
Plumber
Porter
Post Office
Printer
Private Investigator
Probation Officer
Production
Psychologist
Purchasing
Railroad
Ranching/Farming
Real Estate
Recruiter (service)
Refinery/Boilermaker
Rehabilitation Center
Repair electrical equipment
Retired
Sales
Sanitarian
Sawmill Operation
Seaman
Security
Self-Employed
Service Station
Shipping Clerk
Shrimper
Silver Smith
Slaughterhouse
Speech Therapist
State Employee
Steel Company
Stocker

3
12
1
1
1
4
1
1
3
2
1
3
5
1
4
12
1
53
5
2
3
1
1
1
13
4
3
1
5
5
1
24
48
1
1
1

24
11
2
5
1
1
1
1
1
7
1

Store Manager
Student
Supervisor, Computer
Supervisor, Production
Supply Clerk
Teacher
Telephone Company
Tool &amp; Dye
Tree Surgeon
Typewriter Repair
Unemployed
Upholsterer
Utility Company
Vehicle Driver
Warehouseman
Welder
Woodworker
Writer

'"&gt;
14
4
9
1
18
7
1
1
1
110
2
6
63
13
26
4
1

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
INITIAL COMPLAINT (as reported by the veteran)
Abdominal Pain
Acne
Allergies
Anxiety
Apnea (shortness of
breath)
Arthritis
Asphyxia
Asthenia (weakness)
Atrophy
Back Pain
Birth Defect, child
Blackouts
Blood Disorders
Body Aches
Cancer
Chest Pain
Chloracne
Confusion
Constipation
Cysts
Depression
Diabetes
Diarrhea
Dizziness
Dysphasia (speech
impairment)
Dyspnea
(labored breathing)
Edema
Emotional Problems
Epilepsy
Fatigue
Fever, recurring
Gastritis, chronic
Gastrointestinal
disorders
Hair LOSS
Headaches
Heart murmur
Hematoma
Hepatitis, recurrent
Hepatomegalia
Hives
Hyperlipidemia
Hypertension
Infected prostate
Infections

3
17
6
12
10
8
1
9
1
6
37
2
10
4
62
15
10
1
2
9
17
1
9
13
1
4
11
52
1
10
5
1
84
7
107
1
1
2
1
2
1
24
2
11

Itching
Joint pain
Kidney
Lesions
Lethargy
Liver damage
Liver pain
Loss of appetite
Low potassium level
Low resistance to
disease
Lumps on body
Lumps in scrotum
Lung disease
Memory impairment
Miscarriage
Multiple sclerosis
Muscle spasms
Nausea
Nerve problems
Neuralgia (nerve pain)
Numbness
Paralysis, extremities
Personality change
Pneumothorax
Pruritus, intense
(itching)
Rages
Rash
Rectal bleeding
Renal failure, chronic
Respiratory problems
Reversed sperm travel
Seizures
Sensorial impairments
Sexual problems
Skin infection
Skin blistering/peeling
Skin pigmentation,
loss of
Sleeplessness
Sores/boils
Sore throat, chronic
Sperm count—low
Stroke
Sunlight allergy
Tendenitis

17
28
10
10
3
17
4
2
2
3
21
1
4
8
7
3
7
2
100
1
123
4
2
1
1
2
524
5
1
5
1
5
1
35
13
36
10
55
18
3
4
1
2
1

Tingling in extremities
Tumors, skin
Vomiting blood
Ulcer
Urination frequency
Visual disturbance
Weight loss/gain
Withdrawal regression

42
5
5
8
5
11
5
1

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)
PIAG_NOSIS T(JDx)—as reported by physician
Aberrant innervation of third
cranial nerve (child)
Acalculous choleystitis
Acre
Acre keloidalis ruchae
Acrocyanosis
Acrokeratosis verrucofomis
Actonic keratoses
Adenoma, villous
Agent orange symptomatology
Alcoholism
Allergic rhinitis
Alopecia areata
Amebic liver abscess
Amputation, fingers, congential
(chlla)
Anemia
Ankylosis spondylitis
Anxiety, chronic
Anxiety neurosis
Aortic insufficiency
Apnea (cessation of breath)
Arteriosclerosis, advanced
(carotids &amp; femorals)
Arthralgias (joint pain)
Arthritis
Arthritis, cervical
Arthritis, degenerative
Arthritis, gouty
Arthritis, poly, seronegative
Arthritis, post-traumatic
Arthritis, rheumatoid
Arthritic changes of joints
Aspermia
Asthma
Atherosclerotic occlusive peripheral vascular disease
Atrophy of kidney
Azoospermia
Baker's cyst
Barlow's syndrome
Bell's palsy
Bilateral acanthosis
Bilateral internal tibial
torsion (child)
Bilateral rnetatarus adductus
(child)
Bilateral mandibular tori

1
1
10
1
1
1
1
1
2
15
2
3
1
1
4
2
17
11
1
5
2
12
16
5
12
5
1
3
2
1
1
1
1
1
3
1
.1
1
1
2
1
1

Bilaterial calycealcalculi
Bilateral supernumerary fingers,
non-boney (child)
Bipolar disorder
Bowen's disease
Brain syndrome, chronic
Bronchitis, chronic
Bullous emphysema
Buerger's disease
Bursitis
Calcaneovarus deformity of
feet (child)
Cancer (Neoplasra)-total 74
Adenocarcinoma of esophagus
Adenocarcinoma of rectum stage
Dukes C w/ 5/15 lymph nodes
positive for Ca
Adenocarcinoma of rectum, Duke C
Adenocarcinoma of rectum w/seeding
of pararectal fat
Adenocarcinoma of sigmoid colon
Adenocarcinoma of sigmoid colon
with metastasis
Basal cell
Bladder, low grade
Bronchogenic carcinoma, squamous
cell
Carcincoma of esophagus
Carcinoma of rectum w/metastasis
to liver
Differentiated lymphocytic lymphoma,
nodular type, Stage 4 w/widespread
metastasis
Diffuse bilateral adenocarcinoma w/metastases multiple
areas bone/brain
Embryonal cell carcinoma, Stage 1
w/teratoma, left testicle
Epidermoid carcinoma of esophagus
Esophagus
Fibrohistiocytoma (leg)
Giant cell tumor of bone
Glioblastoma multiforme, brain
Hodgkin's disease
Larynx
Malignant melanoma
Metastatic carcinoma in hilar lymph
node
Metastatic embryonal cell
carcinoma (testis)

1
1
1
1
1
8
1
2
3
1
1
1
1
1
1
4
8
1
1
1
1
1
1
1
1
2
1
1
1
2
2
3
1
1

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
DIAGNOSIS (Dx)—as^reggrted by physician
Metastatic malignant melanoma,
bowel and subcutaneous tissue/
renal cell carcinoma, left
kidney
1
Metastatic melanoma lesion, right
parieto-occipital
1
Metastatic squamous carcinoma to
scalene node
1
Mixoid liposarcoma w/chest &amp; spine
metastasis
1
Myeloma, multiple
1
Nasopharyngeal carcinoma
1
Neoplasm, malignant (transitional
cell carcinoma) kidney
1
Oat cell Ca of lung w/liver &amp; bone
metastasis
1
Papillary (transitional cell
carcinoma, Grade I) of bladder
1
Pituitary adenoma (brain)
chromophobe type w/hypopituitarism 1
Plasmacytoma ilium, recurrent
1
Renal cell carcinoma
3
Right apiccal, large cell Ca w/
resultant Homer's syndrome
1
Right breast
1
Sarcoma, left leg
1
Semiroma, right testis
4
Squamous cell carcinoma of ear
(epidermoid carcinoma)
1
Squamous cell of lung
4
Squamous cell carcinoma of anus,
keratinizing
1
Squamous cell carcinoma of
larynx, keratinizing,
Grade I, invasive
1
Squamous cell carcinoma of
pinna of ear
1
Testicular
3
Transitional cell carcinoma of
bladder, Grade III
2
Undifferentiated liver carcinoma
1
Capillary hemangioma
1
Cardiomegaly
1
Carpal tunnel syndrome
3
Cataplexy
1
Cephalhematoma of foot postional
deformity (child)
1
Cerebellar atrophy
2
Cerebellar tumor (child)
1

Cerebello insufficiency
Cerebral convulsive disorder
Cerebral palsy (child)
Cervical adenopathy
Charcot-Mar ie-Tooth
Chest pain syndrome
Chloracne
Cholecystitis, chronic
Chondromalacia, patella
Chronic infection and subcutaneous papular eruption
Chronic sclerosing glomerulonephritis
Cirrhosis of liver
Cleft palate (child)
Club-Foot (child)
Coagulopathy
Colitis
Collagen disorder
Colon, mass in
Colon, spastic
Congential absence of tibia (child)
Congenital athyriotic
hypothyroidism (child)
Congential dislocation of hip
(child)
Congenital heart disease,
pulmonary valve artresia (child)
Congenital polyneuropathy (child)
Condyloma accuminata
Congestive heart failure
Constipation
Convergence insufficiency by
Hx
Conversion reaction (numbness)
Coronary Artery Disease S/P/
Coronary atherosclerosis
Costochondritis
Crohn's disease
Crouzon1s disease (child)
Cyst, sebaceous
Cyst, vocal cord
Degenerated nucleus pulposus
Degenerative changes in joint
Demorphic erythrocytosis
Demyelination of peripheral nerves
Depression atypical
Depression w/anxiety
Depression, endogenous

1
1
3
2
1
1
5
2
2

1
4
2
2
1
4
1
1
1

1
1
1
1
2
1
1
2

1
1
1
1
3
1
1
6
1
1
5
1
1
2
24
2

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)
PI^JL^l^-J^l"!"3.^^reported by physician
Depression syndrome, chronic
Depressive disorder
Depressive neurosis
Dermatitis,
l)f:rm-'i+,Ltis ,
'.i'-r'!.•&gt;'-.: \. -,,
.&gt;&lt;• •r,;.-M MS,

atopic
ohroric
V'r.taot
&lt;:r ythematous

Dermatitis, perineal
Dermatitis, photosensitivity
Dermatitis, pruritis
Dermatitis, scaly
. _
Dermatitis, seborrheic
.-.,
Dermatofibromas
Dermatophytosis, recurrent
Diabetes
Diabetes mellitus
Diastematomyelia (child)
Dumping syndrome
Duodenitis
Dysethesias, diffuse
Dyshidrosis (disorder of
sweat glands)
Dysmethic disorder
Dysphasia
Dyspnea
Ecchymosis of legs
Ecthyma
Eczema
Eczema, atopic
Eczema, seborrheic
Eczematous lesions
Emphysema
Encephalopathy
End stage renal disease
Eosinophilia
Ependymoma, cerebellar (child)
Epididymitis
Epilepsy, idiopathic
Epilepsy (child)
Epistaxis, recurrent (child)
Erythema multiforma
Erythematous macular
Erythematous papular
Erythematous, resolving
Esophagitis
Esophoria (child)
Exfoliative erythroderma
.
Extrarenal Wilms tumor (child)

3
3
4
5
14
6
3

1
2
3
1
11
6
3
4
17
1
1
1
1
4
6
1
3
1
2
12
4
2
5
4
2
1
1
1
7
1
3
1
2
4
1
2
1
1
1
1

10

Fatigue
Fatty Metamorphosis
Feet turned inward (child)
Fibroepithelial papilloma
Fibromas
Fibromyalgia
Fibromyositis syndrome
Fibrosis
Folliculitis
Forefoot Adductus (child)
Fundoplasty
Furunculos.is (boils)
Gastritis, chronic
Gastroenteritis
Gastroesophageal. reflux
Globus heptericus
Glomerulonephritis
Granulatoma, -fit. scrotum
Granuloma
Granuloma Annulase
Granulomatous colitis
Granulomatous pulmonary disease
Granulomatous skin lesions
Granulomatous ulcer
Guillain Barre Syndrome
Gynecomastia, breast
Headaches
Headaches, cluster
Headaches, vascular
Hematoma
Hematuria
Hemoptysis, chronic
Hemorrhoids
Hemorrhaphies, bilateral inguinal
Hepatitis, infectious
Hepatocellular degeneration,
focal
Hepatocellular dysfunction
Hepatomegaly
Hernia
Hernia, hiatal
Hernia, inguinal
Hernia, inguinal indirect
(child)
Herpes simplex
Herpes zoster
Hidrosadenitis, chronic,
supprative (inflammation of
sweat glands)

1
1
1
1
1
l
1
1
15
1
1
3
12
2
2
1
4
1
1
1
1
1
1
1
3
3
16
1
12
1
5
2
18
2
4
1
1
2
2
8
7
1
1
2
2

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
DIAGNOSIS (Dx)—as reported by physician
1
Hilar adenopathy w/calcification
Hyaline membrane disease (child)
2
1
Hydrocele
2
Hydrocephalus (child)
1
Hygroma, cystic (child)
1
Hyperanxiety
1
Hyperbilirubinemia
1
Hypercalciuria
1
Hypercholesterum
Hyperlipidemia
3
Hyper pigmental scaly plaques
3
1
Hyper pigmentation
2
Hypersomnia
Hypertension
59
2
Hyperthesia, extremities
1
Hyperlipemia
1
Hyperlipoproteinemia (Type IV)
Hyperthyroidism (child 1)
Hypertryglycerdemia (Type IV)
Hyperuricemia
1
Hypochondriasis
Hypoglycemia
5
1
Hypopigmented areas (face)
1
Hypoplastic breast (child)
1
Hypospadias (child)
Hypotension
3
1
Hypotonia (child)
1
Hysteronic personality
Infection, persistent, soft
tissue (child)
Infundible pulmonary
1
stenosis (child)
1
Iritis, chronic
Joint disease, degenerative
2
(of back)
1
Joint pain, peripheral
1
Keratitis
1
Keratoderma
1
Left spastic hemiparesis
Leukemia, acute, lymphocytic
2
(child)
2
Leukemia, myelogenous, chronic
Leukocytosis w/atypical lymphocytos 1
Lichen planus
3
Lichen simplex chronicus
3
Lipoma
13
1
Lipoma, cyst in lumbar area
2
Lipoma, spermatic cord

II

Liver pain
Lumber sprain
Lung disease, severe, chronic,
obstructive
Lupus, discoid
Lupus erythematosis
Lymphodenitis, chronic
Lymphoid hyperplasia
Lymphopranuloma inguinale
Macular melasna
Maculo-erythematous (rash)
Mastoiditis, chronic sclerosing
Meniere's disease
Meningitis, cryptococcus
Meningomyelocele (child)
Mental Retardation (child)
Metatarsus adductus (w/medial
tibial torsion) (child)
Microtia of ear (child)
Microcephaly (child)
Missing pectoralis (left)
major muscle (child)
Multiple sclerosis
Musculoskeletal condition
Myelomeningocele, lumbrosral
(child)
Myocardial infarction, acute
Myofacial pain
Narcolepsy
Nephrolithiasis
Neuralgias
Neuralgia w/headache and
recurrent fever
Neurasthenia
Neuritis
Neurodermatitis
Neuroma
Neurosis, depressive
Numbness in extremities
Numbness ulnar aspect upper
extremities
Oligohydramnias (child)
Oligospermia
Onchomycosis
Organic brain syndrome
Osgood-Schlatter's disease
(knee)
Osler-Weber-Rondu disease
Osteoarthritis, cervical

1
1
1
1
3
1
1
1
1
2
1
1
2
1
1
2
2
1
1
1
1
1
2
1
1
1
2
1
1
1
8
1
3
14
1
1
2
5
2
1
1
2

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
DIAGNQ3IS-(Dx)—as reported _by_ physician
Osteoarthritis, degenerative
Osteoarthrosis, degenerative
Osteomylitis
Pancreatitis, hyperlipidemia,
chronic
Papilloma
Papular squamous rash
Paralysis of vocal chords
Paranoid schizophrenia disorder
Paranoid state
Parapsoriasis
Parasthesias of extremities
Paroxysmal atrial tachycardia
Patent ductus arteriosus (child)
Patent ductus arterosis of
formen ovale cordus (child)
Peptic esophagitis
Peroneal palsy
Peripheral neuropathy
Peripheral ulnar palsy
Personality disorder
Peyronie's disease
Photosensitivity
Pityriasis alba
Pityriasis rubra pilaris
Pityriasis versicolor
Plantar, hyperkeratosis, mild
Pleural scarring
Pneumothorax
Pneumothorax, spontaneous
Polyarthralgia
Polyneuropathies
Polyps, nasal/vocal cords
Porphyria
Porphyria cutanea tarda
Posterior cervical pain
Post traumatic stress syndrome
Premature ejaculation
Proctitis, inflammatory
Prostatitis, chronic
Proteinuria
Pruritis
Pruritus/onychomycosis of
extremities
Pseudofolliculitis
Psoriasiform lichen simplex
chronicus
Psoriasis
Psychosis, major

4
1
1
1
2
2
1
3
1
1
3
1
2
1
1
1
5
1
11
2
1
1
2
1
1
1
4
5
2
1
4
1
3
1
71
1
2
16
1
13
1
3
1
13
1

Psychotic depressive reaction
(child 1)
Pulmonary atresia
Pulmonary disease, chronic
obstructive
Pulmonary emboli, massive
Pulmonary embolism, ASC VC CVI
Pulmonary nodule
Pustules, recurrent
Pyelonephritis
Pylorospasm
Radicular neuropathy
Rash
Rash, maculopapular
Raynaud's phenomenon
Reiter 1 s disease
Renal glycasuria (no diabetes)
Rhinitis
Sarcoidosis
Schizoid disorder
Schizophrenia
Schizophrenia, chronic,
undifferentiated type
Schizophrenia, paranoid
Schizophrenia, schizo-affective
type
Schizo-type disorder
Sciatica
Scleroderma
Scoliosis (child)
Sebaceous cyst abscess
Seborrhea
Seizure disorder
Soto's Syndrome (child)
(cerebral gigantism)
Spermatocelectomy
Spermatoceles
Sperm count, low
Spina bifida (child)
Spondylolisthesis
Spondylosis
Stenosis of larynx
Sterility
Stress syndrome
Supple pes planus (child)
Syncopy
Syndactyly index w/absence and
congenital absence of middle
phalanx of 4 fingers (child)

3
1
2
1
1
1
2
1
1
1
7
1
2
1
1
3
4
5
19
11
31
3
4
1
1
1
4
12
4
1
1
3
3
4
5
3
1
5
1
1
1
1

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
DIAGNOSIS (Dx)—as ^reported by physician
Tardive dyskinesia
Telangiectasia
Tendinitis
Tenosynovitis (De Quervain's
Disease)
Testicular mass
Testis, atrophic (child)
Thrombocytopenia
Tibial torsion of leg (child)
Tietze's syndrome
Tinea corpis
Tinea cruris
Tinea cruris pedis w/
onychomycosis
Tinea pedis
Tinea versicolor
Tonsillitis, acute, chronic
Transurethral resection
Trichophytosis
Tricuspid atresia, atrial septal
defect, ventricular septal
defect (child)
Triglycerides, high
Tropical fungus
Truncal dystonia
Ulcer, duodenal
Ulcer, peptic
Uroporphyria
Urticaria, giant, recurrent
Varicocele
Xerosis of skin (dryness)

1
1
1
1
1
2
1
5
1
12
26
4
12
21
1
1
3
1
3
1
1
15
12
1
1
1
3

/3

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
CANCER IN VETS AGE 36 AND UNDER (substantiated by medical records)
Case //

A§e When Dx

#13
#15

30
30

#40
#54
#98
(#106

31
31
35
33

(#106

33

#107

29

#121 *

31

#151
#180 *
#242
#315

33
36
36
30

(#316
(#316
#469 *

30
33
36

#474
#523 *
#551

34
34
25

#603
#621
#631
#676
#1072
#1213
(#1259
(#1259

*
*
*
*
*
*

23
25
32
36
35
28
36
38

(#1672
(#1672
#1684 *
#1732
#1751 *
#1900

35
42
32
30
36
35

Type of Cancer/ICD No.
Metastatic malignant melanoma 172.9 M8720/6
Squamous cell Ca w/adenocarcinomatous
components, rt. lung 162.9 M8070/3
Basal cell Ca 173.9 M8090/3
Ca of esophagus 150.9 M8010/3
Polypoid carcinoma of sigmoid colon 153.9 M8050/3
Renal cell carcinoma, left kidney (died at
age 33) 189.0 M8312/3
Metastatic malignant melanoma, bowel &amp;
subcutaneous tissue (died at age 33) 172.9 M8720/6
Multiple melanomas, Stage I (died at age 31)
172.9 M8720/3
Diffuse bilateral adenocarcinoma w/metastasis
multiple areas bone/brain (died at age 31)
170.9 M8140/6
Ca of esophagus (died at age 34) 150.9 M8010/3
Ca of larynx 161.7 M8010/3
Giant Cell tumor of bone 170.9 M9250/3
Metastatic embryonal cell carcinoma (testis)
with pulmonary involvement (died at age
30) 186.9 M9070/6
Basal cell carcinoma 173.9 M8090/3
Seminoma of right testis 186.9 M9061/3
Squamous cell carcinoma of anus,
keratinizing 154.3. M8071/3
Seminoma, testis 186.9 M9061/3
Malignant melanoma 172.9 M8720/3
Pituitary adenoma (brain) chromophobe type
w/ hypopitutarism 237.0 M8270/0
Basal cell epitheliomas, nose 173.3 M8090/3
Seminoma, right testicle 186.9 M9061/3
Sertoli cell carcinoma, testis 186.9 M8640/3
Seminona, right testis
186.9 M9061/3
Nasopharyngeal carcinoma 147.9 M8010/3
Renal cell carcinoma 189.0 M8312/3
Sarcoma, left leg 170.7 M8800/3
Osteosarcoma left leg w/metastasis
right lung 170.7 M9180/6
Malignant melanoma (Level III)
w/cerebral metastasis 172.9 M8720/6
Renal cell Ca. 189.0 M8312/3
Plasmacytoma right ilium, recurrent 203.8 M9731/3
Undifferentiated liver carcinoma 155.2 M8020/3
Myxoid liposarcoma w/spine &amp; chest
metastasis 171.9 M8852/6

Veterans who have sought treatment at a Veterans
Administration Medical facility.for their malignancies.

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH

DATA SHEET (as of July 31, 1985)
CANCER IN VETS OVER AGE 36 (substantiated by medical records)
Case

Age When Dx

#16
#24 *

51
47

#30
#70 »
#76
#146 *
#214

53
44
40
41
48

#239

48

#249

53

#295

52

#304 *

41

#360 *

58

#535
#567 *
#622 *

39
46
50

#638
#806 *

45
68

#829

46

#890 *
#894 *
#1041 *

47
46
60

#1053

52

#1089
(#1093
(#1093
#1178
#1182
#1421

50
50
56
60
44
52

#1477

*
*
*
*

41

Renal cell Ca left kidney 189.0 M8312/3
IGA, Multiple myeloma-lumbar spine (died at
age 50) 170.2 M9730/3
Ca of lungs, squamous cell 162.9 M8070/3
Transitional cell Ca, Grade I 188.9 M8120/3
Ca breast w/metastasis to axilla 175.0 M8010/6
Basal cell Ca of nose 173.3 M8090/3
Squamous cell Ca anterior fascialpillar
146.2 M8070/3
Neoplasm, malignant (transitional cell
carcinoma) right kidney 189.0 M8120/3
Glioblastoma multiforme, brain (died at age 53)
191.9 M9440/3
Squamous cell carcinoma of larynx,
keratinizing, Grade I, invasive 161.9 M8070/3
Adenocarcinoma of lung w/brain metastases
162.9 M8140/6
Adenocarcinoma of sigmoid colon metastasized
to liver 153.9 M8140/6
Basal cell Ca on scalp 173.9 M8090/3
Testicular cancer 186.9 M8010/3
Bronchogenic carcinoma, squamous cell,
poorly differentiated; metastatic carcinoma
in hilar lymph node 162.9 M8010/6
Fibrohistiocytoma, leg 170.7 M8831/3
Carcinoma of rectum w'/metastasis to liver
154.1 M8010/6
Metastatic squamous carcinoma to scalene
node 195.0 M8070/6
Epidermoid carcinoma left lung 162.9 M8070/3
Epidermoid carcinoma of esophagus 150.9 M8010/3
Adenocarcinoma of sigmoid colon and
metastatic to 1 of 3 lymph nodes (Duke C)
w/metastasis to liver 153.9 M8140/6
Right apical (lung) large cell Ca w/
resultant Horner's syndrome 162.9 M8012/3
Chronic myelogenous leukemia 205.1 M9863/3
Basal cell epitheliomas 173.9 M8090/3
Bronchogenic carcinoma, left lung 162.9 M8010/3
Adenocarcinoma of rectum, Duke C 154.1 M8140/3
Ca of bladder, low grade 188.9 M8010/3
Adenocarcinoma of sigmoid colon w/metastasis
to liver and lymph nodes 153.9 M8140/6
Basal cell carcinoma, nose 173.3 M8090/3

•Veterans who have sought treatment at a Veterans Administration
medical facility for their malignancies.

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH

DATA SHEET (as of July 31, 1985)
CANCER IN VETS OVER AGE 36 (substantiatedI by medical records)
Case #

Age When Dx

#1496

48

#1578 *

50

#1582

48

#1622
#1741

37
44

# 1820

55

#1830

37

#1833

39

#1881

65

Type of Cancer/ICD ^Nq,,
Adenocarcinoma of rectum stage D u k e s C
w/ 5/15 lymphnodes positive for Ca 154.1 M8140/6
Adencarcinoma of rectum w/seeding
of pararectal fat 154.1 M8140/6
Bladder - papillary, transitional cell,
grade I 188.9 M8130/3
Adenocarcinoma of esophagus 150.9 M8140/3
Squamous cell Ca of pinna right ear
(epidermoid carcinoma) 173.2 M8070/3
Transitional cell Ca og bladder, Stage II
188.9 M8120/3
Differentiated lymphocytic lymphoma
nodular type, Stage 4 w/widespread
metastasis 202.8 M9620/6
Oat cell Ca of lung w/liver &amp; bone
metastasis 162.9 M8042/6
Basal cell Ca 173.9 M8090/3

"Veterans who have sought treatment at a Veterans Administration
medical facility for their malignancies.

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)

QUESTIONABLE RANGERS (substantiated by medical records)

#45
#169

24
29

Granuloma Rt. scrotum
Liporna cyst in lumbar area

CHILDREN WITH LEG DEFORMITIES (substantiated by medical records)
Club-foot, secondary to spina bifida
Feet turned inward
Congenital absence of rt. tibia
Cephalhematoma rt. foot positional deformity
at birth
Metatarsus adductus w/medial tibial torsion
Congenital dislocation of hip
Club-Foot/Forefoot Adductus
Supple pes pianus
Bilateral internal tibial torsion
Bilateral metatarsus adductus
Metatarsus adductus, right foot
Club-foot
Short leg
Tibial torsion, both legs
Calcaneovarus deformity of feet
Bilateral internal tibial torsion
Tibial torsion of left leg

#25
#40
//68
#152

#188
#207
#296
#330
#571
#582
#583
#770
#872
#978
#1603
#1622
#1754

CURRENT JRASHES ^(substantiated .by jrcedical records)
No. of cases

62

II

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)
TINGLING/NUMBNESS IN EXTREMITIES (substantiated by tnedioal records)
Case #

Year Dx

#14
#22
#37
#41
#85
#119
#145
#192
#195
#206
#211
#212
#224
#229
#267
#306
#338
#341
#389
#415
#422
#423
#450
#500
#872
#1315
#1417
#1758
#1808
#1858

1981
1968
1981
1977
1980
1980/1981
1981
1978
1981
1981
1982
1982
1980
1964
1980
1982
1979
1978
1981
1982
1972
1981
1982
1981
1983
1984
1981
1983
1975
1983

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
MISCARRIAGE/STILLBIRTH (substantiated by medical records)
Case //
#36
#38
#41
#44
#63
#67
#82
#83
#85
#86
#97
#99
#142
#156
#173
#179
#181
#183
#209
#241
#310
#323
#328
#331
#386
#494
#568
#571
#591
#608
#647
#653
#688
#699
#722
#773
#774
#822
#841
#854
#879
#926
#930
#948
#953
#954

Case #

Year Dx
1970
1972 (2)
1973 (2)
?
1980 (2)
Between 1974-1981 (2)
1971, 1975, 1978
1974, 1977
1974
1979, 1980
1980
1974
1976, 1978
1976
1972
1970
1971
1978, 1980, 1981
1975
1979
1971,1979
1979
1977
1975
1977, 1980
1976
1983
1976
1982, 1983
1975, 1976
1971
1973
1980
1981, 1982
9

1974
1978,
1973,
1972
1982
1982
1981
1970
1977
1974
1978

1979
1974,

1978

#978
#997
#1019
#1095
#1275
#1278
#1283
#1395
#1421
#1655
#1677
#1754
#1780
#1809
#1821
#1835

Year Dx

1971
1981
1978, 1982
1975, 1976
1975
1976, 1977
1974
1972
1971, 1978
1979
1977
1983
1983
1980 &amp; ?
1971
1968

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)
SCHIZOPHRENIA (siftstantiated by medical records)
Case #
#16
#3^
#43
#47
#123
1125
#128
#139
#144
#164
#190
#229
#232
#238
#245
#248
#253
#256
#294
#301
#361
#371
#378
#381
#397
#401
#405
#431
#449
#455
#463
#552
#564
#565
#571
#634
#635
#809
#838
#841
#872
#953
#967
#101?
#1080
#1084
#1107

Year Dx

Case #

#1183
#1198
#1200
#1291
#1303
#1323
#1336
#1519
#1581
#1625
#1631
#1615
#1669
#1678
#1708
#1718
#1718
#1776
#1871

1971
1976
1980
1981
1978
1974
1981
?
1979
1977
1983
1982
1979
1982
1982
1968
1976
1975
1970
1971
1969
1970
1976
1976
1972
1971
1973
1971
1981
1971
1972
1972
1970
1969
1971
1977
1970
1967
1982
1981
1980
1981
1982
1976
1980
1982
1981

3.0

Year Dx

1971
1982
1982
1980
1973
1983
1981
1982
1968
1968
1977
1982
1969
?
1976
1983
1977
1978

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
POST TRAUMATIC STRESS DISORDER (Substantiated by medical records)
Case //

Year Dx

Case #

#10
#32
.
#50
#60
#78
#104
#128
1141
#173
#177
#223
#229
#270
#278
#298
#310
#361
#362
#364
#365
#366
#367
#378
#388
#430
#446
#449
#456
#459
#489
#600
#603
#623
#663
#697
#775

?
1981
1981
1982
1982
1982
1982
1982
1982
1982
1982
1982
1982
1982
1982
1981
7
?
1982
1983
7
7
1982
1982
1983
1982
1981
1982
1983
1981
1980

#1308
#1325
#1327
#1475

#783
#784
#838
#842
#849
#872
#875
#920
#967
#971

1983
1983
1983
1980
1981
1982
1981
1981
1982
1982
1982
1981
1985
1982
1982

#1516
#1541
#1604
#1613
#1776
#1936

Year _Dx
1981
1981
1981
1981
1982
1982
1981
1981
1981

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS
DATA SHEET (as of July 31, 1985)
OTHER MEDICAL CONDITIONS (as reported by veterans and physicians)
Acne
19
Acne, cystic
2
Alcoholism
8
Allergic bronchitis
3
Allergies
19
Alopecia areata (spotty
baldness)
1
Anemia, iron deficiency
5
Anorexia
3
Anxiety
23
Apnea (cessation of breath) 16
Arteriosclerosis
3
Arthralgia
1
Arthritis
34
Asthenia (weakness)
35
Asthma
10
Ataxia (lack of muscle coord) 7
Back pain
29
Birth defects/medical
problems—child
13
Blackouts
15
Blisters
10
Blood disorders
214
Body cramps/aches
15
Boils
18
Bones, decaying
2
Burning sensation in
back/extremities
8
Calcium loss
.2
Cancer
44
Chest pains
43
Chloracne
23
Colitis
4
Comedones
1
Constipation
8
Cyst
22
Cyst, retention
2
Delayed healing by first
intention
2
Dementia, in remission
1
Depression
86
Dennatitis
6
Diabetes
22
Diarrhea
28

Disruption of circadian
rhythms
1
Dizziness
78
Drug addiction
1
Dumping syndrome
2
Dysmorphic erythrocytosis
(unusual shape of blood
cells)
1
Dyspnea (labored breathing) 11
Dysesthesias, diffuse
1
Ear fungus
1
Ecxema
2
Edema
16
Emotional problems
502
Endocrine problems
1
Epilepsy
1
Fatigue
60
Fat tissue lumps
11
Fever, recurrent
9
Fungus
10
Gall bladder w/mass
1
Gastrointestinal disorders 650
Glands, swollen
4
Gout
7
Growths, skin
32
Hallucinations
3
Hair loss
27
HBsag-Carrier
1
Headaches
566
Hearing problems
29
Heart attack
7
Heart problems
20
Hematuria
2
Hemorrhoids
4
Hepatitis
6
Hepatomegalia
1
Herpes
3
Hirsutism (abnormal body hair
growth)
1
Hives
2
Hyperlipidemia
1
Hypertension
80
Hypertension, essential
1
Hypoglycemia
1
Hysteria
1

�TEXAS VETERANS AGENT ORANGE ASSISTANCE PROGRAM
TEXAS DEPARTMENT OF HEALTH, AUSTIN, TEXAS

DATA SHEET (as of July 31, 1985)
OTHER_MED^AL^CpNDITIONS&gt; (as^reportedI by veterans and[.
Infections, chronic
20
Immuno suppression
3
Irritability
18
Itching
34
Joint pain
83
Kidney problems
24
Liver problems
161
Loss of appetite
11
Loss of concentration
10
Loss of smell
3
LOSS of taste
2
Low blood sugar
3
Lung problems
30
Melanomas
5
Memory loss
69
Meningitis, cryptococal
1
Moles
6
Muscle problems
37
Myocardial infarction, acute
inferolateral.
1
Nails fall out
11
Nausea
24
Nerve problems
575
Neuritis, traumatic
1
Nose bleeds
1
Numbness
323
Pancreatitis, chronic
3
Paresthesias of distal
arms/legs
3
Peripheral neuropathy
3
Peripheral tumescense
(swollen extremities)
3
Personality change
11
Pleurisy, chronic
2
Polyps

1

Porphyria
Post traumatic stress
disorder
Prostatitis
Psoriasis
Pulmonary embolisms,
multiple

3
6
22
1
1

Pulmonary fibrosis
1
Rash
385
Rectal bleeding, history of 29
Renal cysts
1
Reproductive problems
90
Restricted blood flow
7
Rhinitis (nose inflammation) 2
Respiratory problems
25
Seizures
7
Sensitivity to change in
heat/cold
6
Sex, pain during
1
Sexual dysfunction
268
Shingles
1
Sinus problems
24
Skin, dryness
23
Skin hyper/hypopigmentation 24
Sleep disturbance
338
Sores
12
Speech problems
1
Sterility
6
Sweating, excessive
5
Tachycardia
2
TB, subclinical
3
Teeth, loss of
3
Throat, sore, chronic
8
Thyroid problems
1
Tingling of extremities
163
Tinitus (ringing in ears)
22
Ulcer
37
Upper respiratory infections (URI)
3
Urinary infections
21
Vascular insufficiency
6
Venous thrombosis, deep
1
Vision, blurred
22
Vision, decreased
27
Vision, sensitivity to
light
9
Vomiting
19
Warts
6
Weight loss/gain
43

�SUMMARY
of
PILOT STUDY PROTOCOLS

for the
TEXAS VETERANS AGENT ORANGE PROGRAM
September 1984

Protocols for four pilot studies have been developed by faculty of
the University of Texas for use in the Texas Veterans Agent Orange Program
administered by the Texas Department of Health. They are:
1. Cytogenetic/Bleomycin Testing
2. Aryl,Hydrocarbon Hydroxylase (AHH) Assay
3. Immune Evalution of Veterans Exposed to Agent Orange
4. Uroporphyrin Testing
These protocols are described in the attached documents. These
studies have special subject selection requirements. They also have limitations and pitfalls that should be recognized by everyone interested in the
outcome.
SUBJECT SELECTION. Interpretation of data gathered by the proposed pilot
studies will depend heavily on the criteria and care used in selecting study
subjects. Three categories of age-matched study subjects are required:
1) Vietnam veterans (at high risk), 2) Vietnam veterans (at low risk), and
3) unexposed controls.
Vietnam Veterans (at high risk). The establishment of a reliable
exposure index is critical and very problematical. It may well be impossible
to estimate degree, duration, and route of exposure to Agent Orange in most
Vietnam veterans. However, it should be possible to identify some Vietnam
veterans whose contact with Agent Orange, as reflected in personal histories
and verified in military records submitted to the Texas Department of Health,
was substantial and prolonged. From among this group of individuals,
participants in the pilot studies should be selected on the basis of a detailed
personal interview and medical history that would exclude subjects whose present
or previous occupation, habits, or lifestyle might introduce obvious confounding
factors into the study.
-1-

�Vietnam VeteransL (at 1j3W_r1_s_k). Veterans whose service records and
personal histories indicate an improbable contact with Agent Orange or other
herbicides. Obvious confounding factors would exclude these veterans the same
as the "high risk". It would be safe to state that in assigning high or low
risk that increasing probability of a difference prevails as the size of the
total group increases and the number of veterans determined to be in the nonselected medium group increases.
Unexposed Controjs. These individuals, selected to exclude confounding
factors, will serve as the normal control group for the pilot studies. These
individuals are matched for usual factors and may be civilians or non-Vietnam
veterans.
LIMITATIONS AND PITFALLS. The limitations of the laboratory-based pilot studies
should be clearly understood. Some of these limitations are:
1. Uncertainty regarding degree, duration, and route of exposure
to Agent Orange in individual study subjects is a major
limitation of these studies. Efforts to cope with this
uncertainty are discussed under the topic of Subject Selection.
2. Since exposure of veterans to Agent Orange or other herbicides
used in Vietnam occurred more than a decade ago, any evidence
or consequences of that exposure may have diminished to such
an extent that it is no longer detectable.
3. The tests to be performed in these pilot studies will not
detect effects that are specifically attributable to Agent
Orange or any other herbicide. Chromosome damage, enzyme
abnormalities, and suppressed immune responsiveness can
result from any number of causes, some well-known and others
yet unrecognized. Because of this, it will not be possible
to conclude that disorders detected in any given individual
are due to Agent Orange. However, this is not to say that
populations of matched veterans whose detailed military,
occupational, medical, and personal histories suggest that
they differ as groups only in their exposure to Agent Orange.
4. Individuals whose test results are positive cannot be offered
therapeutic manipulation or corrective intervention. There
is no known way of reversing chromosome damage.
-2-

�5. Negative results from these tests would not be definitive. In
other words, absence of overt chromosome damage in the study
population would not mean that other, less easily recognized
effects were absent.
COSTS. The University of Texas has made every effort to minimize the costs
that cannot be absorbed for tests done on veterans in these studies. For
each matched set of exposed and unexposed individuals, the Texas Department of
Health will cover the unabsorbable costs of $380 for cytogenetic testing,
$800 for aryl hydrocarbon hydroxylase assay, arid $800 for immune evaluation
and uroporphyrin testing.
REPORTS. These studies will proceed at different rates. Upon completion, the
investigators responsible for each study will present their data and results
to the Texas Department of Health and, in addition, will prepare and'submit
their findings for publication in the scientific literature. Interim progress
reports will be provided according to a schedule to be decided by mutual
agreement of the Texas Department of Health and the individual investigators.

-3-

�CYTOGENETIC/BLEOMYCIN

TESTING.

Peripheral blood samples are set up with the standard blood culture medium
to stimulate lymphocytes to grow. Standard cytogenetic harvest method
(Colcemid block for 1 hr., hypotonic solution treatment for 20 min., fix
and air-dried) is used to prepare 48-hr and 72-hr culture samples. The
slides are stained with Giemsa. Thus, each blood culture will have two
harvest samples.
Whenever possible, 100 metaphases are analyzed from each harvest sample
to record chromatid-type and chromosome-type aberrations, and the
aberrations are finally converted into breaks per cell for comparison.
ARYL HYDROCARBON HYDROXYLASE (AHHLASSAY.

The purpose of this study is to evaluate veterans for evidence of
abnormalities in the levels, activity, or regulation of the cytochrome
P-450 microsomal mono-oxygenase enzymes." Lymphocytes will be cultured
from blood samples obtained from veterans and matched controls. The
cultured lymphocytes will be assayed for levels of the enzyme aryl
hydrocarbon hydroxylase both with and without a challenge by 3-methyl
cholanthrene to induce the enzyme. Induction of the cytochrome P-450
associated enzymes is the most basic biological effect of TCDD, the toxic
contaminant of Agent Orange.
IMMUNE EVALUATION/UROPORPHYRIN

TESTING.

This study will examine various measured immune parameters of 1) Vietnam
veterans from Texas who were at high risk for exposure to Agent Orange,
2) Vietnam veterans from Texas who were at low risk for exposure to Agent
Orange and 3) matched veteran-controls who were not exposed to Agent
Orange. In addition, urine specimens will be collected from these same
groups and tests will be performed to measure levels of urinary porphyrins.

�AGENT ORANGE ADVISORY COMMITTEE
to the

TEXAS DEPARTMENT OF HEALTH

Development and Preliminary Results
of Pilot Clinical Studies

Report of the Chairman

Guy R. Newell, M.D.
Professor of Epidemiology and Chairman,
Department of Cancer Prevention
The University of Texas System Cancer Center

Monday, March 26, 1984'

�ACKNOWLEDGEMENTS

The principal investigators, their colleagues and I wish to first
acknowledge William B. Neaves, Ph.D. of The University of Texas Health Science
Center at Dallas who was the first chairman of The University of Texas System
Agent Orange Program Committee. It was under his skillful, thoughtful, and
statesman approach that the initial pilot studies were reviewed, selected and
initiated.
We are all indebted to Ms. Harriet Franson, the Program Manager for the
Texas Department of Health, who sees to our requests and to those of the
veterans we are trying to assist with both speed and compassion.
I want to thank Paul K. Mills, M.S., M.P.H. of the Department of Cancer
Prevention, UTSCC, who prepared the section describing the criteria/selection
methodology and analysed the criteria used in review of the first 255 Vietnam
veterans.
Without the unending wealth of first-hand knowledge of Vietnam and its
environs provided by George R. Anderson, M.D., Director of the Texas Veterans
Agent Orange Assistance Program, the task of estimating gross exposure of
veterans would have been impossible.
Finally, the support given to this program by Robert Bernstein, M.D.,
F.A.C.P., Commissioner of the Texas Department of Health has been unyielding.

�Background
During the Vietnam War, U.S. military personnel sprayed large quantities
of a herbicide called "Agent Orange" over the Vietnamese countryside. The
herbicide, named because of its shipment in orange-striped barrels, consisted
of approximately equal portions of the n-butyl esters of 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T).

These

shipments of Agent Orange were contaminated during the manufacturing process
with traces of a highly toxic chemical, the dioxin
dibenzo-p-dioxin (TCOD).

2,3,7,8-tetrachloro-

Its concentration varied from batch to batch but

averaged about 2 pom of 2,4,5-T.

TCOO is known to be an exceptionally toxic

chemical.
Concerns have been frequently raised by Vietnam veterans that Agent
Orange exposure may result in Infertility, genetic damage, birth defects in
offspring, and cancer.

No studies to date have confirmed these suspicions.

In 1981, the Texas Legislature established a program to assist veterans who
may have been exposed to certain chemical defoliants or herbicides, including
Agent Orange.

An important goal of the Texas Veterans Agent Orange Assistance

Program was to determine 1f veterans have suffered physical damage as a result
of substantial exposure to Agent Orange.

The bill establishing this program

called for a cooperative effort between the Texas Department of Health and The
University of Texas System to conduct studies that would address the health
effects of exposure to Agent Orange.
Pi 1ot Studies of VIetnam Veterans
Faculty of The University of Texas developed protocols for pilot
studies of selected veterans in the Texas Veterans Agent Orange Program.

�Three pilot studies were selected for implementation. These were cytogenetic
testing, sperm evaluation, and analysis of the immune response in putatively
exposed veterans and suitable control subjects.
Cytogenetic testing to be conducted at The University of Texas System
Cancer Center, will determine if Vietnam veterans presumed to have been
exposed to Agent Orange during their military service have more genetic damage
as measured by chromosomal abnormalities in cultured lymphocytes than does a
suitable comparison group of veterans presumed not to have been exposed to
Agent Orange. Sperm evaluation, to be conducted at The University of Texas
Medical Branch at Galveston, will determine whether an association can be
detected between current production of abnormal sperm and prior exposure to
Agent Orange. The percentage of morphologically abnormal sperm and the incidence of nondysjunction of the Y chromosome will be assessed in this study.
Analysis of the immune response, to be conducted at The University of Texas
Health Science Center at Houston, will compare the immunocompetency of Vietnam
veterans thought to have been exposed to Agent Orange with that of age-matched
controls having no history of exposure to Agent Orange.
In addition, a birth defects study was to be Initiated by the Division of
Clinical Genetics of The University of Texas Health Science Center at Dallas.
A summary of this study by Jan M. Friedman, M.D., Ph.D. is attached.
Study Limitations
Every attempt was made to explain the inherent limitations of these
studies to all concerned with their outcome. These include, briefly:
• Inability to establish a reliable index of exposure to Agent Orange
for any individual Vietnam veteran. No exposure Index was available from the
Department of Defense, Veterans Administration, or other official source.

�• Control subjects could be selected on gross variables such as obvious
lack of previous contact with Agent Orange. Ability to match on other variables was limited.
« Because exposure occurred over a decade ago, damage or adverse consequences of such exposure may have diminished to an extent that they are no
1onger detectable.
• The tests performed in the pilot studies are not specific for measuring effects of Agent Orange or any other specific agent.
• Chromosome damage, sperm abnormalities, and altered immune responsiveness can result from any number of causes; therefore, it will not be possible
to conclude that any abnormal findings in the group or in any individual are
due to Agent Orange.
« Individuals whose test results are positive cannot be offered therapeutic manipulations or corrective intervention in that there is no known way
of reversing chromosomal damage or sperm abnormalities.
9 Negative results of the pilot tests would not prove the absence of
other, less easily or impossible to measure, effects.
Although these limitations are substantial, the laboratory-based pilot
studies represent a positive step toward resolution of the Agent Orange
dilemma. These studies have become part of a diverse and rapidly expanding
national effort to answer pressing questions about the health effects of herbicides used in Vietnam. In addition, results of these initial pilot studies
could suggest avenues for future scientific investigations of this national
concern.

�Agent Orange Subject SelectionCommittee Criteria/Selection Methodology
The Agent Orange Subject Selection Committee was established to review
evidence (military records, medical records, arid other supporting documents)
which would indicate if a given veteran was Indeed exposed to Herbicide Orange
in Vietnam, and if so how much exposure occurred.
Seven criteria were used to evaluate a given veteran's category of
exposure. Depending on the combination of exposure variables veterans were
classified into one of six exposure categories.

These categories included:

highly exposed, medium to highly exposed, medium exposed, low to medium
exposed, low exposed and disqualified.
Those veterans deemed to be In the highly exposed category were then
included in the Pilot Phase of the clinical studies. These studies included
cytogenetic testing, immune competency, and sperm mobility and mOtility
assessment.
The criteria which the committee considered when reviewing the military
records, medical records, questionnaire, and other supporting documents
included the following.

1.

Exposure to herbicides. The committee noted the amount (in

gallons) of Herbicide Orange, White, and Blue sprayed in the area where
the veteran was assigned during the time period he was assigned to that
area. This criterion included estimated rates of exposure and exposures
other than "Ranch Hand" exposures.

�2.

Repo rt ed symptoms
A.

At the time of exposure: since the chloracne rash is path-

o gnomon ic of exposure to dioxin, the committee considered the
appearance of a rash at exposure in evaluating the individual's
exposure status.
B.

After time of exposure:

reports of chloracne after initial

exposure were also considered by the committee for evaluation of
exposure.
3

*

Cu r rent ned ica

o b S * T"6 occurrence of current disease which

could possibly be related to herbicide exposure was viewed by the committee as an important criterion for evaluating exposure status.
*•

Current or past^jpccufij^t0^"^L^ffUJ-Al, Jixpgsjjre. Since exposure to

non-herbicide related chemicals could occur on the job outside the military, the committee regarded such occupational exposure as a potential
confounding factor in the evaluation of exposure status. Such exposure
could disqualify a veteran from participating in the Pilot Phase.
s

*

Hi scarriages or sti 1 1 bi rths. The potential genotoxic effects of

phenoxy herbicides, including Herbicide Orange were noted by the committee.

Hence, the occurrence of miscarriage or stillbirth among the off-

spring of the veterans was considered when evaluating the exposure
status of a veteran.
te 1n (5) "above, the phenoxy herbicides are potential teratogens in addition to being mutagens and carcinogens. Hence,
the committee noted the occurrence of birth .defects in evaluating exposure status.

�7

'

Dates and types of service dut^. The heaviest spraying of Herbi-

cide Orange in Vietnam occurred between 1967 and 1969.
operations ceased in early 1971.

All spraying

Hence, the committee closely evaluated

the service dates in Vietnam in establishing the exposure status.
duty type in Vietnam was considered.

Also,

Clerks, truck drivers, repairmen,

and personnel assigned to base camps were not considered to be at high
risk of exposure in comparison to infantrymen in the field where potential exposure was much higher.
The following table {Table 1) demonstrates the relative importance of
each of the selection criteria used by the committee in arriving at a judgment
of exposure status. The percentages reflect the importance the committee
placed on each criteria in placing veterans in a given exposure category.

�8

Table 1.
Percentage Summary of Criteria Considered in Exposure Classification of 255* Vietnam Veterans
Exposure Status

High

Med./High

Medium

Low/Med.

Low

Criteria
Exposure (Gallons)

96.4

100.0

94.7

Symptoms at Exposure

42.3

46.1

13.1

16.6

0.0

Symptoms After Exposure

42.3

61.5

18.4

16.6

0.0

Current Medical Problems

70.5

84.6

31.5

50.0

0.0

Occup. /Chemical Exposure

4.7

0.0

2.6

33.3

5.9

Miscarriages

18.8

15.3

10.5

50.0

1.4

Birth Defects

11.7

15.3

10.5

83.3

0.0

Dates and Type of Service

94.1

100.0

68.4

16.6

5.9

38

6

Total No. Veterans

85

13

100.0

52.2

57

*46 veterans were disqualified from the pilot phase of the study for various reasons. Veterans who had
previously received chemotherapy were disqualified since such treatment would affect cytogenetic and immune
parameters. In addition, veterans with occupational exposure to chemicals which could affect laboratory
testing of sperm, cytogenetic or immunological parameters were removed from further consideration.

�As of February 29, 1984, the Selection Committee reviewed 320 cases of
which 99 were selected for the clinical studies (fifty cases were reviewedmore than once after more Information had been obtained).
The goal set for the pilot studies was 50 veterans selected for having
received the highest possible exposure to Agent Orange based on all available
information. Thus, the study group was intentionally skewed toward exposure
and was not intended to be "representative" of veterans who claimed exposure.
Nor within the study group was there a gradient from high to low exposure.
All veterans in the study group were selected for high exposure. A doseresponse effect was, therefore, not built in to the pilot study design. The
controls, by contrast, were intentionally selected because of no possible
exposure to Agent Orange in Vietnam. Matching for associated factors such as
occupation or for other sources of exposure to dioxin was attempted, but was
recognized to be imprecise.
The intentional study design to Include maximum possible exposure among
cases (Vietnam veterans) contrasted to least likely exposure among comparison
subjects (matched controls) was selected because there was virtually no
literature describing similar studies in humans. Since these pilot studies
represented a "first," it was thought most desirable to design the study for
maximum likelihood of detecting a biologic abnormality among the veterans, if
one existed and could be measured by the available methods used.
Collection of samples of specimens from both veterans and controls was
arranged by staff of the TON and shipped to the individual investigators.
Samples were coded so that the tests were performed in all three laboratories
without knowledge of whether the sample was from a veteran or a control
(specimens were "blinded"). After all specimens were analysed by the

�10
laboratories the code was sent to each Investigator on the same day so that
appropriate analyses could be performed.
Preliminary Results of the Pilot Studies
A summary of findings of the three pilot studies are presented.

All

three studies were performed on specimens from the same Vietnam veterans and
controls.

The total numbers in each group may vary from study to study and

from specimen to specimen.

These do not represent errors, rather they

indicate variability among the techniques used for the studies.
The investigator(s) along with their title and affiliation are given for
each study.

They can provide more technical details if

requested.

Cytogenetic Testing
T. C. Hsu, Ph.D., Principal Investigator
Professor of Cell Biology
Sen Pathak, Ph.D., Collaborator
K. L. Satya-Prakash, Ph.D., Collaborator
The University of Texas System Cancer Center
M. D. Anderson Hospital and Tumor Institute
Each blood sample was set up for short-term culture with standard blood
culture medium.

Cell chromosomes were examined at 48 and 72 hours after

initiation of cultures.

This technique 1s standard and has been published by

Dr. Hsu and his colleagues.
Each cell speciman was critically examined for chromosome changes.
These include:
1.

Chromatid breaks, isochromatid breaks and exchanges.

�11
2.

Chromosomes showing acentric fragments, dicentrics, rings, and

marker chromosomes indicating translocations.
The percentage of cell specimens with chromosome breaks and chromatid
breaks were recorded. The frequency of chromosome changes was calculated as
breaks per cell (b/c). In previous studies of large numbers of patients,
families, and population subjects the b/c ratio was found to be the most
useful expression of genetic damage.
The results of this pilot study of cytogenetics on veterans exposed to
Agent Orange and matched controls are summarized below:
Table 2.
Cy toge n e t i c data_ojii j^eteranisL and_cp_nt_ro]_s_
Vietnam
Veterans
% cells with chromosome breaks

0.78

breaks/cell (b/c)

0.03

Matched
Controls
0.62
-

0.02

�12
Table 3.
Cases with Chromosome-type Aberrations and Breaks/Cell

'Cytogenetic
Change

Vietnam Veteran
No.
(*)

Matched Control
No.
(*)

0.0 - 0.9

17

(S6.7)

22

(73.4)

1.0 - 1.9

9

(30.0)

4

(13.3)

2.0 - 2.9

2

{ 6.7)

3

(10.0)

3.0 - 3.9

1

( 3.S)

0

( 0.0)

4.0 ~ 4.9

1

( 3.3)

1

( 3.3)

5.0 and over

0

( 0.0)

0

( 0.0)

Metaphases with
Chromosome -type
abberrations *

30

100.0

30

100.0

0.00 - 0.02

16

(61.S)

20

(66.7)

0.03 » 0.07

7

(26.9)

10

(33.3)

0.08 - 0.12

2

( 7.7)

0

( 0.0)

0.13 and over

1

( 3.9)

0

( 0.0)

Breaks/cell *

26

100.0

30

100.0

* Chi square not significantly different between veterans and controls.

�13

It should be pointed out that the lack of positive results does not
necessarily indicate the lack of genomic toxicity in persons soon after the
Agent Orange exposure.

Genetic effects induced by Agent Orange, if any, might

have been sufficiently diluted by years of lymphocytic proliferation. In
other words, we do not have a complete chronological study following persons,
before, soon after, and long after exposure to a genotoxic agent. However,
the present data, collected some 15 years after the exposure, appear negative.

Sperm Tests
Jonathan 6. Ward, Jr., Ph.D., Principal Investigator
Marvin S. Legator, Ph.D., Collaborator
Division of Environmental Toxicology,
The University of Texas Medical Branch at Galveston
Up to 3 semen specimens were obtained from each study subject at 2 and 3
month intervals. Upon receipt of the samples, a sperm count was determined,
morphology (appearance) was classified by shape and size using standard,
published methods.

Reference slides were randomly included to serve as an

internal control for scoring consistency.

At least 500 sperm were examined

per sample and the percentage of morphologically abnormal sperm was recorded.
The percentage of fluorescent bodies (F-bodies) was recorded as well.

�14
The results are shown in the table below:
Table 4.

Mean Values (± Standard Deviation)
of Sperm Test Results for Veterans and Controls

Sperm
Characteristics
Sperm Count

(X 106)

Vietnam
Veterans
(Mean ± SO)
(No. Subjects/
Samples)

Matched
Controls
(Mean ± SD)
(No. Subjects/
Samples)

103.7 ± 76.0

116.3 ± 79.3

32 (76)

32 (64)

P = 0.43*
% Morphologically
Abnormal

50.6 ± 14.8

48.7 ± 12.6

31 (73)

31 (61)

47.7 ± 2.1

47.8 ± 2.5

P = 0.78

% One F-body

P - 0.96
% Two F-body

P = 0.82

30 (70)
0.7 ± 0.2
30 (70)

30 (58)
0.7 ± 0.3

30 (58)

*Kolmogorov-Smirnov 2 sample test used for significance of
difference of mean values

�15

Interpretation and Conclusion:
The results of the sperm tests are reported for 32 pairs of veterans and
non-veteran controls.

No statistically significant differences were observed

between the two groups for sperm count, abnormal morphology and 2 F-body
frequency.

The preliminary conclusion is that none of the three tests

employed demonstrated any effect among individuals with prior military service
in Vietnam where exposure to herbicide was probable.

However, based on the

numbers tested, large differences in sperm count could escape detection, while
small differences in morphology and F-body frequency could exist, which would
not have been detected.

Imntjinologic Studies
The immune system is charged with the defense of the body against both
internal as well as external antigenic challenges.

The cells which make up

this system are several different types of lymphocytes - T and B cells,
macrophages, and a poorly characterized cell referred to as null cell.
T-lymphocytes (derived from the thymus gland, hence also called T-cells) play
a central role in the overall regulation of immune responses, including both
antibody synthesis and the development of cell-mediated immunity.

�16

Several measures of T-cells and their functions were determined from
blood lymphocytes of Vietnam veterans and matched controls.

A brief descrip-

tion of these is given below:
Table 5.
Test
Performed

Explanation of Test

% Total T-RFC

All T-cells in the peripheral blood
leukocytes (PBL) as measured by
sheep red blood cell rosette
formation (RFC).

% Pan-T cells

All T-cells in PBL measured by
monoclonal antibody (OKT 3).

%Active T-RFC

Subpopulation of T-cells which
function as immune surveillance
cells.

% Helper/Inducer T cells

"Helper T cells" required for
antibody formation, measured by
monoclonal antibody OKT 4.

% Suppressor/Cytotoxic T cells

"Suppressor T cells" Suppress
antibody response after initiated,
measured by monoclonal antibody OKT
8.

Helper/Suppressor Ratio

Ratio of T-helper to T-suppressor
cells.

% HNK

Human natural killer cells measured
by Leu 7.

% OKT 9

T cell actlvational antigen measured
by OKT 9.

% OKT 10

T cell activational antigen measured
by OKT 10.

PMLC (S.I.)

Panel of mixed lymphocyte culture,
measures ability to respond to 3-5
peripheral blood leukocytes.

�17
Table 5. (Continued)
Test
Performed

Explanation of Test

PHA (S.I.)

Response to a mltogen stimulant,
phytohemagglutinin

S.I. = Stimulation Index
Spont. Blasto.

Spontaneous blastogenesis, measure
of metabolic activity of round cells
in peripheral blood leukocytes.

The numbers of individuals tested, the mean values for the groups and
the standard deviation are given in the table below:
Table 6.
Mean Values (± Standard Deviation)
of Immune Tests Results for
Veterans and Controls

Immune Test
Total T-RFC
Pan T cells
Active T-RFC
Helper T cell (Inducer)
Suppressor T cell (Cytotoxic)
Helper/Suppressor Ratio
HNK
OKT-9
OKT-10
PMLC (S.I.)
PHA {S.I.)
Spont. Blasto.

VTetnam
Veterans
(n*66)

38
61
20
39
24
1.8
11
3 ±
5 ±

29 ±
114 t
17.367 ±

15
13

Matched
Controls
(n=50)

44 ±
64 ±
15
14 ±
39 ±
11
23 ±
10
1.8 ±
08
.
6
12 ±
3±
5
11
6±
22 ±
21
90
98 ±
9.787 19,943 ±

*Stati st1cal ly~TTTfer5nt~at'"P 1ess~than ~O57

19*
13
11*
10
8
0.7
7
1
7
13
78
10,136

�18

Interpretation and Conclusion;
Of the 12 measures of the Immune system examined in this pilot study,
the Active T-RFC was higher among the Vietnam veterans (20 t 15) than among
the matched controls (14 t 11), (P less than 0.05). This test measures the
% of Active T~cells which is the subpopulation of T-lymphocytes that function
as immune surveillance cells. These cells are a subpopulation of the total
T-RFC cells, which is reflected in a decrease of the % total T-RFC among
Vietnam veterans (38 t 15) compared to matched controls (44 ± 19), (P less
than 0.05).

�i

19

.Summary:
Because of concerns of Vietnam veterans that exposure to Agent Orange
and its contaminants may have caused adverse health effects, The University of
Texas System working closely with the Texas Department of Health, initiated
three pilot research projects. These were (1) a study of the cellular characteristics of lymphocytes in the peripheral blood (cytogenetics), (2) a study
of the number and physical appearance of sperm, and (3) several measures of
the immune system.
Vietnam veterans were purposely chosen who had the greatest likelihood
of heavy exposure and were compared with age matched individuals with maximum
likelihood of no exposure. The pilot phase called for 50 veterans and SO
matched controls. Specimens were coded so that their Identities were blinded
to the investigators when the laboratory tests were performed.
The several limitations of these studies were made known from the
beginning to concerned and interested Individuals.
Preliminary r-esults of the three pilot studies are:
Cytogenetlc Testing. No differences were found between the % of cells
with chromosome breaks or the number of breaks per cell between Vietnam
veterans and matched controls.
Sperm Tests. Mo differences were found between the number of sperm,
appearance of sperm, or percent of fluorescent bodies of sperm between Vietnam
veterans and matched controls.
Immunologic Studies. Of 12 tests performed to measure the immune
system, the % Active T-RFC (which measures Immune surveillance cells) was
higher among Vietnam veterans than among the matched controls (P less than 0.05).
The % Total T-RFC was lower among veterans than among controls {P less than 0.05)

�SUMMARY OF U.T. AGENT ORANGE
BIRTH DEFECTS STUDY
26 MARCH, 1984

Data for the period 1 February, 1982 - 1 February, 1984

Center

New Patients Seen

17
8
5

UTHSC Dallas
UTHSC Houston
UTHSC San Antonio
UT Medical Branch
TOTAL

Disease Type

Paternal
Agent Orange
Exposure*

_2

33 = 0.6%

Frequency in
General Patient
Population
(Based on Partial Data)

Frequency in
Children of
Agent Orange-Exposed
Fathers*

Possibly due to Agent
Orange exposure in
father (sporadic
dominant or chromosomal anomaly)

15%

18%

Not due to Agent
Orange exposure in
father (inherited
dominant or chromosomal anomaly,
autosomal recessive,
or X-linked recessive)

18%

3%

(Differences are marginally
statistically significant)

�Estimates of Frequency of Agent Orange Exposure*
in Fathers of Children With Birth Defects
of Certain Etiological Classes
Class
Conditions possibly
due to Agent Orange
exposure in father

0.75%
(Difference is marginally
statistically significant)

Conditions not. due
to Agent Orange
exposure in father

0.1%

CONCLUSION;

Trend observed is consistent with fathers' exposure to
Agent Orange causing birth defects in offspring, but numbers
are very small; most fathers in the "exposed" group do not
actually claim exposure; and the trend has become less clear
as more data are collected.

RECOMMEND;

Continue data collection phase for 1 more year and
re-evaluate at that time.

J.M. Friedman, M.D., Ph.D.
Associate Professor of Obstetrics
and Gynecology and of Pediatrics
Head, Division of Clinical Genetics

*Defined as military service in Southeast Asia between 1969 and 1971.
Most fathers were unaware of direct exposure to Agent Orange.

�en c

en «3&gt; en cs&gt; en

SS.SiMlffiMiniKiTOWf^ijjlCIIIfiffiSffiWSSiaKffi-

D

en

en

cs:»

KmiSqji!'Bii!i;i«fii9im

KH*
CJt ""^

O
CO

ni
f ifii

1 5

Cu
11

%'"l:l;

:~3l

fJl

,,i.

LJ

"11
WIMIHtl

u.»

ni

en
rri
—I

LJ
«.lH»m.ll
" " I
" "

en

CO

CD

1

L™.*

CO

O
nmitu, ui

fn

«jMc:.-wJ

ANALYSIS OF MAJOR DEMOGRAPHIC STATISTICS
FY 82,83,84 AGENT ORANGE CLINICAL STUDIES
MAY 3, 1985 REPORT TO THE TEXAS AGENT
ORANGE ADVISORY COMMITTEE BY
GUY R. NEWELL, JR., M.D., CHAIRMAN

�Demographic Characteristics of Vietnam Veterans and Controls

Characteristic

Vietnam
Veterams
(n-84)

Controls
(n=65)

P Value

(*)

Race

0.44
Black
Hispanic
White
Other

11.9
15.5
71.4
1.2

4.6
13.8
80.0
1.5
0.67

Language Spoken
English
Spanish
Other

85.7
13.1
1.2

86.2
13.8
0.0
0.58

Religion
Protestant
Catholic
Other

65.5
26.2
8.4

64.6
33.8
1.5
0.66

Marital Status
Married
Single
Separated
Divorced

66.7
13.1
2.4
16.7

76.9
9.2
1.5
12.3

0.0001

Education
Through High School
Through College
Post College

35.7
56.0
8.3

13.8
53.8
32.3

0.0001

Income/Year

&lt;$5,000
5-&lt;10,000
10-&lt;20,000
20-OO.OOO
30-&lt;40,000
40-&lt;50,000
&gt;50,000

13.2
17.1
21.1
23.7
17.1
3.9
3.9

0.0
3.1
10.8
27.7
27.7
18.5
12.3

�Current Consumption of Tobacco
Type of
Tobacco

Vietnam
Veterans
(n=84)

Controls
(n=65)

P-Value

52.5

35.5

0.04

20.0
20.0
17.5
22.5
20.0

28.6
19.0
23.8
9.5
19.0

1.8
98.2

3.7
96.3

0.97

8.1
91.9

5.5
94.5

0.85

8.9
91.9

3.7
96.3

0.46

Cigarettes (Pk/Yrs)

Yes
&lt;9
9-&lt;20
20-&lt;26
26-&lt;41
41+

Cigars
Yes
No

I

Pipe
Yes
No

Chewing
Yes
No

�Current Consumption of Beverages
Vietnam
Veterans
(n-84)

Controls
(n=65)

(X)

Beverage

(X)

0.24

Decaffeinated Coffee
None
1-4 cups/day
5+

76.9
18.5
4.6

84.9
15.1
0.0

Regular Coffee
None
1-4 cups/day
5+

P Value

0.65
32.1
52.6
15.4

29.7
59.4
10.9

Tea

0.83

None
1-4 cups/day

36.8
63.2

33.3
66.7
0.27

Cola, Regular
None
1-4
5+

31.9
63.9
4.2

30.5
69.5
0.0
0.59

Cola, Dietetic
None
1-4

85.5
14.5

80.0
20.0
0.92

Beer
None
1-4
5+

49.3
46.6
4.1

52.5
44.1
3.4
0.69

Wine
None
1-4

89.1
10.9

92.9
7.1

Liquor
None
1-4

0.21
89.4
10.6

79.7
20.3

�History of Drug Use

Type of Drug

Vietnam
Veterans
(n=84)

(«

Controls
(n=65)

m

Medication, Regularly Prescribed
Yes
No

0.004

51.9
48.1

27.9
72.1
0.22

Medication, Past '60 Days
Yes
No

58.2
41.8

45.5
54.5
1.00

Recreational Drug
Yes
No

P Value

8.5
91.5

7.7
92.3

�History of Exposure to Chemicals
Vietnam
Veterans
(n-84)

Exposure

Controls
(n=65)

Routinely Exposed

P value

0.85
Yes

30.5

27.7

No

69.5

72.3

Symptoms Related
to Chemical Exposure

0.06

Yes

8.8

1.5

No

91.2

98.5
1.00

Solvent

Yes

2.7

3.1

No

97.3

96.9
0.64

Paints

Yes

10.1

14.1

No

89.9

85.9
1.00

Pesticides
Yes

5.3

4.7

No

94.7

95.3

�History of Exposure to Specific Chemicals

Chemical

Vietnam
Veteran

Control

P Value

&lt;«
1.00

Solvent
Yes
No

2.7
97.3

3.1
96.9

0.64

Paints
Yes
No

10.1
89.9

14.1
85.9
1.00

Pesticides
Yes
No

5.3
94.7

4.7.
95.3

�Miscellaneous History
Vietnam
Veterans
(n=84)

Controls
(n=65)

(«

History

w
0.76

Family History of Cancer
Yes
No
Unknown

41.7
53.6
4.8

47.7
47.7
4.6
0.16

History of Cold or Flu
Yes
No

48.2
51.8

35.4
64.6
1.00

History of Vasectomy
Yes
No

20.2
79.8

20.0
80.0
0.001

X-Rays for Diagnosis
Yes
No

P value

36.6
63.4

9.2
90.8

�Present or Past Employment by Occupation

Occupational Titles

Vietnam
Veterans
No.
(«)

Professional, Technical, and
Managerial

47

(04
2.)

107

(57
5.)

Clerical and Sales

27

(.)
H7

31

(61
1.)

Services

33

(43
1.)

20

(04
1.)

Agricultural, Fishery, Forestry

6

( 26
.)

4

( 2.1)

Processing

6

( 26
.)

3

( 1-6)

42

(83
1.)

7

( 36
.)

6

( 26
.)

2

( i.o)

7

( 36
.)

11

( 57
.)

Machine Trades
Benchwork
Structural kbrk

41

(78
1.)

Miscellaneous

22

( 96
.)

Total
No. of Individuals
No. per Individual
X 2 = 80.22, P = 1.00
10

Control
No.
()
%

230

192

83

65

2.8

3.0

�Present or Past Employment by Industry
Standard Industrial
Classification

Vietnam
Veterans
No.
()
%

Control
No.
()
%

Agriculture, Forestry and Fishing

5

( 2.2)

4

( 2.1)

Mining

3

( 1-3)

2

( 10
.)

Construction

20

( 86
.)

5

( 26
.)

Manufacturing

28

(12.1)

18

( 9-4)

Transportation Communications
Electric, Gas and Sanitary Services

25

(08
1.)

9

( 47
.)

7

( 30
.)

5

( 26
.)

Retail Trade

30

(29
1.)

22

(11.5)

Finance, Insurance and Real Estate

10

( 4-3)

5

( 26
.)

Services

36

(15.5)

60

(13
3.)

Public Administration

64

(76
2.)

61

(18
3.)

4

( 1-7)

1

( 05
.)

Wholesale Trade

Not Classified

232

Total
No. of Individuals

No. per Individual
X2

- 26.58, P = 1.00

192

83

65

2.8

3.0

�History of Major Health Problem

Vietnam
Veteran
(n-77)

History

Control
(n=64)

Yes

32 ( 1 6 )
4.%

13 ( 0 3 )
2.%

No

45 ( 8 4 )
5.%

51 ( 9 7 )
7.%

= 6.3, P = 0.01
Twice as many Vietnam veterans gave a
history of a major health problem as did
controls.

�Frequency of "Major" Health Problems
«

Veterans

Controls
No.

Health Problem

No.

()
*

HBP

35.7
2.4

Hepatitis

15
1
0
0
2
1
2
0
0
0
0
0
1
1
1
3
1
1
1
1
1
1
1
1
1
3
1
1
1

Total

42

17

No. persons

32

13

Heart Irregularity
LBP

High triglycerides
Heart disease, NOS
Rh art
Ulcerative colitis
Low blood sugar
Chronic bronchitis
Hypersensitive insects
High blood sugar
Gout

Ulcers
Hidradenitis
Feels sickly
Anxiety
Tbc
Chloracne
Liver cirrhosis
Blood disorder
Headaches
Insomnia
Chronic proctitis
Spinal fracture
Combat injury
Diabetes

Chronic discoid
Edema

Problem/person

18/42

—
—
—
—
—
2.4
2.4
2.4
7.1
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
7.1
2.4
2.4
2.4

1.3

Heart problems

—
—8
4
.
2.4
4.8

()
*

7
1
1
1
1
1
0
1
1
1
1
1
0
0
0

41.2
5.9
5.9
5.9
5.9
5.9
-—
5.9
5.9
5.9
5.9
5.9
___

0
0

—
—
—
__
—
__
—

0
0
0

0
0
0
0
0

0
0
0
0

—
—
—
—
—
__
--—

1.3

(42.9%)

11/17

(64.7%)

�History of W&gt;rk and Chemical Exposure

Vietnam
Veterans

Controls

(n=82)

Exposure

(n=65)

Yes

25

No

57 (69.5%)

X 2 = 0.14, P = 0.85

(30.5%)

18 (27.7%)
47

(72.3%)

�History of Kbrk and Chemical Exposures

Types of

Veterans

Controls

Exposure

No.

()
%

No.

15

50.0

6

19.4

Radiation

2

6.7

4

12.9

Heat

4

13.3

1

3.2

Embalming fluids

0

1

3.2

Solvents

1

3.3

3

9.7

Fumes

3

10.0

1

3.2

Leaded gasoline

0

1

3.2

Paint thinner

0

1

3.2

Tylene

0

1

3.2

Phenol

0

2

6.5

Alcohols

0

1

3.2

Acids

0

1

3.2

Ether

0

1

3.2

Mold spray

0

1

3.2

Insecticides

2

1

3.2

Epoxy

0

1

3.2

Monomers

0

1

3.2

Miscellaneous

3

3

9.7

Noise/sound

6.7

10.0

Total exposures

30

31

No. exposed

25

18

Exposures/person

1.2

1.7

()
%

�DEPARTMENT OF THE ARMY
OFFICE OF THE ADJUTANT GENERAL
A R M Y AGENT ORANGE TASK FORCE
ROOM 21O. 173O K STREET N.W.
WASHINGTON. DC 2OOO6
R E P L Y TO
A T T E N T I O N OF

HERBICIDE STATUS REPORT

The name Herbicide Orange comes from the identifying orange
stripe painted on the drums containing a particular herbicide which
contained equal proportions of the commercially-available herbicides
2,4-D and 2,4,5-T. These herbicides have been used extensively and in
large quantities in agriculture and forest management in the United
States (US) as well as worldwide for more than three decades. Only the
2,M,5,-T has been implicated as causing any potential health problems
due to the presence of toxic contaminant - dioxin
(2,3,7,8,-tetrachloro-dibenzo-paradioxin (TCDD)) - which is formed in
low concentrations (parts per million) in the manufacturing process of
the herbicide.
At the request of the President of the Republic of Vietnam (RVN),
the use of herbicides in Vietnam was approved by the President of the
United States to primarily deny cover to the enemy and, secondarily,
to deny food crops to the enemy. This was done only after testing in
Florida, Hawaii, and South East Asia during 1961-1962, and limited
operational use during 1962-1965. At that time, the herbicides used
had the desired effects of improving visibility in dense jungles and
were then believed to be harmless to humans. From 1965 to 1970,
extensive aerial spraying was carried out over approximately 10 percent of the land mass of RVN, dispersing 11,300,000 gallons of
Herbicide Orange in over 6,000 separate missions conducted by the U.S.
Air Force under the code name "Ranch Hand". The missions were often
carried out in remote or enemy-controlled areas as a result of the
military need to improve observation of enemy activity and to reduce
the potential for ambush. Each mission was carefully approved by
identical staffing procedures within the US and RVN chains of command.
The missions were flown under strict meteorological and operational
conditions designed to minimize the drift of herbicide. Additionally,
US and RVN commanders were advised to keep their troops out of the
target areas at the time of spraying so that Vietcong grouncjfire might
be returned by the fighter aircraft protecting the spraying missions.
Nonetheless, spraying did occur over US troop positions. These
missions are now recorded on computer tape (HERBS tape).
In a typical spraying of dense jungle, tests have shown that only
6 percent of the herbicide reached the ground. At normal rates of
application, this equals U millionths of a pound per acre of 'the contaminant 2,3,7,8-TCDD. Repeated testing reveals that 2,3,7,8-TCDD is
rapidly detoxified by exposure to daylight in a matter of days, with a

�half-life of approximately 6 hours. However, pure dioxin which has
penetrated below the surface of the soil will persist for years,
though it, too, will slowly detoxify. Dioxin is very insoluble in
water and has a low vapor pressure.
From 1965 on there are detailed computerized records of the
dates, locations, types and amounts of herbicide used in fixed-wing
"Ranch Hand" spray missions. The enclosed copies of maps, which were
drawn from the records of spraying missions, show the locations of all
"Ranch Hand" defoliation and crop destruction missions from 1965 to
1971. Herbicides were used, additionally, to clear the perimeter
areas around US and RVN bases and along routes of communications to
deny the enemy concealment capability and were applied with hand
sprayers, and from tank trucks, riverine boats, and helicopters.
While there are records of over 3.000 of these smaller scale applications, a complete compilation and computerization has not yet been
accomplished, as documenting the instances and locations of firebase
perimeter spraying is a painstaking, time consuming process. The DOD,
however, considers this as another possible source of exposure and we
are, therefore, continuing to search the records to determine the
locations, dates, and magnitude of this type of perimeter herbicide
spraying. The RVN armed forces are known to have used aerially
"dispersed herbicides; however, no records exist of this usage.
Finally, a small amount of herbicide was applied during 196? - 1969 in
the Demilitarized zone (DMZ) in Korea. This was applied by hand spray
apparatus and from trucks operated by Korean Army personnel. No US
troops are known to have been involved or exposed in Korea.
A study by Monsanto Chemical Company, of an accident which
occurred at their Nitro, West Virginia facility in 19^9 has not shown
an excess of deaths, cancers or heart disease among the 122 male
workers who were conclusively proven to have been exposed to dioxin,
in this incident when compared to the general US population. A similar study by Dow Chemical Company of 61 males exposed during a 1964
accident failed to establish a cause and effect relationship.
However, because of the small population size in each of these studies, there is an acknowledged limited capacity for detection of normally infrequently occurring abnormalities or effects. Reflecting
worldwide interest in the subject, studies of other similar accidents,
including the one at Seveso, Italy, in 1976, are being conducted.
Recent studies from Europe on forestry, agriculture and railroad
workers suggest that two kinds of cancer, lymphoma and soft tissue
sarcoma, may result from chronic, high exposure to dioxin. In animal
studies, dioxin has been shown to be capable of acting as a promoter
of cancer, 'fetal death and congenital defects but, to date, these
effects have not been confirmed in humans. The reproductive effects
have so far been observed only in pregnant rats and mice from large
doses of dioxin, but not in rabbits, sheep or monkeys. There are
marked species differences in sensitivity to dioxin1s effects. A
recently completed study of male mice exposed to dioxin did not show
any increase in fetal deaths or fetal abnormalities in the mated

�females thus reducing concern about male-transmitted congenital abnormalities. An extensive study of the use and effects of herbicides in
Vietnam was conducted by the National Academy of Sciences (NAS) and
was reported to Congress in 1971. That study did not identify any
specific health problems.
Present interest in Herbicide Orange use in Vietnam centers on
a wide range of exposures, from very low to high, actual and potential, htach of the present difficulty with the herbicide issue stems
from the lack of concrete information about exposure and its consequences, expecially at low dose levels. There are no known, proven
effects on health or reproduction from exposure to low levels of
2,4,5-T or dioxin. Nor do the health complaints voiced by those who
believe they may have been exposed to Herbicide Orange fall into any
discernible pattern. There is no significant marker or unusual condition such as chloracne, the rare skin condition which is a uniform
sign of large, acute exposures to dioxin, to serve as a specific clue
that low level exposure may have occurred. For example, with exposure
to polyvinyl chloride or asbestos the remarkably consistent high incidence of otherwise very rare cancers substantially hastened an association of exposure to these substances and subsequent ill health.
However, such a causal relationship has not been the case with dioxin.
Thus, to date, there is no scientifically proven evidence that exposure to dioxin in very low doses leads to ill health or genetic
defects. However, the matter is not being allowed to rest on that
conclusion.
There are many studies presently being carried on, both in and
outside the Government, which are designed to investigate many of the
unknown aspects of herbicide exposure. The lack of definitive information has heightened public and private concern about the possible
human effects of exposure to dioxin. Within the DOD, the Air Force is
conducting a study of the 1,200 men from "Ranch Hand" who performed
the fixed-wing spraying of herbicides in Vietnam. The Ranch Hand
study has been projected over a 20-year period and will be studying
the long term health of the members of the "Ranch Hand" crews. The
conclusions for the initial phase of this study, which was released in
July 1983, were not Indicative of a cause and effect relationship.
The conduct of an epidemiology study, originally to be by the
Veterans Administration, has been assumed by the Centers for Disease
Control (CDC) in Atlanta, and will examine the health of ground troops
who were likely exposed to herbicide, as well as those who were likely
not exposed to herbicides. Additionally, there will be considered the
broader question of health effects of service in Vietnam in general,
as it is possible that troops in Vietnam may have been exposed to
other potentially toxic substances and exotic diseases. In addition
to this large scale study (30,000 soldiers), the Centers for Disease
Control is conducting a study to examine the possibility of increased
incidence of congenital abnormalities among the offspring of Vietnam
veterans. These studies will take several years to complete; however,

�they offer the best possible hope of definitive answers to questions
which at present have no answers.
Critical to these studies, and to concerned individuals, will be
information about whether a given individual was actually exposed to
Herbicide Orange. In 1980, the Department of Defense initiated an
intensive search of Army and Marine Corps unit operational records,
morning reports/unit diaries, Combat After Action Reports, and other
related troop movement records to determine if it would be possible to
correlate locations of battalion and company size units with the Ranch
Hand spray missions. We have found it is possible to identify certain
selected companies as having been within close proximity of fixed-wing
herbicide spray missions.
The legislation of PL 96-151 mandated the Veterans Administration
to conduct a study of possible health effects related to Agent Orange
exposure. Following subsequent Congressional hearings, it was determined, since the majority of personnel who served in Vietnam were
Array affiliated, that the Array would play the foremost role in providing the Department of Defense related data to support the VA's and
related studies. Consequently, on 21 May 1980, The Adjutant General
of the Array established the Array Agent Orange Task Force, drawing on
the expertise of staff members already experienced in research methods
and intensely familiar with the organization of the Vietnam War
records collection. The Army Agent Orange Task Force, originally
three full-time and two part-time members, now has a complement of 29
personnel and includes representation from the Air Force, Navy, and
Marine Corps, comprising a joint services staff effort to support the
veterans. The role of the Task Force involves in-depth research into
the Vietnam War records of all branches of the services to locate
units, identify those in relation to known herbicide spray missions,
identify personnel within units, record incidents of herbicide sprays
found in the records and previously undocumented, and to provide support to state and federal agencies conducting Agent Orange related
studies.
The records searches have demonstrated that there are significant
differences in the quality, completeness and accuracy of the data contained in the records of the many units involved. It was never envisioned that these records, compiled and organized under combat
conditions, would ever have to serve as th'e basis for scientific studies in determining exposure probabilities. Hence, some of the information needed is simply not available.
During 1981, while DOD personnel were researching troop movement*
records, another possible source of exposure to herbicides was uncovered — aircraft mission incidents. Records found to date indicate
that over the years during which Ranch Hand missions were carried out,
there were 155 incidents. These incidents were necessitated for a
variety of reasons - engine failure, bad weather, radio malfunction,

�navigational errors/problems and, in some instances, battle damage to
aircraft. A mission incident did not necessarily mean that the pilot
"dumped" the herbicide; however, the herbicide could be rapidly jettisoned through an emergency dump valve in less than a minute, to
lighten the aircraft. To date, we have documented that emergency
releases of herbicides took place 126 times, 58 of which definitely
involved Herbicide Orange. The majority of these releases occurred at
high altitudes, over the sea, or in remote areas in the vicinity of
enemy held targets. A few, nonetheless, did occur near our bases.
Those individuals who have unresolved health concerns from
possible exposure to herbicides while serving in Vietnam may contact
their nearest Veterans Administration hospital or regional office.
Those persons still serving on active duty in the military services
should contact their service medical facility.
We remain dedicated to seeking answers to questions relative to
Herbicide Orange and other dioxin-contaminated substances.

�AGENT ORANGE STUDIES IN PROGRESS
Compiled by the Veterans Administration
STUDY

AGENCY

DESCRIPTION

PROJECTED
COMPLETION DATE

Vietnam Veteran
Mortality Study

Veterans
Administration

To compare mortality
To be Determined
patterns and specific
causes of death between
those veterans who served
in Vietnam and those
veterans without Vietnam
service.

*Vietnam Veteran
Identical Twin
Study

Veterans
Administration

To compare mental and
physical health status of
identical twin veterans,
one who served in Vietnam
and one who did not.

1986

Survey of Patient Veterans
Treatment File
Administration

To identify morbidity
patterns among Vietnam
veterans from VA inpatient files.

Retrospective
Study of Dioxins
and Furans in
Adipose Tissue

Veterans
Administration

To devise a method for
1985.
determining levels of
dioxins and furans in
adipose tissue of Vietnamera veterans from samples
in EPA's Survey of Human
Adipose Tissue, to identify
Vietnam veterans among the
tissue samples and to analyze
samples.

Case-Control
Study of SoftTissue Sarcoma

Veterans
Administration

To determine whether Viet- 1985
nam service, Agent Orange
exposure and other factors
increase the risk of softtissue sarcoma.

Department of
Health A Human
Services, Centers
for Disease
Control

To evaluate possible longterm health effects of
Agent Orange exposure on
ground troops in Vietnam
and to assess possible
health effects of Vietnam
service; 30,000 veterans
expected to participate.

*Epidemiological
Study of Ground
Troops Exposed
to Agent Orange

Initial
1983

1987

�Birth Defects
and Military
Service in
Vietnam

Department of
Health &amp; Human
Services, Centers
for Disease
Control

To determine possible
Early
association between Viet- 198U
nam service and subsequent
fathering of congenitally
malformed children; based
on Birth Defects Registry
in Atlanta area which
includes families of approx.
5,^00 case babies and 3iOOO '•
control babies.

Soft-Tissue
Sarcoma .
Investigation

National
Institute for
Occupational
Safety &amp;
Health

To study tissues from
Indefinite
seven cases of soft-tissue
sarcoma in U.S. (H who had
been exposed to dioxin and
3 who may have been) in
order to identify patterns
of cancer that may be
unique among those exposed
to dioxin.

Investigation of
Leukemia in
Madison
County, KY

National
Institute for
Occupational
Safety &amp; Health

To determine possible
association between cases
of leukemia and exposure
to wood ammunition boxes
treated with hexadioxins.

Dioxin Registry

National
Institute for
Occupational
Safety &amp; Health

To analyze causes of death 1985
among workers at 12 production sites where dioxincontaining products were
manufactured.

Internationa]
Registry of
Persons
Exposed to
Phenoxy Acid
Herbicides &amp;
Contaminants

National
Institute of
Environmental
Health Sciences,
with International Agency
for Research on
Cancer

To establish an interIndefinite
national registry of
workers in some 20 plants
where phenoxy acid herbicides were manufactured;
mortality study planned
when enough workers have
been added to registry.

Case-Control
National. Cancer
Study of Lymphoma Institute
and Soft-Tissue
Sarcoma

Fall
1983

To compare herbicide
198U
exposure among cases of
soft-tissue sarcoma and
lymphoma with controls of
the same age, sex and
Kansas county of residence.

�Air Force Health
Study

Department of
Defense

To compare mortality and
morbidity of Air Force
personnel involved in
Agent Orange spraying
in Vietnam with a group
of Air Force personnel
who were not exposed
•to the herbicide.

Agent Orange
Registry of
Vietnam
Veterans
Biopsy Tissue

Armed Forces
Institute of
Pathology

To determine disease
Indefinite
patterns in biopsy tissue
from Vietnam veterans;
1,200 specimens thus far
show no unusual patterns,;
especially of cancer.

Preliminary
Mortality
1983
Complete
1999

* Indicates those studies which are being supported through records
research and review by the Array Agent Orange Task Force. .

�Science Panel
of the
White House Agent Orange Working Group
Represented by the following agencies:
Department of State
Department of Defense
Department of Health and Human Services
Department of Agriculture
Department of Labor
Environmental Protection Agency
Office of Management and Budget

Office of Science and Technology
Veterans Administration
Office of Technology Assessment
Council on Policy Development of the White House

�' VETERANS HEALTH SURVEY'

Page l

CDC continues to get inquiries regarding the status of its Agent
Orange studies. Following is an update, which includes:
Background
Description of the CDC Research Project
Agent Orange and Vietnam Experience Studies
Selected Cancers Study
Investigation Results
h********4HH

BACKGROUND
Between August 1965 and February 1971 approximately 11.3 million
gallons of the herbicide 'Agent Orange' (so named because of the
orange markings on the drums in which it was shipped) were sprayed
over much of South Vietnam in military operations designed to
deprive the enemy of cover and food. A chemical contaminant,
2, 3, 7, 8-tetrachlorodibenzo-p-dioxin, more often called TCDD, or
simply dioxin, was created during manufacture of and contained in
the Agent Orange which was sprayed. Dioxin has been shown to be a
highly toxic substance.
In January 1978 the Veterans' Administration (VA) received the
first of what was to become many claims from veterans who felt
that their current health problems had resulted from their being
exposed to Agent Orange while serving in Vietnam. In January 1979
the U.S. Congress enacted legislation (Public Law 96-151)
directing the VA to design and conduct an epidemiologic study to
determine if exposure to Agent Orange had caused long-term adverse
health effects in Vietnam veterans. In November 1981 the scope of
the study was expanded (by Public Law 97-72) to include other
factors in the 'Vietnam experience,' including medications and
environmental hazards or conditions.
In January 1983 the responsibility for designing and conducting
the investigation was transferred from the VA to the Centers for
Disease Control (CDC). In May 1983 CDC scientists completed
detailed guidelines (protocols) for the Agent Orange and Vietnam
Experience studies, recommending that a third investigation be
conducted at the same time to determine the risk of Vietnam
veterans developing selected types of cancers.
Public 'Notice of Research Project Initiation' was published in
the Federal Register on March 13, 1984.
DESCRIPTION OF THE CDC RESEARCH PROJECT
The study includes three separate but related components:
1)
2)
3)

Agent Orange Study. (Study of the* long-term health effects
of exposure to herbicides in Vietnam. )
Vietnam Experience Study. (Study of the long-term health
effects of military service in Vietnam.)
Selected Cancers Study. (Study to determine the risks of
specific cancers among Vietnam veterans. )
July 1985

�Page 2

DESCRIPTIONi"AGENT"ORANGE'AND"VIETNAM'EXPERIENCE'STUDIES
«

Although both of these historical, or ''retrospective,1 studies are
in some respects similar, each has a separate purpose. The Agent
Orange study is designed to find out if troops who were exposed to
the herbicide during service in Vietnam have suffered long-term
adverse health effects as a result of that exposure. The Vietnam
Experience study is designed to demonstrate whether or not there
is any difference in the health of veterans of the Vietnam era who
served in Vietnam compared to the health of veterans who served in
other countries during the same period of time.
The studies require the cooperation of a large number of Vietnam
era veterans willing to be interviewed about their health status
and experiences before, during, and after those years. TO ENSURE
STATISTICAL ACCURACY, NO VOLUNTEERS CAN BE ACCEPTED AS
PARTICIPANTS IN THE STUDIES. Participants are selected following
scientific guidelines established by the research protocols.
With the help of the Department of Defense and other agencies, CDC
will identify a minimum of 30, 000 qualified veterans to
participate in the studies: 6,000 in each of five separately
defined groups or 'cohorts.1 The five cohorts are to be made up
of veterans who:
1)

Served during 1967-68 in a specified area of Vietnam, and
were likely to have been exposed to Agent Orange.

2)

Served during 1967-68 in the same area of Vietnam as cohort
1, and were less likely to have been exposed to Agent Orange.

3)

Served during 1967-68 in another area of Vietnam than cohorts
1 and 2, and were not likely to have been exposed to Agent
Orange.

4)

Served in Vietnam during 1966-71.
areas.

5)

Served during 1966-71 in countries other than Vietnam.

Randomly selected from all

Data for the Agent Orange investigation will be gathered from
cohorts 1, 2, and 3. Cohorts 4 and 5 will provide data for the
Vietnam Experience study.
PARTICIPATION IN THE CDC STUDY IS ENTIRELY VOLUNTARY. AGREEING OR
DECLINING TO PARTICIPATE IN THE STUDY WILL HAVE NO EFFECT UPON
BENEFITS A VETERAN MAY BE RECEIVING OR TO WHICH HE MAY BE ENTITLED
IN THE FUTURE.

�Page 3

fill information given by each veteran will be held in complete
confidence. The names of the participants will never be
associated with their answers in the statistical summaries studied
by scientists. Names and other identifying information, such as
addresses and social security numbers or service numbers, will be
kept in a separate file that no one will have access to but the
U.S. Public Health Service and the private research firms working
on this study. No other researchers or government agencies,
including the Veterans Administration and the Department of
Defense, will be able to learn if a veteran participated or what
his answers were. This promise of confidentiality is guaranteed
by Federal laws—42 U.S. Code 242(b), (k), and (m). Unless the
veterans gives written permission to CDC to release personal
information, no one, including the veteran1 s family, will ever be
ible to get the personal information provided by the veteran.
The interview takes about 45 minutes and is conducted by telephone
by CDC's contractor, Research Triangle.Institute (RTI), Inc.
Veterans who are selected to be called by RTI receive a letter
from CDC telling them to expect the call. From those being
interviewed, approximately 2000 veterans from each cohort will
have been preselected for the medical examination component of the
study. The RTI interviewers have no control over which veterans
will be asked to take the medical exams.
Only veterans who have already been interviewed by RTI will be
selected to be asked to take the medical exams which will take 3
days to complete. Several weeks after being interviewed, each
veteran selected will receive a letter explaining the examinations
and a telephone call from Lovelace Medical Center asking when he
can come to Albuquerque. Veterans can select dates convenient to
themselves.
The 10,000 medical examinations are being conducted at
non-hospital clinical facilities specially constructed for this
project by another CDC contractor, the Lovelace Medical
Foundation, in Albuquerque, NeW Mexico. All examinations are
being done at the same place to ensure that standard testing
procedures are used. The examination includes about 60 physical,
psychological, and laboratory tests. Blood and urine samples are
required, but no tests are included that most persons would find
painful. Participants can refuse to take any test or to answer
any question. Veterans who complete all the tests receive a $300
stipend.
Veterans* expenses for travel to and from Albuquerque, food and
lodging, etc., will be paid by!the government. Veterans will stay
in private rooms at a first-class downtown hotel and have their
evenings free. Each room will accommodate up to four persons
without1 cost to the veteran. (The government cannot pay for family
members travel or food.)
Physicians and other health providers working on the CDC studies
will not provide any treatment for individuals. If a veteran1s
medical examination indicates the possible existence of a problem
of any sort, the veteran will be advised immediately and
encouraged to seek treatment from the VA, private, or other
sources of medical services.

�Veteran interviews for the CDC study began in September 1984, and
M i l l continue until about October 1987. The first medical
examinations were conducted in March 1985. fill examinations are
expected to be completed by about January 1988.
RTI, Lovelace, and other non-government research firms have been
contracted to collect the data for these studies. These firms are
monitored closely by CDC officials, fill analysis and
interpretation of data is done by CDC.
(((((((«((((((((((((((((«(((((((((((((((((((((((((((((((((((((((
DESCRIPTIONS SELECTED CfiNCERS STUDY
There is some scientific evidence that exposure to herbicides may
increase the risk of several serious, but relatively rare, cancers
in workers in industries which manufacture or use similar
products. Because these cancers are so infrequently seen, the
30,000 veterans in the other study cohorts do not offer a large
enough sample population upon which to base this investigation.
Instead, two other groups w i l l be studied in a * case-control*
investigation. Because of the design of this study, veterans and
non-veterans will be included in both the case and control groups.
The tumors selected for the study aret lymphoma, soft-tissue
sarcoma, nasal and nasopharangeal cancer, and primary liver
cancer. Other types of tumors may be added to the study later.
The first (case) group in the Selected Cancers Study w i l l be made
up of male patients who have actually had these tumors, and who
could have been in the military during the Vietnam conflict. The
second (control) group will include men of the same age and from
the same current geographic area as the case cohort, but without
the tumors.
Using information from interviews and military records, CDC w i l l
determine which men in both groups are veterans, which veterans
served during the Vietnam era, and which veterans may have been
exposed to figent Orange. Comparison of data collected from both
groups may indicate significant differences in their risk of these
cancers which could be associated with military service, service
in Vietnam, and exposure to figent Orange.
INVESTIGATION RESULTS

»
The exact rate of progress of epidemiological studies of this size
cannot be forecast. Collection and analysis of the large amounts
of data needed for scientifically valid findings takes time;
particularly when so many thousands of veterans must be
identified, located, interviewed, and examined.
CDC w i l l report on each component of the study when it has been
completed. Final reports on the figent Orange and Vietnam
Experience components are expected by September 30, 1988. The
final report on the Selected Cancers Study component is expected
by September 30, 1989.
CDC hopes that these studies w i l l provide answers to many of the
important questions being asked about figent Orange and other
factors related to service in Vietnam. But, as in every
epidemiologic investigation — no matter how carefully designed and
professionally conducted--the possibility exists that definitive
answers to some questions may never be found.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24343">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24345">
              <text>1867</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24348">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24341">
                <text>Anderson, Ron J.</text>
              </elementText>
              <elementText elementTextId="24342">
                <text>Robert Bernstein</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24344">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Texas Veterans Agent Orange Assistance Program, Texas Department of Health, Austin, Texas</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24346">
                <text>1985-08-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24347">
                <text>Annual Report</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24349">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24350">
                <text>cancer risk assessment</text>
              </elementText>
              <elementText elementTextId="24351">
                <text>PSTD</text>
              </elementText>
              <elementText elementTextId="24352">
                <text>morbidity trends</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3290" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24332">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24333">
              <text>1866</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24337">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24326">
                <text>Lawrence, Charles E.</text>
              </elementText>
              <elementText elementTextId="24327">
                <text>Andrew A. Reilly</text>
              </elementText>
              <elementText elementTextId="24328">
                <text>Phillip Quickenton</text>
              </elementText>
              <elementText elementTextId="24329">
                <text>Peter Greenwald</text>
              </elementText>
              <elementText elementTextId="24330">
                <text>William F. Page</text>
              </elementText>
              <elementText elementTextId="24331">
                <text>Amy J. Kuntz</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="24334">
                <text>American Journal of Public Health</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24335">
                <text>1985-03-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24336">
                <text>Mortality Patterns of New York State Vietnam Veterans</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24338">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24339">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24340">
                <text>cancer risk assessment</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3289" public="1" featured="0">
    <fileContainer>
      <file fileId="1700">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/403236bd326cf1a04a59a070dbaa0943.pdf</src>
        <authentication>3029d54552eaac96712704282c810623</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63649">
                    <text>Item ID Number

°1865

Author

Greenwald, Peter

Corporate Author

state of New York

Department of Health, Office of Publi

ROpOrt/ArtiGto TltlO Epidemiological Study of Soft-Tissue Sarcoma

Journal/Book Title
Year

1981

Month/Day

Januar

Color

v

n

Number of hnaoes

28

DOSCrlpton NotOS

project period: February 1,1981 - March 31,1983.
Item includes 1) State of New York Senate Assembly
May 6,1980 establishing a temporary state commission
on dioxin exposure, etc. 2) Sample New York State
Department of Health Certificate of Death

Wednesday, July 11, 2001

Page 1866 of 1870

�\. STATE OF NEW YORK
DEPARTMENT OF HEALTH ^ OFFICE OF PUBLIC HEALTH
VOWER BUILDING

•

THE GOVERNOR NELSON A. ROCKEFELLER EMPIRE STATE PLAZA

. . . - - . &lt; . , .

DAVID AXELROD. M.O.
Ccwr.-11/../on.r '
"61.ENN E . HAUGHIE. M.O;--

-

.

„

-

-

.

,

,

.

,

-

--.

'
"

- .

0,,«c.or c( PubHe ««««"«

ALBANY, N.Y. 12237
™w- jp ...y.---*f-'-*" 1 -*-• wv?j'' '

-OIVI«Ofc| Of; EPIDEMIOLOGY-,
" '"'*' ^'i ' . - "•? "'• ' -"^V^r^

'
' '

•
"Wte •(•&gt;•;&lt;

« . . - • .

.

PETER CREfcNw*l-t). M.O., OR. P.H.

..-

.

.

.

Epidemiological Study o£ Soft-Tissue Sarcoma

Peter Greenwald, M.D., Director, Division of Epidemiology
N.Y.S. Department of Health, NARESP - Tower Bldg. - Rm. 503,
Albany, New York 12237, (518) 474-2353

Project Period:

Performance Site:

February 1, 1981 - March 31, 1983

New York State, Exclusive of New York City

January 1981

�Page 2.

Abstract
Military experience of men in upstate New York reported with"
soft-tissue sarcomas will be studied epidemiologically for
Vietnam service with potential herbicide exposure.

Case

ascertainment will be via the New York State Cancer Registry
of men 18 through 29 years of age at any time from 1962.through
1971 and followed through December 31, 1980.

Age and area-

matched control groups will be selected from death certificates
and drivers license files.

Military service experience will

be obtained from notations on death certificates, hospital
records, telephone interviews, and Veterans Administration or
Department of Defense records.

Other factors previously sus-

pected as being associated with soft-tissue sarcoma also will
be studied.
In addition, occupation and industry of -all men age 20 and over
dying with soft-tissue sarcomas as residents of upstate New York
from January 1, 1970 through December 31, 1980 will be examined.
Matched controls will be selected from death certificates.

The

purpose of this study is to determine whether any occupation or
industry is over-represented among the case group, thus raising
a question of/whether occupational or industrial exposure in New
York State may contribute to soft-tissue sarcoma.

�Page 3.

Specific Aims

' "
"'

»'

~- """'' " " " *
-i'"

"

''

'

" ...... ' *"
:;
&gt;

'.""• '. c -.' ?':.'.;'•••• *'^l'" "ftr-^^ vr •• ' • ^ .
u.

• • ' •«.'•-"&lt; i - ' - ^ ^ . " ^ . ^ ^
V
'a"''-^.-^^^

-,.,,.,.
:

- *'",'•'•&amp;}.•

:.. ^ - • . v . . J M M
..yiwiit

1) To determine if men in New York State exclusive of New Ydrk
VJ
'"' '" " ......&lt;•••'-:-•-'•"•*--.•'•"•'-.-*'••••. b- «&gt;*• ---.«,.« ,-«v.,,,-,i »,»•.. .-«i^..,............'-••''^•..^'-^^1,.-.;,.^x.&gt;r.**.i^k™»B.VVAsV'^^^---'-»'.&gt;.&gt;-^.-^
'

City of draftable ages during the Vietnam War and reported
to the New York State Cancer Registry as having soft-tissue
sarcoma through December 31, 1980 were more likely to serve
in Vietnam than an age-matched control group.
2) To compare areas of service within Vietnam by case and control
veterans who served in Vietnam, in order to attempt to assess
potential for herbicide exposure.
3) To compare the histopathology and anatomic site of soft-tissue
sarcomas amongst Vietnam veterans to the site and pathology of
sarcomas in non-Vietnam veterans and non-veterans.
4) To determine whether deaths from soft-tissue sarcoma are
associated with occupations or industries in New York State,
as identified through death certificate reports.

�Page 4.

Legislative Mandate
.,,.,.........._„..,,.,,,,,,,...„.,.-«,, •,&gt;„.. .-

..

,,.-•&gt;,.,.,,.

- \!/"j;;f;l?i;gl|fc?:^

.. ...... ••-."*.....v«V.*.w..x... ^ Y * * !
^*,*^

The New York State. Legislature, determined that there-is a public

&gt;- fc- j^':tjf -f^ •

need to know the health effect's of exposure to herbicides containing dioxin for residents of the State of New York, including
those Vietnam era veterans who may have been exposed to these
substances during their period of military service.

The New

York State Public Health Law was amended effective September 1,
1980 to require the Commissioner of Health to ''initiate an
Epidemiological Study of the health effects of exposure to herbicides containing Dioxin." This project is developed as part of
the response to this new legislation.

�Page 5.

Preliminary Studies
.,-:.,.•«,«„, ...
...

, . , . . „ . •;.
•...,,

"'
„• .. •'.„

--

.i'(...

! _

. , i,- ;,;&gt;«; ,,..»* . . . , A4&gt;tfi«'t.&gt;' ..,. i,-;v,,.,^,«»v. '.,«&gt;•* ti'.ij"&lt;&gt;hnv*i%- '•.» J-V- *•»»*#..'••-•
^.
'..
'.(,
•.•

In a report from Sweden, Hardell and Sandstrom (1979) reported
a six-fold increase in the risk for soft-tissue sarcomas in

workers exposed in phenoxyacetic acids or chlorophenols. Phenoxy
herbicides have been used to control unwanted hardwoods in Swedish
forests and commercial preparations nearly always are- contaminated
with dioxin.

The Hardell and Sandstrom study explored potential

for exposure among 52 men with soft-tissue sarcoma and reported
"•"•••"

that 19 of the 52 men may have had exposure compared to 19
of 208 control men.

Soft-tissue sarcomas are a broad category

of tumors derived from different types of cells and the authors
did not provide information about which specific histologic
types were studied.

Nevertheless, a striking conclusion necessitates

independent study of this reported association.
• •
The New• York State Cancer Registry was- searched for soft-tissue
sarcomas among men born between January 1, 1933 and December 31,
1953 who had attained the age of 18 years or more.

This cohort

includes men 18-29 during the years 1962-71.
The sites of cancer selected and International Classification of
Disease codes (9th revision) are as follows:
Connective and Other Soft Tissues (171)
Head, Face and Neck (171.0)
Upper Limb, including Shoulder (171.2)
Lower Limb, including Hip (171.3)
Thorax (171.4)
Abdomen (171.5)
Pelvis (171.6)
Trunk, Unspecified (.171.7)
Other (171.8)
e Unspecified (171.9)

�Page 6.

In addition, malignant neoplasms of the retroperitoneum arid
;
: • . . , . . ' ' • • - • • ,••;..".'.

-. ii. ££•,•'.# '.;..;', .••

-

:-'

-

/:••"- 'tty&lt;?;&gt; •

••

.-

*•

w

-peritoneum* (-iS8) 'as'-well- as -those &lt;o£~'the thymus , • heart and......— mediastinum (164) will be reviewed ini order to locate all
possible soft tissue tumors.
The number of men in the Vietnam era cohort reported to the
Registry, classified according to the American Cancer Society's
1968 Manual of Tumor Nomenclature and Coding (MONTAC) , are
as follows:
*

*.*•

ICB 171 Connective and Other Soft Tissues
Total = 250
800
Neoplasm, Malignant
18
807
Squamous Cell Carcinoma, NOS
1
869 Nonchromaffin Paraganglioma, Malignant
1
880
Sarcoma, NOS
12
881
Fascial Fibrosarcoma
2
882
Fibrosarcoma, NOS
42
883
Fibroxanthoma, Malignant
13
884 Myxosarcoma
1
885
Liposarcoma
'
•
41
889
Leiomyosarcoma
17
8.90
Rhabdomyosarcoma, NOS
11
891 Embryonal Rhabdomyosarcoma
4
' 892 Alveolar Rhabdomyosarcoma
1
899 Mesenchymoma, Malignant
6
904
Synovial Sarcoma
28
905 Mesothelioma, Malignant
'
1
912
Hemangiosarcoma
4
913
Hemangioendothelioma, Malignant
2
914
Kaposi's Sarcoma
4
915
Hemangiopericytoma, Malignant
6
922 . Chrondrosarcoma
1
937
Granular Cell Myoblastoma, Malignant
6
939
Ependymoma, Malignant
1
949
Ganglioneuroblastoma
1
950,' Keuroblastoma, NOS
2
954
Keurof ibrosarcoma
9
956
Neurilemoma, Malignant
15
The following tables show the distribution of these tumors by
&gt;

anatomic site and by geographic area within New York State:

�Page 7.

Table 1

Connective and Other Soft-Tissue Tumors
Among Men in Vietnam Era Cohort
New York State Cancer Registry
Anatomic Site
171

Connective and Other Soft Tissues

Total * 250

171.0

Head, Face and Neck

19

171.2

Upper Limb, Including Shoulder

26

171.3

Lower Limb, Including Hip

171.4

Thorax

2

171.5

Abdomen

2

171.6

Pelvis

6

Trunk, Unspecified

33

. 171.7
171.8

Other

171.9

Site Unspecified

101

61

�Connective and Other Soft-Tissue Tumors
Among Men iri^ Vietnajn Era Cohort
New York State Cancer Registry ;
Histologic Type by Anatomic Site

Table 2

JQ

0&gt;

u

;

Anatomic Site &amp; Histologic Type
3 . • ='
^
.
•
^

300 Neoplasm, Malignant
307 Squamous Cell Carcinoma, NOS
369 Nonchromaffin Paraganglloma, Malignant
B80 Sarcoma, NOS
581 Fascia! Fibrosarcoma
882 Fibrosarcoma, NOS
883 Fibroxanthoma, Malignant
884 Myxosarcoma
885 Uposarcoma
689 Leiomyosarcoma
890 Rhabdomyosarcoma, NOS
.891 Embryonal Rhabdomyosarcoma
892 Alevolar Rhabdomyosarcoma
899 Mesenchymoma, Malignant
904 Synovia! Sarcoma
905 Mesothelioma, Malignant
912 Hemangiosarcoina
913 Hemangioendothelioma, Malignant
3514 Kaposi's Sarcoma
915 Hemangiopericytoma, Malignant
922 Chrondrosarcoma

•r- C. J.

•r-

U &lt;J*-&gt;
.

&lt;u o

*z
z •
•
O
f
—

fo "o r—
r^
(U C
ac ro*-*

E o&gt;

-O -O CM

i 3 i— «
.
ttl r— f*» f—
O O O 3
.
Q C JC r—
.

C

"O
£• 13

CO
•

G f^
)

T~~

"&amp;. u a.r-»

O C «r- ^~

x^?
10 •

J- rO f^
JZ r—

cu in
C'—

6 •
O f—
•a r&gt;.
JO r—

t—

v&gt; vo

•r- •
&gt; i—
^™" J ^
^
QJ r"^

a.«—

7
2

3

1
4

* o r^.
^£ &lt;u - •
C CX»—
u 1/1 r-^

-.
1

J^

'oo
•

'Z

Q*

(U C

( r—
U
r* fx^

4-&gt; r—
&lt;=&gt;-"

fc. C i—

4
^ IS"

vo r;

•f- C

15

2
-

5
1
1
2
2

1
1
2
1

1

14
4
1
28
6
8
1
1
1
16

1
1

1

2

1

2
1

1

= ' 3 ;;
2

3
4

i i}
ij

2

4v

2

;1^
z

1

'

2

t ;1

..

i
\
- I
j j

V

t
s
- I *•
; ' X

•

1

1

3

v

26

6
2

:i:
"'

• 5j
11

4

1

8!

•f
;

1

19

U-

; 2!

8

All Histologic Types

• r—

;

2
4
4

Ependymoma, Malignant
Ganglioneuroblastoma
Meuroblastoma, NOS
Neurofibrosarcoma
Neurilemoma. Malionajit

a&gt;

• -r" i
^-^

2:

1
1
1

937 Granular Cell Myoblastoma, Malignant
939
949
950
D54
956

; •%}

.
a

E en

i

2

•

•

6
' 10

]
' . 1

; 1

; i
101

2

2

6

33 f

'

i

-•

^

61

- -

00 -.

�Page 9. '

Table 3

Connective and Other Soft-Tissue Tumors
Among Men in Vietnam Era Cohort
New York State Cancer Registry
Geographic Distribution
New York State, exclusive of New York City
Buffalo Region

37

Rochester Region

27

Syracuse Region

37

Binghamton Region

8

Albany Region

45

Westchester Region

49

Long Island

45

Unknown Residence

2

Total = 250

�Page 10.

Epidemiological reports on soft-tissue sarcomasi are "scant." '"""""
Several factors have, been hypothesized^to be.^important*to^*«w«-^-*--etiology but little evidence has been 'provided in support'sof""
these ideas.

The main factors are as follows:

1) Trauma. Fibrosarcomas occasionally develop in scar tissue
(Stout, 1961).

It is doubtful that sarcomas develop from

contusing blows although this has not been ruled out. Local
sarcoma of the rat may be induced by the subcutaneous
injection of many substances. In particular'"implants of
a variety of plastic or metal discs or films can induce
sarcomas in rats and mice.

The relevance of this to man

is uncertain (Lancet editorial, 1969).

Greenberg (1976)

reported four cases of sarcoma of the buttocks following
intramuscular iron injection.
Morman, et al (1979) reported a locally aggressive
dermatofibrosarcoma in a soldier who had received multiple
immunizations for plague, yellow fever and tetanus.
sarcoma developed at the injection site.

The

Five months after

the injection a small nodule was noted, and eight years later
gradual enlargement was first observed.

2)

Infection.Morton (1974, 1969) outlined the observations which
suggest the close association of a viral agent with human
sarcomas.

Morton writes:

�Page 11.

"1.
,..,.,„..

Type C viral particles, morphologically similar to
the avian, murine,and feline sarcoma,,,viruses, have
been seen in human sarcomas.

"2. All different types of human skeletal and soft-tissue
sarcomas contain a common sarcoma-specific antigen
to which patients with these neoplasms form antibody.
Since all animal neoplasms induced by the same virus
contain a common virus-specific tumor antigen, the
finding of a common antigen in human-sarcomas suggests
viral etiology of these neoplasms by analogy.
"3.

Relatives and close associates of sarcoma patients
also possess a high incidence of antibody to the
sarcoma-specific antigens...."

Kaposi's sarcoma has been reported in association with
lymphoreticular malignancies (Safai, et al, 1980).

These

investigators note clustering of Kaposi's sarcoma in endemic
areas and .cytomegalovirus
culture cell line.

isolation from a Kaposi's sarcoma

A mechanism is hypothesized by which

cytomegalovirus can lead to the development of multiple
primary malignancies in Kaposi's sarcoma patients.
Soft-tissue sarcomas are said to be common in Afghanistan,
ranking third among cancers (Sobin, 1968).

Sobin believes

that sarcomas could be related to arthropod vectors.

He

contends that subepidermal connective tissue is particularly
exposed to mosqu'itos and other arthropods which pierce the

�Page 12.

epidermis.

The hamster reticulum cell sarcoma has been

, v.=.,transmit.ted..by. a mosquito by transfer of -tumor cells and

- ~ -

the Shope fibroma virus can be transmitted By bites of ""fieas
and mosquitos.

Sobin further speculates that the distribution

of bites from crawling arthropods, for example, fleas, ticks
and bedbugs, may relate to the common location of soft-tissue
sarcoma on lower extremities, and finally, he believes that
the age incidence is compatible with an arthropod vector.
Unfortunately, little data are provided to support these
contentions.
No difference in family exposure to domestic cats, dogs and
parakeets was found by Hanes, et al (1970) in a survey of
households which included 127 persons with sarcoma.•
3) Radiation.

Eleven patients with postirradiation

sarcoma

have been described by Hatfield and Schulz (1970).

These

followed radiation treatment of primary carcinoma of the
breast, three after megavoltage therapy.

Other reports also

indicate that radiation may induce sarcomas.
4)

Familial Occurrence. Li and Fraumeni (1969, 1969, 1975) reported
several families with more than one member having rhabdomyosarcoma
and other soft-tissue sarcomas or other cancers.

Mieraii and

Favara (1980) felt that all childhood forms of rhabdomyosarcoma
are essentially embryonal tumors based on ultrastructural

�Page 13.'

study.

In one series four of twenty children with soft-

tissue sarcomas had associated-congenital anomalies (Sloane
and Hubbell, 1969).

the simultaneous occurrence of sarcomas

in a husband and wife was reported by Goldenberg, et al (1974)
5) Chemicals.

The possible association with dioxins raises

questions about the induction of sarcomas by other chemicals.
As noted above, intramuscular iron and multiple immunizations
have been suspect.

In this study, the main effort to obtain

a lead on other potential chemicals will focus on occupation
and industry.

�Page 14.

Methods

I.

Cancer Study
'•

(a)

.

-

,

.

-

.

.

,

.

,

..
„

_

,. •!,„,. ..WAarJl..-!!..-..-

Case Ascertainment "- The case group will be all male
residents of New York State exclusive of New York City
who were 18 to 29 years old anytime from 1962 - 1971,
and who were reported to the New York State Cancer
Registry as having soft-tissue sarcoma first diagnosed
at any time through December 31, 1980.
The New York State Department of Health maintains one
of the worlds largest cancer registries.

By law all

physicians, hospitals, and laboratories must report
newly diagnosed patients with cancer to the New York
State Cancer Registry. We believe this Registry to
be about 90% complete.

A copy of the cancer registry

report form is shown below.
New York State Cancer Registry Report
— CO*** •&amp;( *tfTlAi

NAM(

Dote •* t+Mt Report

O' * AT 11 NT

OATI or

ADtXttU

• O

S ACC

OlCW

wt,*,

SD

i.c

»OC"-l UCUIITr

CO

&gt;D

TI ew

IKX** die '

» O

UM

»^

»C

.

JtATui

I • O

* C

* —

5&lt;»T1 M COUNT! r
or tcntM

DIAGNOSIS

IM*«V sue
Vn

i.O
STAG! Of DlUASC

c if
C A l l l V C&gt;

HOS*ITAl Ot.
1kiMO&gt; •IG:S'

f l f t M Oft

No

: 3

« 3

�Page 15.

(b) Control Group Selection - Two overlapping control
groups will be used, each having a control to"case

'"*

"."""

*

ratio of 1:1.

The first group of controls will be

selected from drivers license files matched on 5-year
age group and zip code (see appendix).

The method is

based on that developed by P.C. Nasca and J.O. Moore.
Alternate controls also will be selected and stratification during analysis shall include race.

The

••"••

sarcoma case group will be matched against drivers
license files to see the extent to which the case group
have drivers license.

This will provide an indication

of how representative the control sampling frame is of
the case group.

As most of the case group would have

been expected to live had they not developed sarcoma,
«.

this live control group is considered most representative
of the general population and thus the appropriate control group for this 'study.
In order to take into account the possibility that informants for dead cases may not be able to provide equivalent
information to that for live controls, a dead control
group will also be selected for dead cases.

Controls

found to be ineligible for military service because of
a condition which lead to their subsequent selection as
a control will be excluded. Together with the matched
controls for the live cases, these will provide a second

-.&lt;/*

�Page 16.

control group for analysis.

For each dead case two

. death certificates will be selected for men.of,the
same 5-year age group, years of education, race and
health systems area.

Health systems areas contain

about 10 counties each.

Persons dying from all causes

except cancer will be eligible to serve as a control.
Positive Control - In addition to the "negative con-,
trols" noted above, we will attempt to -obtain an
age-matched group of "positive controls" -- that is,
men known to have served in Vietnam.

These controls

will be selected only for sarcoma cases with a Vietnam
service history.

Information on dates of service,

battalion company, etc. for these two groups will be
collected and compared.
(c) Tumor Comparisons - Pathology slides will be borrowed
from hospital pathologists for review by Dr. Doris
Collins of the Division of Labs and*Research.

Dr. Collins

will use a standardized classification form, and be
blinded as to the military service experience of the
case under study.

The distribution of histolopic pat-

terns of Vietnam veterans then will be compared to nonVietnam veterans and non-veterans.
Hospital records w i l l be abstracted for anatomic site of
the tumor, diagnostic procedures, and historical infor' • nation.
"^

Again, Vietnam veterans K i l l be compared to non-

�Page 17.'

Vietnam veterans and non-veterans.

(It should be

noted that this section relates only to comparisons

-

with the case group rather than case-control comparisons.)
(d)

Interview - Cases and controls, or a close relative
or friend if the study subject has died, will be
interviewed using a standardized questionnaire.

The

interview will be done by trained interviewers who
have pilot tested the questionnaires.

A 10 percent

callback will be done by a different interviewer to
check on reliability.

The survey will be conducted

by telephone, or if the study subject prefers, in person.

Data will be collected about conditions known

or suspected of being associated with soft-tissue
'sarcoma or which might relate to the possibility of
exposure.

Thus, in addition to military service his-

tory, we will gather data on smoking, alcoholism,
occupation, other activities that might be associated
with exposure to toxic chemicals, and on questions
which relate to the various hypotheses discussed in
the background section.
Validation of interview responses relating to military
service and further information will be collected by
checking against Veterans Administration records. This

�Page 18.

procedure will be kept blinded as to case or control status insofar as possible.

.-

(e) Analysis - Results will be analyzed using traditional
epideroiological and biostatistical methods, including
current raultivariate statistical techniques.

This

will include the linear logistic model for matched
analysis as described by Holford et al (1978) and
Breslow et al (1978).

The logistic model allows for

the direct consideration of continuous risk variables'
and for multivariate analysis.

Further when a single

un'ivariate binary risk factor is considered, this model
reduces to the method of Miettinen (1974).

Statistical

power will be shown through the use of confidence limits
or other methods.
Associations between selected diseases and putative exposures may arise through a number of biases which
affect the collection and interpretation of data from
epidemiological studies.

The following attention will

be given to these potential biases:
(1) Associations may be based on systematic bias
due to non-response.

We will attempt to reduce

non-response to minimum.

Past experience of the

Division of Epidemiology shows that we can
anticipate a response rate of better than 80%

�Page 19.

in both the case and control groups in interview
""""studies.

We also plan to compare respondents and '•

non-respondents among both cases and controls
according to the variables which are present in
the record systems used for case and control ascertainment.
(2) Bias might be the result of preferential recall
on the part of case or control subjects.

To minimize

"••"•

this potential bias wherever possible we will use
established records to identify or validate military
service experience.

We also will compare the absolute

frequency of military service experience in our
study to the data reported from other similar investigations.
(3) Bias may occur as a result of a systematic

differences

between cases and controls in terms of access to
medical care.

We do not expect this to be a major

problem for patients with the conditions under study.
However, we will collect information about
diagnostic procedures and analyze for this
possibility.
(4) An artifactual association or absence of association could occur if eligibility for military
service varied between cases and controls.
avoid this,

To

controls found to be ineligible for

�I.

Page 20.

military service because of a condition which lead
to their death' and subsequent selection as a control will be excluded.

We do not know if other

causes of death; for example, motor vehicle accidents,
are more or less likely to occur among veterans.

We

. feel the best way of handling this type of possibility
is to select the controls broadly from all disease
categories except those under study.
(5)

Confounding by other variables is"one of the most
frequent sources of bias.

We will attempt to

minimize this possibility through matching,subject restriction, and multivariate analysis.
Attention will be paid to the distinction between
variables which are true confounders and those which
are part of a causal network.

NOTE THAT A MAJOR

LIMITATION OF THIS STUDY MAY BE AN INABILITY TO MAKE
A DEFINITE STATEMENT ABOUT DIOXIN EXPOSURE EVEN IF
CASES TURN OUT TO HAVE MORE MILITARY EXPERIENCE THAN
CONTROLS.

Part II Study - Part II Study will be an analysis of
occupation and industry as reported on death certificates.
\

Study subjects will be all male residents of New York State
exclusive of New York City listed on death certificates as
dying of soft-tissue sarcomas during the period January 1,
]970 through December 31, 1979.

Controls will be selected

�Page 21.
•

from death certificate

*

files matched on date of birth,

years of education, race "and health systems area,

decupation''

and industry from the certificates will be analyzed in order
«
to see if any particular occupations or industries are overrepresented in the case group.

x

This is considered a hypothesis

generating study that may yield a lead for further investigation.

III.

Human Subjects - Risks, if any, from epidemiologic studies of
this type are minimal.

The use of telephone interviews to

collect epidemiologic data seems reasonable in light of the
number of interviews to be completed.

This method does, of

course, preclude the procurement of personally signed participant
informed consent forms.
to serve this purpose.

A substitute method has been developed
Prior to the interview we will read a

standardized text which explains the purposes of the research
and the rights of participants.

This method has been reviewed

and approved by the Human Subjects Committee of the New York
State Department of Health under the Federal rules and
regulations governing the protection of human subjects
(Subtitle A of Title 45, Section 46.10(c)).

Signed informed

consent will be obtained in the event of a personal interview
or medical procedure.
confidential.

Individual records will be kept

Division of Epidemiology employees are trained

in confidentiality procedures and the offices protected by
security measures which help to assure this confidentiality.

�REFERENCES

Breslow NE, Day NE, Halborsen KT, et al. Estimation of multiple
relative risk functions in matched case-control studies. Am J
Epidemiol. 1978.; 108:29.9-307.
.. .
. ... .
Goldenberg, GJ, Spurll GM, Hogg GR. Simultaneous occurrence
of sarcomas in a husband and wife. Can Med Assoc J. 1974;
110:49-50.
Greenberg G. Sarcoma after intramuscular iron injection.
Br Med J. 1976; 1:1508-09.
Greenberg G. Sarcoma after intramuscular iron injection.
Br Med J. 1976; 2:233-34.
Hanes B, Gardner MB, Loosli CG, Heidbreder G, Kogan B,
Marylander H, Huebner RJ. Pet association with selected human
cancers: a household questionnaire survey. J Natl Cancer Inst.
1970; 45:1155-62.
Hardell L, Sandstrom A. Case-control study: soft-tissue sarcomas
and exposure to phenoxyacetic acids or chlorophenols. Br J
Cancer. 1979; 39:711-17.
Hatfield PM, Schulz MD.
1970; 96:593-602.

Postirradiation sarcoma.

Radiology.

Holford T, White C, Kelsey J. Multivariate analysis for matched
case-control studies. Am J Epidemiol. 1978; 107:245-256.
Li FP, Fraumeni JF. Soft-tissue sarcomas, breast cancer, and other
neoplasms - A familial syndrome? Ann Intern Med. 1969; 71:747-52.
Li FP, Fraumeni JF. Rhabdomybsarcoma in children: epidemiologic
study and identification of a familial cancer syndrome. J Natl
Cancer Inst. 1969; 43:1365-73.
Li FP, Fraumeni JF. Familial breast cancer, soft-tissue sarcomas,
and other neoplasms. Ann Intern Med. 1975; 83:833-34.
Mierau GW, Favara BE. Rhabdomyosarcoma in children: ultrastructural
study of 31 cases. Cancer. 1980; 46:2035-40.
Miettinen OS. Confounding and effect-modification.
Epidemiol. 1974; 100:350-353.

Am J

Morman MR, Lin RY, Petrozzi JW. Dermatofibrosarcoma protuberans
arising in a site of multiple immunizations. Arch Dermatol.
1979; 115:1453.
Morton DL. Soft tissue sarcomas. In: Holland JF, Frei E, ed.
Cancer medicine. Philadelphia: Lea, Febiger, 1974:1845-61.

�-2-

Morton DL, Malmgren RA, Hall WT, Schidlovsky "Gr
virus s-tudies with human sarcomas. Surgery. 1969; 66:152-61.
Relevance of animal tumours to man.

Lancet. 1969; 2:418-19.

Safai B, Mike V, Giraldo G, Beth E, Good RA. Association of
Kaposi's sarcoma with second primary malignancies - possible
etiopathogenic implications. Cancer. 1980; 45:1472-79.
Sloane JA, Hubbell MM. Soft tissue sarcomas in children
associated with congenital anomalies. Cancer. 1969; 23:175-82
Sobin LH.

Sarcomas in Afghanistan.

Nature.

Stout AP.

Sarcomas of the soft tissues.

Ca.

1968; 217:1072-73
1961; 11:210-31.

�Male Soft Tissue Sarcoma Study Live Control Selection Procedures
Request a selected 5-year age group distribution of male licensed
drivers by selected zip code areas of New York State, excluding Hew York" City
from the New York State Department of Motor Vehicles. Using these data,
determine what percentage.of those-files must be sampled and put on-tape—•
in order to .generate the appropriate number of controls. Ask the New York
State Department of Motor Vehicles to sample licensed drivers using "the'"""""""
following procedures:
1.

Select all male licensed drivers between the ages of twenty-five and
forty-nine inclusive who reside in selected zip code areas.

2.

Stratify each 5-year age group by zip code and using a random starting
number between 1 and _ _
(to be based on predetermined percentage),
choose every
th driver in each zip code area until the appropriate
number of controls has been selected.

3.

Create a tape file consisting of the individuals selected in the
systematic sample.

Our programmer will then prepare a program which will allow us to
print out the information on the tape in a form enabling us to select the
controls by random number order. One primary control and five alternate
controls will be chosen for each case. They will be matched with the case
by sex, year of birth or if necessary, year of birth within a 5-year age
group, and zip code at the time of diagnosis. This will be done for each
case in the following manner:
1.

From a case list including year of birth and zip code .at time of diagnosis
find year of birth and zip code for the case.

2.

Locate the same zip code on the Motor Vehicle printout and the year of
birth that matches that of the case.

3.

Using the random number generator on the calculator, choose the first
six controls that can be used.

4.

Fill in a control selection form in duplicate.

12/11/CO

�APPENDIX

STATE OF .NEW YORK
S. 9722—A

'

A. 11729—A

ENATEW:
Hay 6, 1980

IN SENATE—Introduced by' Sens. COOK, LOMBARDI. BABBUSH, BARTOSIEWICZ,
BERMAN, CONNOR, DUNNE, FLYNN, LACK, LAVALLE, LEVY, PISANI, TAURIELLO,
VOLKER—read twice and ordered printed, and when printed to be connit. '
ted to the Committee on Health—reported favorably from saj^d cocssittee
and committed to the Committee on Finance—committee discharged,-bill
amended, ordered reprinted as amended and recocsitted to said cocaaittee
'
.
•

••"•

IN ASSEMBLY—Introduced by COMMITTEE ON RULES —(at request of M. of A.
Tallon, Behan, Robach, Conners, Grannis, Hinchey, Kidder, Z firmer,
Casale; Hannon, • McCabe, Schioiminger, Larkin, Saland)—read once and
referred .to the Cosaittee on Health—reported end referred to the Coonittee on Ways and Means—committee discharged, bill amended, ordered
reprinted as amended and recommitted to said committee•

•*

*

*

'

i

•

&lt;

•

AN

ACT creating'a temporary state commission on dioxin exposure and to
amend the public health lav, in relation to health effects of exposure
to herbicides containing dioxin and naking an appropriation therefor
* •

•

• The People of the State of New York, represented in Senate and Assembly, do enact as follows;
'
•
"
1
•2
3
A.
5
6
7
8
9
10.
11
12

Section 1. A tenporary state commission on dioxin exposure is hereby
created to obtain information relating to the health effects of exposure
to herbicides containing dioxin for residents of the state of New York,
including those Vietcaa ere veterans who- nay have been exposed to these
substances during their period of military service. The commission shall
direct its attention to at least the following:
(a) Deter.-3ir.iag vhat ccedical, adrainistrative and social assistance is
r.eeded for victias of dioxin exposure and submit its recommendations to
the legislature for its consideration;
(b) Conducting an extensive outreach program to inform Vietnam era
veterer.s who 52}- hava been exposed to herbicides containing: dioxin of
any federal or st£:e assistance available to then;, and

EXPLANATION—Mstter ir. italics (underscored) is new; matter in brackets
( ] is old law to be omitted.
LBD02120503A

�S

- " "
" A

"

'"

'"

2

'" " • "
- " -

'T
: I1729--A'

1
(c) Acting as the official agent of the state for disseminating in2 fornation to Vietnam'era veterans about epideraiological or other studies
3 relating to dioxin exposure which are being conducted by the federal or.
. 4 state governnents.
5
§ 2. The commission shall consist of nine members; each to serve for a
6 tern of two years, to be appointed by the governor. Five members shall
. 7 be honorably discharged Vietnam era veterans, with at least one froa
8 each judicial department; one shall be a representative of a public ea9 ployees union; one shall be a 'representative of a private employees
10 union; one shall be a representative of the business community; and, one
11 nesber shall be the state health commissioner, or his representative.
12 .-The commission shall elect .a chairman from among its members. Vacancies
13 in the membership of the commission and its officers shall be filled in
1^ the oanner provided for original, appointments; The commission shall oeet
15' on the call of the chairman at least four tines per year. However, the
16 coasissioner of health'shall call the initial meeting of the commission
17 not later then December first, nineteen- hundred eighty.
. . .
18
§ 3. The coranission may employ and at pleasure remove such personnel'
19 as it'nay deea necessary, including an executive director, for che • per20 foraance of its functions and fix their compensation within the amounts
21 oade, available therefor. •
,
'• "
"
'
.
22
§ 4. The cenb.ars of the commission shall receive no compensation for
23 their services.but shall be allowed, their actual and necessary expenses
.24 incurred in the performance of their duties hereunder.
"_
. '
25
§ 5..-To the naxinua extent feasible, the coxoission shall be entitled
26 .to*request and rective and shall utilize and' be provided with such
27 facilities, resources and data of any court, department, division,
.25 bqerd; bureau, ccsaissioa-ox agency .of .the state or any political . sub29 division thereof as it nay reasonably request-to carry out properly its
30 powers' and duties hereunder. The commission shall not disclose jLnforma31 tion received pursuant to this act so as to divulge the identities of
32 the persons to whoa it relates except as is necessary to carry out the.
33 purposes of this act.
•
.
.;
•
34
§ 6. The coraission shall make a preliminary report'to the governor
^35 and the legislature of its findings, conclusions, and recommendations
^ ' - not later than March first, nineteen hundred eighty-one, and a final
3^
37 report of its findings, conclusions and recommendations not later then
33 March first, nineteen hundred eighty-two.
.
'
39
§ 7. Ths public health lav is aaended by adding a new article twenty40 four-B to read as follows:
41
ARTICLE 24-B
42
INFORMATION PROGRAM ON DTOXIN
43 Section 2475. Special policies with respect to dioxin exposure.
44
§ 2475.
Special policies with resoect tc dioxin exposure. 1. For
45 the purpose o~f idem: fying persons who were exposed to an herbicide cors46 lair.inz dicxir. ar.d for the purpose of co?npilir.z data on the health ef47 fee's of this »xpcsura, she commissioner of health shall:
43
(a)
establish, prsr.ote and maintain' a public information program on
49 dioxin. S'jc'n progr:- shall include, but way not be limited to, an ef-

50 for: ro c-jri'.;.: V:o:r..'.-j «;ra veterans nnd ccptoyces of the public and
51 private scc'ors wi::hir. the state .who were exposed to an herbicide con5 2 io|r. ir.g dioxin;
53
O')^_.'r.j.-is'-". ... cpitjcniolo^tcnl study of the ho.nlth;&lt;-t forts of^cxpo'"
5 . :.ur&lt;.- co hTinciiJ"'; ^.or.t.i in ins &lt;lioxtn:
'

�S. 9722--A

3

A. 11729--A

1
(c)
rr.iir.iain a central data bank within-the deparcnfc.-.c for iriforrea2 rion collected or. the health effects"of exposure to dioxin and for the
3 cataloguing of existing scientific and medical literature on the health
4 effects of this exposure; and.
5 . (d) initiate education for health professionals to assist them in un6 dcrstanding the potential risks and state-of-the-arc knowledge vith
7 regard to,detection, diagnosis and treatment of acute and chronic syrop8 toss associated vlch dioxin exposure.
9
2. The cor-raissioner may request and shall receive from any deaart10 oer... division, board, bureau, commission or agency of che state or of
11 F.r\y political subdivision thereof such assistance and dgta as vill ena12 ble him to properly carry out his activities hereunder and effectuate '
13

the

purposes

herein

set forth.

The comgissioner may also enter into.

14 any contract for services as he deems -necessary vith a private^,agency or
15 concern upon said terns end conditions-as he deeps appropriate. -Infortna- •16 tion concerning oatient and medical data provided to the eo.-aaissioner
17 pursuen; to this subdivision shall be kept confidential according to the
13 provisions of paragraph (\) of subdivision one of section two hundred
19 six of this chapter.
. '20
3. The corrjr.issioner shall make an annual report to the legislature of
21 his findings end recommendations concerning the effectiveness, impact
22 ar.d benefits derived froia the special policies .as provided for in this
•23 s act ion. Such report shell be delivered on or before the first day of.
24 .^srch and shall conteir. evaluations of the policies and any legislation
25 deeded necessary a n d proper.
.
.
.
.
.
26
§ 3. The sun of ~vo hundred twenty-five thousand dollars C$225,000), '
27 or so nuch thereof as.cay be necessary, is hereby appropriated .out of
28 any 'moneys in the state treasury in the general fund to the credit of
29 .. rheostats purposes fund not otherwise .appropriated.. Of such amount, the.
30 sus of seventy-five thousand dollars ($75,000)j is appropriated and aade
31 available Co the temporary state commission on dioxin exposure and the.
'32 sun of on-s hundred fifty thousand dollars (§150,000), is appropriated
33 ar.d r.ade available to the departaent of health, to carry out -the* pur34 -ases of this act. Such moneys shall be payable on the audit and war35 rant of the comptroller on vouchers certified or approved in the manner
36 prescribed by Isu.
..
"
37
§ 9. This act shall take effect on the first day o f September,
'
33 nineteen hundred eighty. •
.

/.i

�».

&gt;

«*

m^c

S

RECORDED OiSlRiCI

J

1

RECiSU* NUMBER

1

CERTIFICATE OF DEATH
•CAL DIS"&gt;'C"

I

I

NAVE

FiAST

M DOLC

LAJT

J St&lt;

\

All

'I

1
1

NEW YORK STATE
DEPARTMENT OF HEALTH

'

r
1

J» I « 1 K 1- 1 L t NUMUEF1

APPENDIX

SUB'

3&lt;l

MALC

u
1

EC.
ES.

4 AGE

IF UNDER I YEAR
MONTHS

IF UNDER ( D A Y

DAYS

HOURS

I
YEARS

DECEDENT

1

n

| MINUTES

MONTH

I

'

•A COUNTY OF DEATH

&gt; DECEDENT BORN
|

OA»

|

I

'

YEAR

NO

YES

D

OA

TE OF D E A T H

MONTH

u
»

DAY
1
1

• VETERAN OF u S ARMED FORCES? ..

1

'

FEMALC

1
1

- ,

'
&lt;

1

T. SOCIAL SECURITY
NUMBER

IF YES. SPECIFY WAP. OR DATES •
O*"""1"

D

' «C HOSPITAL OR OTHER INSTITUTION
(If NEITHER, GIVE ADDRESS)

' «O IF IN HOSPlI
ALOR
INSTITUTION ICHECK
»OOOA

U «="»«&gt;*
Q TOWN OF

2 DEMERGING

D—"°'

• «E IF INPATIET
ONE) ' ADMISSION Ovnoou
. -ON.M | DAY | ,

.

2RS£«SJrM

'° SSS8&amp; ""*'

1

'

«B LOCALITY ICHECK ONE AND SPECIFY)

' &amp;SW5M!VSS. USA,

• 30 HCu"

YEAR

' ', p NEVE'R'MAR^ED"'" *"" Q W.DOWEO

.
•

:

,
•

"' S°RV'V""i ^^ "' "''" ^ "*""" "*""

t Q MARRIED OR SEPARATED 4 Q DIVORCED
1
1

AMCR|WANT|NB-ANCK"

'* S^EVoiECMSNE*4'

D

OT&lt;HERCiSPECIr-Y|N'

1 O MEXICAN

, Q OTHER SPANISH

J
•."""•XJ--^

/hESIDENCE\/

r"

USUAL RESIDENCE
WHERE DECEDENT
LIVED.

L_

Ci

»Q NO

l». EDUCATION INDICATE HIGHEST GRADE COMPLETED ONLY
ELEMENTARY

R CFNT^ALOR

*

'NG?^y.

00

01

02

OS OB

07

DDDD

0*

OO

10

.1

1
1

DDDD;
11

14

1

f^\

1
1

18

1

l/^\

tl'BiCOpNTY
^"*^f-^
,t • " j j A
•^V. '
JT \.

f^T

:

.'X&lt;i»«-«.-vl"

\

1?e. IF CITY OR VILLAGE. IS RESIDENCE
WITHIN COY OH VILLAGE LIMITST
JTES
NO
^EP"~™«tQ.
IF NO. BPECIFYTOWN:

"&amp;-*&gt; """
£5
^^
J*J

V

&lt;
^
_

.

f"1

LAST

I 1&gt;B

N

C*"EOF
AYuCC
FATMEfi

. T S. ,
T m I.

itjAM^OF
( rt«"F»t \jr
MOTHER-

t-:W

-•*•&gt;

-•\

L-AVDDLE

*

LAST

:vjjt
-^
4»^?^^fc,
^. y^.*^^7T^J

f

1GA.NAMEOF INFCAMANT

N

jjjj

^

/??'
••"

MIDDLE

:

'

* &amp;k'C fOCAllTY (CHECK pNErKNO.Si'.ECIFY)
3 V ! D CITYX&gt;F
{ ."/
'V
/
t1 .«' D ^^J* or
."7'^V?i
L
i '' «O vittioE OP
J'^.Jf
&gt;.;^

-1"1FIRST

04

&gt; ICC. NAME AND LOCALITY OF FIRM OR COMPANY

ifo. STREET AND NUMBER OF RESIO£T?CE (INCLUDE ZIP CODE)

1»&lt;k

03

COLLEGE

ll«B. KIND OF BUSINESS OR INDUSTRY

*\

17A. STATE Sj/l
tj^
*j
-&lt;t^
ff

HIOH SCHOOL

DDDDDDDDD

*O ISuTH AMERICAN

ItAw USUAL OCCUPATION (DO NOT ENTER RETIRED)
" ' "

TES

, 1 0B. MAILING ADDRESS IINCU/DC ZIP CODE)

/ DISPOSITION \

1
1

B

•

~;.

20A. BURIAL. CREMATION. RSMQVAl Oft' MONTH |

•
•

DAY JYEAR* 2OB. PLACE OF BURIAL. CREMATION. REMOVAL OR

i
i

i
i

i
i

21 A. NAME AND ADDRESS OF FUNERAL HOME

21 B. REGISTRATION NO.

22A. NAME OF FUNERAL DIRECTOR

1
j 23B

'MONTH! DAY (YEAR 24A. BURIAL OR REMOVAL PERMIT ISSUED

1 FILED |

X

|

'

•

•

a.
MONTH! DAY I YEAR

CEHTiri

1

A. ON THE BASIS OF EXAMINATION AND/OR INVESTIGATION.
IN MY OPINION DEATH OCCURRED AT THE TIME. OATF
AND PLACE AND DUE TOTHE CAUSES STATED

,

I

SIGNATURE r

|

,

.

i

AND
TITLE

I C. LAST SEEN ALIVE

I

I

I

TO:

I

I

I

I

I

1

I

D
D

^

p*

-

B. PRONOUNCED DEAD

I

I

I

ON

I

1

I

I

D. NAME OF ATTENDING PHYSICIAN. IF OTHER THAN CERTIFIER

I
1

m__.« .,
LjCOHONl
CORON!
PHYSICI

SIGNATURE
_

t

1 AT

MONTH

M '
1
t

*

MEDIC*
EXAMIK

ID. DATE SIGNED

1 C. HOUR

1
FROM.

I
1

TO BE COMPLETED BY
CORONER OR MEDICAL EXAMINER ONLY

nR

A. TO THE BEST OF MY KNOWLEDGE. DEATH OCCURRED AT THE
TIME DATE AND PLACE AND DUE TO THE CAUSES STATED

B. THE PHYSICIAN ATTENDED THE DECEASED

1
1

BY:

TO BE COMPLETED BY
CERTIFYING PHYSICIAN ONLY

„

24B. ' MONTH j (JAY j Y

|

'

r»

c
in

22C. REGISTRATION NO.

1 22B. SIGNATURE OF FUNERAL DIRECTOR:

21A. SIGNATURE OF REGISTRAR

*

1 2OC LOCATION (CITY OR TOWN. STATE)

'
"

DAY
I
1
i

|

YE,'

I
1
i

E. SIGNATURE OF CORONER'S PHYSICIAN. IF OTHER THAN CERTIFIER

i

&gt;•

26 NAME AND ADDRESS OF CERTIFIER (PHYSICIAN. CORONER. MEDICAL EXAMINER. CORONER'S PHYSICIAN, MEDICAL DIRECTOR!

\
it. DEATH WAS CAUSED BY
^

cc!&lt;oiTi:&lt;(: if

•

*NT. W1.Cr&lt;
CAVf F.:«:TO
IMW£OliI£
C^US! a
S1S7ISG T«r

fs:^ir:s:
ctujf u;t

APPROXIMATE INTERVAL

ENTER ONLY ONE CAUSE PER LINE FOR 1*1 (BL ANDICI

BETWEEN ONSET AND DEATt

PART 1 IMMEDIATE CAUSE

f

'A:
DUE TO. OR AS A CONS£CUE&gt;'CE OF.

IB:

i

:

i

Out 1O CR AS A CONSEQUENCE Or.
CAUSE

(

•c&gt;
*"•- It OTM'H VG;."'(-»sT rf}li[)IT&lt;O"-, CONDITIONS CONTRIBUTING TO
L"l*fH BUI NO' R l L A I C O IO CAUSE GIVEN IN PAOI 1 (A.

•
VJ'iirH U'^^'ETEHVINitJ PLNLJIIJC;

D
t
' DJO DATE Of INJURV
•' MONIM
1
1

|N,UI&lt;» A l y.i^^f

V£s

'

tit if.(1(«y IF Al'.iSEr.T M.O'/iC'Cr

Vit

"A AUtOPSrl

OA»
,

'
1
3(,f Pl»L'E OF IIJIIIMY HOM£
J
I AClOfiv.Cin HC OlOo . trc

f
.
1
-

NO

CD
2

'IOC HOUil OF

YEAR

'

; | IF YES »VCHt FINDINGS CONSIDER! O 1 N
g)
DETERMINING THE CAUSE OF DEATH'

i D ves

2 D NO

2» WAS C A S C HEFERHE
TOCORONEaOR
MCniCAL EXAMINER

T D

100 DESCRIBE HOW INJURY OCCURRED

INJURY

1
'
M
t
. SOO IOC A1 ION ($TRC CT t NO . Cl T Y OR VILLAGE. T OWN. COUNT Y. ST AT E 1
,

VES

2 D

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24317">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24319">
              <text>1865</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24322">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24316">
                <text>Greenwald, Peter</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24318">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;State of New York Department of Health, Office of Public Health</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24320">
                <text>1981-01-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24321">
                <text>Epidemiological Study of Soft-Tissue Sarcoma</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24323">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24324">
                <text>cancer risk assessment</text>
              </elementText>
              <elementText elementTextId="24325">
                <text>soft tissue sarcoma</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3287" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24301">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24305">
              <text>1864</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24311">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24297">
                <text>Greenwald, Peter</text>
              </elementText>
              <elementText elementTextId="24299">
                <text>Vito Logrillo</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24303">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;State of New York Department of Health, Office of Public Health</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24307">
                <text>1980-11-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24309">
                <text>Proportional Mortality of Vietnam Veterans, Other Veterans and Matched Controls in New York State, Exclusive of New York City</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24313">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24314">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24315">
                <text>cohort study</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3285" public="1" featured="0">
    <fileContainer>
      <file fileId="1697">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/4d98a0d57e31f6a0c20ed1507e793b90.pdf</src>
        <authentication>937afc88f2448c778e2b9b2401c65ea1</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63646">
                    <text>ItemDNunbor

°1863

Author
Corporate Author
Report/Article Title Conference Call Announcement, New Jersey Agent
Orange Study

Journal/Book Title
Year

1986

Month/Day

September

Color

n

Number of hiagos

8

DeSCTlptOn NOtOS

Announcement discusses the New Jersey State Agent
Orange Commission press conference that announced
the results of New Jersey's Agent Orange Vietnam
Veterans Study. Also included in this item are several
clippings, interviews, etc. on the New Jersey study.

Wednesday, July 11, 2001

Page 1864 of 1870

�Conf Gcuiieu Cal 1 A
tfcvi/ jkjfHoy Aqeat Orange ytivly
!•
1 wish to bring to ./out attention this iwrnifjy ei isi-jan; Leant aeveiGpsiiont o&lt;i
is Agent Orange "sc^ao," an «vtwit ot: which you u.ty ali.eaci/ oo well aware au a
o£ news reports or contact.;; oy the ineaia oc the jerierai public wita
your. .facilities,

Laat Wednesday, Seat«m:i«5£ 17, tao Me** Jet soy State Ayent Ocange Commission
held a £&gt;reua conference to announce the results oL' a .study, do.si.gna ted as tue
"Point Man" Study,, to m^eujure •'U.oxin .levels in i.at. tuxj i^lood in Vietnam
veterans, Thia study cxrapated the isvehj of ttioxia in tat of J.U vietnasft
n)if.h tliat 01: two .cot^tcoL qt'oupa, tivat IG, (x&gt;nur,oi,s ooiitiutlny oE 10
veterans wno tia&gt;'i iio knon/n exjwsuc^ diiu 7 Vietnum eta vstorai'w wao
nevec served in. Vietnam.
tatudy'y invescicjatocs diuo.i.t)33d tisat tiie Vietnam votetaas .vaom wiiitary
records «howoi3 to nave ;U-.1 hi^u «^qxj^ure to Ayjnt uran-je had ::t.jit..i.stlcaliy
siojaifiGiirit hiyiior luv^Lr. of tao '^.,3,7,b .lioxiu .i.yu;&lt;wr in tnoir uiooJ and fat
than dici the contcox ijcuuoir. ai the basi.y o£ tholf tJi'Hoct., they concluded
thcjt 2,3,7,8 tetcach Lof'.v-tj-viioxin GVJU be detected in i.docw an;] Lnt &lt;it
extrein-ily low leveia (pou'tr. ixcj tt.ili.ion); that c»a analysis OL' j.Lood can L&gt;e
perforce! to identify tnu ^ru3&lt; aco ot UKJ Agent Oran^t- oiuxin LSCTIOI ; and t.iat
there i;j a correlation i&gt;,jt.i-/een exj-o-iute to Ajsnt Qcan-jo dno thy lev-cJ.s of
dioxin found ia trie biOo&lt;; r Ta^ i!iVtj3tio&lt;»Uoca stateu tnat tney 'iad ao
information concerning whether t.n??re \/&amp;,s a relation s n i p between lovely of
dioxin founa in taa i&gt;loo;i and t.io pi ^!&gt;enc^ of .ulvot.;c 1health. Tho second
pbiiie oi: their eficoit, ..v.i unvdiiy cae .stab.} or tlow Jetot: / dgr«svjK co provide
iiunoiny, v'?lil ixs to iw* -tt .thu .aicaical intoi.'iii'itijn t.v.it whs tjath^raii f.i:on ttie
atucty subjects ..*nj att^iaj.&gt;r. LO t;0t; it; .-my .-ioca &lt;x&gt;i:ro.Lf»f.ion tf/usts. i^K-&gt;/ J«i;atjy
currently has iatroUuc^ t iegiolafioa to yu..&gt;c\&gt;r;t ftu.v. ou:ort.
Preoont at tne news cosuu-ruaoe wore muutoera of tho &gt;.&amp;••.r Jer.st/ A9ent (3
Cojmu.-3JLon, RcprostiJitat ivo Plot io ftoui Now Jyisey (wuo .ias ueon .active in
enyiroriioental issues aa-i j.st,ue.s relating to cotiijxuis.iti-ja Lot exoc&gt;sure to 1
toxic
substances) and Kopi'arjrvitati.veio Dasc.ily aad liUgat froi.i the fiotis&lt;^ Vetuians
Affairs Coj.imttee, Mr. 1^.01:io prwified the stuuy ai&gt; a t i r u t effort in what
could eventually have pi.abound ii^act on toxic iLti'-jntiou and leyiolation. •
Mr. uaschltj and Mr. iviyai i:&gt;otn exi'sre^eu cjr.5titvid« thuc prcxjtuys La ooiny made
ai)J statcvi that tne c;x -^loujvi &lt;jive sttoaq coasideiMticn to tne f-tew Jersey
eftoit before nvui;iri'j a^r/ i'iajj (.'viternunatiods* conwvni.iiy the totiuia-Atloa of
the Ag^nt Orange stuoy* -j'ht' C'onyr.^.s Lonal Ofiico o-. 'LVofinoloj/ Awaossmetit
(OTA) will be asked to c;. Ltj.caiiy rwicw tne ctu-jy.
Copiets of Hew Jersey's ;&gt;ta&lt;iy aavii not yet been iiude av.-ulablo to OTA, tii^ VA,
or for that matter, to -my gcoup or orcjcuuzation. Wo ate in the process of
attempting to obtain a copy tor: ouz own inter.naL rt;7j\iw. The study nas been
puesentc-c'i at che International synpcxiiun on Di.oxin n&lt;jw going on in Japan.
In tae meantijnc you w i l j us-.cioabtociiy rwcoivc* a^.Ua &lt;HKI other Lajuiries on this
late breaking dovelopneut. ite uavo oaon .iUvisoJ oy i-bs. Doana St. John in tno
VA'a Office of PuoUc unJ Curioumer Affairr, that you saould rot'ei ili i!&gt;e&lt;'iia
contacts to your tea^ctive Rogiondl Public Ai

�received within VA Central Office are owing routinely referred to
Ms, St. John. Public and Consumer Affairs is in tno process of providing uach
of their regional offices with information relative to the proas conference
at&gt;d the study.
Essentially, tne VTv'.'i otauot.1 is tint we ..u«-.; inter:e.yt.'i(.i in tu^ stu&gt;.iy au-J tto have &gt;.t reviowed ny a.,'Af tue VA'S Auviyory Committee on liivd.th-i'iej.atua
Eff&lt;;ct3 oi ilettnciUc^ «n..i tiw VA'.s Bnvitouiayutai ila/,«uofi Coinsui tt.ee. It woulti
be preinatare to cojiunent oa the ccvsulta of tlici .stuay, or of the ciJ.i.-iijility and
validity or its inetiiouoiogy, until suou teviews ,-ux1 corn.iucteu .
I'll Koyp you fully eJcJvis&lt;2J 3iioaltJ anything further tian.ypire which needy to
be brought to your attention. If you have tiny ^uestiontJ concerniny what I've
just covered I'll be yiad to r:esj.:&gt;ond to than at t'us

�UPI, 9/17/86
Panel: High dioxin levels found in Agent Orange victims
By JOSEPH MIANOWANY
WASHINGTON (UPI) - The New Jersey Agent Orange Commission said
Wednesday it had found abnormal dioxin levels could be detected in the
blood of Vietnam veterans exposed to the herbicide t a possible
breakthrough in learning if exposure caused health problems.
Commission members, releasing in Washington the results of a
three-year study, cautioned that the findings did not prove the dioxin
levels found in the veterans were the cause of health problems.
However, they stressed that the fact the dioxin levels were
detected 11 years after the end of the Vietnam War could be a crucial
step in determining if exposure to Agent Orange, a defoliant used during
the war, was responsible for a variety of health problems suffered by
some veterans years later.
Reps. Tom Daschle, D-S.D., James Florio, D-N.J,, and Bob Edgar,
D-Pa., said they would ask the congressional Office of Technology
Assessment to review the New Jersey study, labeled "The Pointman
Project."
Daschle, a member of the House Veterans Affairs Committee, said
officials from the Centers for Disease Control, which is conducting its
own Agent Orange study, told Congress three weeks ago that it seemed
impossible to determine if exposure to the herbicide had caused health
problems.
They said the biggest problem was that there was no way to
differentiate positively between dioxin the veterans may have in their
bodies because of exposure to Agent Orange and background dioxin to
which they may have been exposed elsewhere.
The New Jersey study, done in conjunction with the University of
Texas Medical School and the University of Umea in Sweden, tested 27
people from three groups: Vietnam veterans who were likely heavily
exposed to Agent Orange, Vietnam veterans who were not exposed and
Vietnam-ear veterans who did not serve in Southeast Asia.
Toxicologist Ralph Fogleman, who worked on the study, said the
findings showed the level of dioxin in the blood was much higher for the
veterans exposed to Agent Orange than it was for the other two groups.
He said the results were similar for fat samples taken from the
veterans. He stressed that the blood tests were simpler and less
expensive.
Commission Chairman Allen Falk said he hoped the results could help
change a May 1984 settlement of an Agent Orange lawsuit. That
settlement, he said, was based on the presumption that there was no
litmus test for determining if exposure to Agent Orange had caused
health problems.
Florio called the New-Jersey study "an historic medical research
event" which he said could also help in dioxin exposure cases other
than those related to Agent Orange.
"Agent Orange victims are the first cousins of prisoners of war,"
added Daschle.

�BY SGB NCHU6H
WASHINGTON (flP) -- A GROUP OF VIETNAM VETERANS? SCIENTISTS AND
CQNGRESSHEN ON HEBNESBftY ANNOUNCED RESULTS OF fi STUDY THEY SfiJB PROVES
HI LAST THE DEADLY EFFECTS OF THE WftRTINE HERBICIDE flGENT-ORANGE.
SCIENTISTS SAIB THE RESEARCH*' FINflNCEB BY THE STfiTE OF NEW JERSEY,
SHOWS FOR THE FIRST TIKE fi BIOLOGICAL "FINGERPRINT" LEFT IN VETERANS'
BLGGB BY BIQXINi fi KEY AGENT ORfiNGE INGREDIENT,
SCIENTISTS AND SPOKESMEN FOR THE N.J. &lt;NEW JERSEY) AGENT ORfiNGE
COMMISSION, THE STUBY'S SPONSOR? SftID THE NEW TESTING TAKES THE CftSE
RGENT ORfiNGE TWO CRUCIAL STEPS FORWflRD.
T
THEV SRIB THE RESEflRCH SHOWED TELL-TflLE TRflCES OF BIQXIN CfiN ST i l I
IE SUCCESSFULLY SEEN YERRS AFTER EXPOSURE. FURTHERMORE? THE TESTS FOUND
LEVELS OP JIGXIN 10 TINES HIGHER IN EXPOSED VETERANS THftN IN OTHER
UlETNrtH-ERA SERUlCEflEN.
THE RESERRCH.ON 10 HIGHLY EXPOSES VETERftNS? HOWEVER? STOPS SHORT OF
LINKING THEIR HEfiLTH PROBLEMS BIRECTLY TO THE WIDELY USED BEFOLIANT,
TH£ SCIENTISTS ftCKNOyLEBGEB, BUT THEY ftSSERTEB RT fl CfiPITOL HILL NENS !_'_

CONFERENCE THRT THE STUDY REPRESENTED fl "BREflKTHROUGH" IN EFFORTS TO
LEnRN THE TRUE EFFECTS OF THE HERBICIDE. •
THE RESULTS OF THE STUDY? THEY SHIB? SHOULD PROHPT THE FEBERRL

GGU-ZRNREKT TO DROP ITS LONG3TRNBING CL8IM THfiT THERE'S NO KflY TO PftDUE
fi CfiliSE-RhL-EFFECT RELRTIONSHIP BETWEEN fiGENT ORRNGE RNB POOR HEflLTK.
:?
T H £ UIETNfl-1 UETERHN HfiS BEEN IN fi LONG? BBRK TUNNEL? fiNB HRYBE NQU
^ SEE TME L I G H T ? " SRIB CHARLES KRRUSS? fl MfiYNE? N.J.? RflN WHO HfthDLED
•SGENT QRAftGE IN UIE T NflH ftN3 UOLUNTEEREB TO BE TESTED.
UETERnKS HNB THE GOUERNHENT HfiUE BEEN DERDLOCKEIJ IN THE BEBRTE BBOuT
T
H£ DEFOLlHNT USED TO CLERR UIETNBH'S DENSE JUNGLES,
THE UETERBNS CLfllH flGENT ORfiNGE IS THE CflUSE OF HEftLTH PROBLEHS TO
THEN RNB THEIR FftMILIESi RANGING FROM SERIOUS fiCNE TO CfiNCER,
GQUERNHENT OFFICIALS COUNTER THfiT NO SUCH LINK HfiS BEEN PROUEN — A
CLHlll THRT PREVENTS UETERRNS BENEFITS FOR THE ILLNESSES.
fi LflHSUIT FILED PGfllNST SEUEN flGENT ORANGE HRNUFflCTURERS'BY METERflNS
FRGK fi^ERICh? fiUSTRRLIfi flNB .NEM ZEHLft^B RESULTED IN fi $200 HILLION
S£ T TIEKENT IN 1S34. THE LITIGflTION? CURRENTLY UNDER ftPPERL? INCLUDES
2 4 5 ? m CLfllNS OF HERLTH DfiHRGE,
K R A U S S - f l N D NINE OTHER UIETNfifl VETERflNS WITH fi HISTORY, OF HANDLING
TME BEFGLISNT SERUED fiS PfiTIENTS IN "THE POINT NflN PROJECT?" NftHED
FOR THE SOLDIERS MHO DREW ENEHY FIRE AS LEftDERS OF THEIR UNITS,
THE VETERANS I^ERE STUDIED ALONG yiTH 1? "CONTROL" .CBSES? INCLUDING
liETERHNS NHG SERUEB IN MlETNflH WITHOUT DIRECT ftGENT ORfiNGE EXPOSURE?
AND VETERflNS OF THE ERfl MHO BIB NOT 5ERVE IN SOUTHEAST ASlfl.
LEVELS OF fi BIOXIN FORM KNOWN-AS TCDD ftVERftuEB ABOUT 4.8 PRRTS PER
TRILLION IN EXPOSES VETERflNSi CONPflREB TO RBOUT 4 OR 5 PfiRTS PER
TRILLION IN THOSE'MHO SAW NO VIETNflN SERVICE* SffIB TOXICOLOGIST RftLPH
FQGELHRN,
fiP-HX-*}3~l?-86
1432EBT
.
;

�Dioxin Found in Vietnam Vets
*

Los Angelas Times

on a new high-technology method of
, A medical study released yester- measuring tiny amounts of dioxin in
day verifies for the first time that tissue. Samples of blood and fat
;
Vietnam veterans who were ex- were taken from three groups of
| jposed to the herbicide Agent veterans: 10 who the Pentagon con| prange still carry high levels of firmed had handled Agent Orange
.
poisonous dioxin in their sys- regularly, 10 who served in Vietnam but had little or no exposure to
tems.
The report is considered a break- the defoliant, and seven Who were
•
through in the difficult effort to link not stationed in Vietnam.
The study found that the average
veterans' ailments to the wartime
dioxin level in the high-exposure
herbicide.
"We have found some startling group was seven times higher than
evidence that we believe will re- the low-exposure group and 10
open the Agent Orange issue," said times higher than the group outside
Allen Falk, chairman of a New Jer- Vietnam.
Dioxin has been linked scientifsey commission that organized a
three-year investigation of selected ically to cancer, and veterans have
veterans by U.S. and Swedish sci- claimed they also have suffered
entists.
from nerve defects, skin conditions
The New Jersey study was based and defects hi offspring.
1

�CBS Morning News, 9/17/86

Faith Daniels: Agent Orange — It's one of the most bitter legacies of the
Vietnam War. It's been at the center of controversy and medical confusion
ever since the troops came home. There is still no direct medical l£nk
between Agent Orange and the diseases that afflict so many Vietnam vets. But
today scientists are now seeing an important step toward finding that link.
Dr. Bob Arnot is here to tell us about it. Good morning.
Dr. Arnot: Good morning, Faith. When Agent Orange was first produced for the
Vietnam War a highly toxic biproduct called dioxin appeared during the
manufacturing process. Now until recently it was assumed that if you were
exposed to dioxin it disappeared within several years. Now for the first time
researchers announced they have found large,, quantities of dioxin still present
in soldiers exposed to it in Vietnam. These are not the findings of
government researchers, but that of a private research group headed by Vietnam
veterans and funded by the State of New Jersey.
Wayne Wilson, New Jersey Agent Orange Commission: I wish that Vietnam
veterans were healthy. I wish that all of us were able to put this Vietnam
War behind us, and that we can get on with our lives. But the fact is there
appears to be large numbers of Vietnam Veterans who are sick. They turned for
their government for some understanding and for some help. And the federal
government turned its back on them.
Dr. Arnot: So Wilson and his colleagues at the New Jersey Agent Orange
Commission launched their own research under the help of the Vietnam
Veterans. That was two years ago. Twenty-seven carefully selected men
checked into a New Jersey hospital. Ten of the men were known to have been
heavily exposed to Agent Orange in Vietnam. Seventeen others were not. The
men were subjected to two days of testing and a surgical procedure, parts of a
new technique to measure dioxin in fatty tissue and blood.
Charles Price: In 'eighty-one I had a tumor removed from my jaw.
'Eighty-two, had a huge one under my arm that was removed.
Dr. Arnot: Charles Price was part of the study. He, like many vets, believes
Agent Orange has made him sick. Price was a flight engineer for the Air
Force. From 1969 to 1970, he flew the Ranch Hand mission, spraying gallons
and gallons of Agent Orange on the dense Asian jungle. Price says the
chemical defoliant sprayed in his face through the open cargo doors, soaked
his clothing -- and he even waded through it on the ground. Now he knows his
body is full of dioxin.
Price: If I thought about it, a lot of it would probably drive me nuts. So I
just go along every day and just try to remove it from my mind.
Dr. Peter Kahn: And look at spray handlers, men who handled the spray on a
regular basis throughout their time in Vietnam. And we matched them against
unexposed, control veterans.
Dr. Arnot: Dr. Peter Kahn was the principal organizer of the experiment. A
biochemist at Rutgers University, he supervised the surgical procedure to
remove the sample and some preliminary lab work. The samples were then sent
to the laboratories of Dr. Christopher Rappisch(sp), in Umea, Sweden. He
pioneered the new dioxin test.
-1-

�-2-

Dr. Rappisch: What we aimed at was to see whether chemical analysis could be
used to identify exposed Vietnam veterans. And when the studies were
complete, I think we could have an answer on that — yes or no.
Dr. Arnold: And the answer was yes. Dr. Rappisch found high levels* of
dioxin stored in the fat of all but one exposed veteran. But most alarmingly,
he also found that dioxin continued to leak out of fat into blood twenty years
after exposure to Agent Orange. The highest blood concentration? 180 parts
per trillion.
Dr. Kahn: The normal values are typically around 5 and may run as high as
10. And for the heavily exposed men the mean is, I can't remember exactly,
but it's around 40.
Dr. Arnold: Now that the dioxin has been found, what does it mean? The vets
claim that it has caused cancer, liver damage, nerve disorders and birth
defects in their children.
Dr. Kahn: There is a growing body of literature linking exposure to chemicals
that contain dioxin as contaminants to a number of forms of cancer, with
incubation times on the order of 15 to 20 years. Malignant lymphoma, soft
tissue sarcomas have all been mentioned.
Dr. Arnold: But so far, dioxin has only proven to be cancer-causing in
animals, not in humans. And yet another question has been raised. What if a
Vietnam Veteran returned to the United States, and lived and worked in an area
with high dioxin emissions? How can we be sure of the source of his
exposure? The New Jersey study claims to have the answer. With a technique
so sensitive it can differentiate between Agent Orange dioxin and other
dioxins. And this gives him a big boost in future research.
Dr. Kahn: If you are concerned about your personnel health, don't think Agent
Orange, think dioxin. And in that regard, Vietnam veterans have been, as Dr.
Arnold suggested, the point man for every citizen of this country.
Dr. Arnold: Now there are only 1275 "Ranchhanders" who were exposed to the
high concentration of dioxin during the war. But there are over 200,000
claims made by veterans and their families. This check will now make it
possible to identify which ground troops were exposed to high levels of dioxin
in the fields. That then can help scientists to link dioxin levels with
instances of cancer and other illnesses. And it also will help to follow
exposed veterans with signs of disease in the future.
Faith Daniels: Bob, dioxin is believed to be a cancer-causer.
proven?

Why isn't it

Dr. Arnold: The reason is that the incidence of these kinds of cancers is so
low — you know, one or two per hundred thousand -- and an increase of three
or four per hundred thousand wouldn't be seen unless we studied huge numbers
of people. This test will now allow the government and other researchers to
study those huge numbers of people to try and find that link. Not that it
doesn't exist, they just couldn't look for it before.
Faith: All right. Thank you very much, Dr. Bob Arnot.

�THE NEW YORK TIMES, THURSDAY, SEPTEMBER 18, 1986

Researchers Report Finding
Telltale Sign of Agent Orange
WASHINGTON, Sept. 17 (AP) - A The veterans say Agent Orange is
group of Vietnam veterans, scientists the cause of health problems for them
and members of Congress today an- and their families, ranging from serinounced the results of a study they say ous acne to cancer. Government offimay finally prove the deadly effects of cials counter that no such link has been
the wartime herbicide Agent Orange. proved, a position that prevents the
Scientists said the research, financed veterans from receiving benefits for
by the State of New Jersey, snowed for the illnesses.
the first time a biological "fingerprint"
»W Million Settlement
left in veterans' blood by dioxin, a key
A lawsuit filed against seven Agent
ingredient of Agent Orange.
Scientists and spokesmen for the Orange manufacturers by veterans
New Jersey Agent Orange Commis- from the United States, Australia and
sion, the sponsor of the study, said the New Zealand resulted in a $200 million
research showed that traces of dioxin settlement in 1034. The litigation, now
could still be successfully seen years under appeal, included 245,000 claims
after exposure. Furthermore, the testa of health damage.
found levels of dioxin 10 times higher in Mr. Krauss and nine other Vietnam
exposed veterans than in other service- veterans with a history of handling the
defoliant served as patients in the
men of the Vietnam era.
The research on 10 highly exposed study.
veterans stops short of linking their Levels of TCDD, a form of dioxin,
health problems directly to the widely averaged about 48 parts per trillion in
used defoliant, the scientists acknowl- exposed veterans, as against about
four or five parts per trillion in test
edged.
'
subjects who saw no Vietnam service,
said Ralph Fogelman, a toxicologlst.
Findings Termed Breakthrough
But they asserte/at a Capitol Hill The cost of the research, about
news conference tjftat the study repre- $400,000, was paid for through legislasented a "breakthrough" in efforts to tion passed by the New Jersey Legislalearn the tme effects of the herbicide. ture. The tests were begun laet year at
They said the results of the study Barnert Memorial Medical Center in
should prompt the Federal Govern- Paterson, N.J.
ment to drop its longstanding contention that there was no way to prove a
cause-and-effect relationship between
Crossroads for
Agent Orange and poor health.
"The Vietnam veteran has been in a
soltorsend
long, dark tunnel, and maybe now- we
see the light," said Charles Krauss, a
resident of Wayne, N.J., who handled
Arii
Agent Orange in Vietnam and volunTheWtowlfortc
teered to be tested.
Veterans and the Government have
Ttesas
been deadlocked in the debate about
the defoliant used to clear Vietnam's
dense jungles to deprive the enemy of
cover.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24282">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24283">
              <text>1863</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24286">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24284">
                <text>1986-09-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24285">
                <text>Conference Call Announcement, New Jersey Agent Orange Study</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24287">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24288">
                <text>popular press</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3284" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24274">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24275">
              <text>1862</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24277">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24273">
                <text>Bangert, Joseph V.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24276">
                <text>Letter: to Charles H. Hubbs from Joseph V. Bangert, January 30, 1987</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24278">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24279">
                <text>adipose tissue testing</text>
              </elementText>
              <elementText elementTextId="24280">
                <text>dioxin</text>
              </elementText>
              <elementText elementTextId="24281">
                <text>Air Force Health Study</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3282" public="1" featured="0">
    <fileContainer>
      <file fileId="1695">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/bc54fa583efffdef8051d9f49a71404e.pdf</src>
        <authentication>208c08c339cf33fd3b1a079fcdbc1162</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63644">
                    <text>ItomDNunber

°1861

Author

Bangert, Joseph V.

Corporate Author

Commonwealth of Massachusetts Agent Orange Progra

RdDOrt/ArtldO TltlO Health Survey of Massachusetts Vietnam Veterans,
Summary

Journal/Book Title
Year

1986

Month/Day

June

Color

0

Number of Images

12

Descrlpton Notes

Wednesday, July 11, 2001

Page 1862 of 1870

�COMMONWEALTH OF MASSACHUSETTS
AGENT ORANGE PROGRAM
Office of the Commissioner of Veteran's Services
100 Cambridge Street
Boston, MA 02202

"Health Survey of Massachusetts Vietnam Veterans"

SUMMARY

June, 1986

�FOREWORD
The Commonwealth of Massachusetts Agent Orange Program, a program of the
Office of the Commissioner of Veterans' Services, was provided funding by the
1983 Massachusetts Legislature for the purpose of conducting, "medical and
scientific testing related to the possible health effects of Agent Orange on
Massachusetts Vietnam Veterans."
In January, 1984, the Agent Orange Program, Office of the Commissioner of
Veterans' Services (OCVS) was implemented to survey programmatic, medical
and scientific options. The Agent Orange Program instituted the Agent Orange
Medical /Scientific Advisory Board to provide technical recommendations, oversight and review of proposals and implemented medical and scientific programs
and studies.
In January, 1985, the Massachusetts Agent Orange Program, in cooperation with
the Massachusetts Department of Public Health published the "Mortality Among
Massachusetts Vietnam Veterans, 1972-1983" written by Michael Kogan, M.A., and
Richard Clapp, M.P.H., as the first step in the Commonwealth's attempt to find
some answers to the complex questions surrounding the issue of Agent Orange.
This mortality study provides a stable foundation for our continued ongoing
efforts to provide scientific, technical, verifiable data regarding the effects
of Agent Orange where none had been previously available.
The Massachusetts Agent Orange Program's "Health Survey of Massachusetts
Vietnam Veterans, 1986" is the second step in our program's continuing
efforts to determine the needs of Massachusetts Vietnam Veterans and their
families. This survey utilized the "American Legion," or "Stellman questionnaire,"
with minor modifications. The survey results, contained within, are the result
of over 2,000 Massachusetts Vietnam Veterans and their families, and dependents
who took the time out to complete a rather detailed and complex form. Only
1,500 of the 2,000 questionnaires were included in the Massachusetts survey
as they were chosen on the completedness of the questionnaire, and those
filled out by Massachusetts veterans who had not been in the Vietnam theatre
were excluded.
The analysis of the data collected by the Massachsuetts Agent Orange Program
was compiled and analyzed by Mr. Frank J. Bove, M.S., an epidemiologist and
PhD candidate with Harvard University School of Public Health. We are indebted
to the hard work of this young scientist.
The Massachusetts Agent Orange Program also acknowledges the leadership role
of Governor Michael S. Dukakis of Massachusetts as well as that of Commissioner
of Veterans' Services, John Halachis in their ongoing committment to this
program and its importance for the more than 50,000 Massachusetts Vietnam
Veterans. We also acknowledge the General Court of the Commonwealth of
Massachusetts, and in particular to Senator Fran Doris, Representative Thomas
Vallely and former Representative Tom Lynch who took the leadership in bringing
the Massachusetts Agent Orange Program into being. We would be remiss if
we did not acknowledge the pioneering role of Mr. Christopher Gregory, the
former Director of the Agent Orange Program in getting the program on line.
We shall continue first and foremost to aggressively and independently survey
and test Massachusetts Vietnam Veterans who bore the brunt of battle and will
never be forgotten.

Jsefob/V. Bangert, Director
Massachusetts Agent Orange Program

r

�SUMMARY

Fifteen hundred Vietnam veterans in Massachusetts completed
health questionnaires in January 1985. The respondents were
those who filed a claim against the $180 million proposed out of
court settlement reached by attorneys' representing the seven
chemical manufacturers of Agent Orange and Vietnam veterans.
Although not a random sample of the more than 50,000 Massachusetts Vietnam veterans, the findings indicate a considerable
amount of illness among the respondents including tumors, neurobehavioral problems, reproductive difficulties and birth defects among their offspring. These findings are consistent with
the observed symptoms and disease found among those exposed to
2,4-D, 2,4,5-T and 2,3,7,8-TCDD (Dioxin) in the workplace or the
environment.

INTRODUCTION

Concern about the long-term effects of exposure to Agent
Orange is widespread among Vietnam veterans in the U.S. and Australia, as well as among the citizens of Vietnam. In southern
Vietnam, recent studies report a variety of persistent clinical
problems including recurring bouts of headaches, depression and
anxiety, asthenia, loss of libido, GI disorders and adverse reproductive outcomes. Studies of workers exposed to dioxin contaminated substances have found elevated rates of lymphomas and
soft tissue sarcomas. Neurologic and liver effects have also
been reported. Table 1 lists the findings of some of these occupational studies. Table 2 lists the findings of a Massachusetts
Departments of Public Health and Veterans Services study of mortality among Vietnam veterans. This study found elevated rates
of soft tissue sarcomas, kidney cancer, motor vehicle accidents
and suicides. Table 3 lists findings from other studies of
Vietnam veterans.
This survey of the health of Massachusetts Vietnam veterans
is part of an on-going research program that was sparked by the
findings of previous studies as well as the concerns raised by
veterans. The results of this survey are consistent with those
in the studies mentioned above.

METHODS AND SUBJECTS

In January, 1985, The Massachusetts Agent Orange Program
instituted a large-scale media campaign to alert Vietnam veterans

�of the court-imposed deadline for filing a claim against the proposed $180 million settlement reached by attorneys for the seven
manufacturers of Agent Orange and Vietnam veterans. About 2,000
veterans filed claims during a two day period at the state's
Office of Veterans Services. The American Legion health questionnaire was distributed to those filing claims. In addition,
some 300 questionnaires were mailed to veterans who phoned the
Agent Orange Program requesting to participate in the health
survey. Approximately 1800 questionnaires were returned to the
Agent Orange Program, fifteen hundred of these were selected
based on the criteria of completedness and actual service in
Vietnam.
Staff of the Agent Orange Program as well as trained volunteers, all of whom were Vietnam veterans, assisted respondents
with any questions or difficulties they encountered with the
questionnaire. Concerning the birth outcome data requested by
the questionnaire, if the veterans were not sure of the information being asked, they were provided with a self-addressed envelope and permitted to take the questionnaire home to consult with
their spouses.
RESULTS

Analysis of the questionnaire data was performed using DBASE
III.
Over a quarter of the respondents stated that they were
diagnosed with tumors (cancerous, benign, fatty or other). Nine
were diagnosed with Hodgkins Disease. Nearly 22% of the respondents indicated that one or more of their children had birth defects. Out of 1907 live births reported in the questionnaires,
462 (24%) had at least one birth defect and 160 had more than one
defect. Thirty-seven spina bifida, other brain or spine defects
were reported. Table 4 presents the data on other congenital
malformations.
Nearly one-third of the respondents indicated a decrease in
libido and 22% reported fertility difficulties (see Table 4).
Nearly two-thirds of the respondents indicated persistent problems with tiredness, over half reported persistent headaches and
difficulties with memory or concentration, and almost half reported nervous disorders (see Table 5).
Seventy-three percent of the respondents answered yes to the
question: "Have you or your family ever noticed a personality
change?". Eighty-two percent of the respondents claimed they regularly had at least one of the following problems: depression,
violent rage, anxiety and irritability. Most had more than one
problem. Two hundred and seventy-five respondents reported suffering from mental Illness or a breakdown. Symptoms of peripheral neuropathy in the lower or upper extremities were reported
in over two-thirds of the veterans. Indications of asthenia were
found in over half of the questionnaires (see Table 5).

�Many respondents reported GI disorders. Over a third stated
they had repeated nausea without flu or other sickness. Over 25%
reported repeated bouts with diarrhea. One-third indicated that
they regularly experienced loss of appetite and 20% reported
weight loss.
CONCLUSION

We reemphasize that the questionnaires were not randomly
distributed and were completed on a volunteer basis by a selfselected group of MA veterans. This means that we cannot base a
valid, scientific study on the information contained in these
questionnaires. However, the questionnaires clearly indicate
considerable disease and suffering among a relatively young group
of people (93% under age 45, 80% under age 40). The symptoms and
disease found are consistent with findings from other studies of
people exposed to dioxin, 2,4-D and 2,4,5-T.

REFERENCES

Ashe WF, Suskind RR (1949,1950)tReports on chloracne cases,
Monsanto Chemical Co., Nitro, W.VA.
Baader EW, Bauer AJ (1951):Industrial intoxication due to pentachlorophenol. Indus Med Surg 20:289-290.
Barr MM (1982) :letter to editor. ANZ J. Psych. 16: 88-89.
»

Barr MM (1983): Apparent progressive axonal dying back neuropathy
in Vietnam veterans. Neuroscience Letters, Abstracts
suppl. ll:s.29.
Dugois P, et.al. (1956): Acne chlorlque au 2,4,5-T. Lyon Med
88:446-447.
Erickson JD, et.al. (1984): Vietnam veterans1 risks for fathering
babies with birth defects. JAMA 252:903-912.
Goldman PJ (1973): Schwetst akute chlorakne, eine massenintoxikation durch 2,3,6,7-TCDD. Der Hautarzt 24:149-152.

�Moses M, et.al. (1984): Health Status of workers with past exposure to 2,3,7,8-TCDD in the manufacture of 2,4,5-T: Comparison of findings with and without chloracne. Am J Ind Med
5:161-182.
Pazderova-Vejlupkov J, et.al (1980): Chronic poisoning by
2,3,7,8-TCDD. Prac Lek 32::204-209. NIH Library Translation.
Pazderova-Vejlupkov J, et.al (1981): The development and prognosis of chronic intoxication by TCDD in men. Arch Env
Health 36:5-11.
Poland AP, et.al. (1971): Health survey of workers in a 2,4-D and
2,4,5-T plant. Arch Env Health 22:316-327.
Stellman S, Stellman J (1980): Health problems among 535 Vietnam
veterans potentially exposed to toxic herbicides. Am J Epi
112:444 (abstract).
Susklnd RR (1953): A clinical and environmental survey, Monsanto
Chemical Co., Nitro, W.VA.. Report of the Kettering Laboratory, July.
Suskind RR (1977): Chloracne and associated health problems in
the manufacture of 2,4,5-T. Report to the NIEHS/IARC Joint
Conference, Lyon, France. January.
Telegina KA, Bikbulatova LJ (1970): Affection of the folllcular
apparatus of the skin in workers employed in the production
of the butyl ester of 2,4,5-T. Vestnik Derm Ven 44:35-39.

�TABLE 1
REPORTED OCCUPATIONAL EXPOSURES TO DIOXIN-CONTAMINATED
SUBSTANCES RESULTING IN HUMAN ILLNESS*

Year,place &amp;
chemical(s)

Type of exposure &amp; number
of cases

Neurological
effects

Other
effects

References

1949 W.VA
TCP, 2,4,5-T

explosion
117
production
111

nervousness,
irritability,
insomnia,
personality
change,depression,
headache,pain
&amp; weakness in
lower extremities, per ipheral
neuropathy

fatigue, [Ashe &amp;
weight
Suskind,
loss,
1949,
weakness, 1950;
decreased Suskind,
libido,im - 1953;
Suskind,
potence
1977] .

1949 Germany
TCP

production,
industrial
lab 17

pain &amp; weakness,paresthesia,polyneuritis in lower
extremities

fatigue,
decreased
libido,
impotence

1952 Germany
TCP

production
31

pain &amp; weakness,paresthesia in lower
extremities,
memory &amp; concentration deficits,sleep
disturbances,
apathy,dulled
emotional response

fatigue,
[Susmyocardial kind,
damage
1977]

1953 Germany
TCP

explosion
55

hearing impairment,
peripheral
neuropathy

fatigue,
[Golddrowsiness, man,
myocardial
1973]
damage

1956 France
TCP

production
17

peripheral
neuropathy

1964 USSR
TCP 2,4,5-T

production
128

headache,memory loss,
sleeplessness

[Baader
&amp; Bauer,
1951]

[Dugois,
et.al.,
1956]
fatigue,
[Telejoint pain gina &amp;
Bikbulatova,
1970]

�TABLE 1 (continued)
Year,place &amp;
chemical(s)

Type of exposure &amp; number
of cases

Neurological
effects

Other
effects References

1965-68
Czechoslovakia
TCP 2,4,5-T

production
80

pain &amp; weakfatigue, [Pazderoness in lower
weight
va-Vejlupkov,
loss
extremities/
somnolence,
et.al.,
1980;
headache, insomnia,peri19811
pheral neuropathy, emotional
&amp; psychiatric
disorders

1969 NJ
TCP 2,4,5-T
2,4-D

production
73

weakness in
lower extremities,hypomania

*adapted from Moses/et.al.,1984

[Poland,
et.al. '
1971]

�TABLE

2

Standardized Proportional Mortality Ratios for Selected Causes of Death for
Vietnam Veterans Compared with Either Non-Vietnam-Veterans or Non-Veteran Males
ICO NO*

CAUSE OF DcATH

OBSERVES
VIETNAM
VETERAN
DEATHS

All Causes

COMPARISON GROUP
NON- VIETNAM
VETERANS
PMR
95% C.I.

NON-VETERAN
MALES
PMR
95% C.I.

840

140-239

All Neoplasms

153-154

Colo-Rectal

162

Lung, Bronchus

171

Connective Tissue

9

880

189

Kidney

9

183 (96,348)

353 (191,651)

139

88 (75,103)

87 (74,102)

28

111 (77,160)

138 (96,199)

•

129

95

(78,115)

112

(94,134)

8

113

(56,228)

85

(42,172)

98 (66,146)

102

(72,145)

25

(513,1510)

473 (262,855)

390-429 'Circulatory System
439-459 (except Cerebrovascular)
430-438 Cerebrovascular
Disease
571
Cirrhosis of the
Liver

29

94 (65,136)

90 (61,132)

•

E800-E999 All external causes

428

108 (98,119)

H3 (103,124)

E810-E825 Motor vehicle accidents

169

110 (95,127)

127 (106,152)

E950-E958 Recorded suicides

102

93 (77,112)

118 (98,143)

799.9,
Estimated suicides*1*
E850-E869,
E950-E958,

163

113 (96,132)

140 (120,163)

31

80 (56,114)

66 (46,94)'

E980-E982

E960-E969 Homicides

International Classification of Diseases, 9th Revision, code number.
**See reference (6) for discussion of this category. Note that there were
13 deaths in the category 799.9.

�TABLE 3
REPORTS ON THE HEALTH STATUS OF VIETNAM VETERANS

Reference

Exposed

Health Effects

Stellman &amp;

Vietnam Veterans
535

congenital malformations,
GI disturbances,pain in
joints,sleep and psychological disturbances

Barr/1982;
1983

Vietnam Veterans
Australia, 120

peripheral neuropathy,
insomnia,depress ion,
Irritability,lassitude,
memory loss,headaches,
attempted suicides

Erickson,
et.al. 1984

Vietnam Veterans
696

congenital malformations:
spina bifida,cleft lip,
impaired hearing,clubfoot

Stellman,
1980

�TABLE 4
CONGENITAL MALFORMATIONS

Total
Number

Birth Defect

Prevalence *

BDMP Incidence
Rate *

Spina Bifida,other
brain or spine defects

37

195

18.4

clubfoot

24

126

24.5

cleft lip/palate

17

89

13.4

missing, deformed or
extra toes/fingers

31

163

Down's Syndrome

11

58

7.9

hip abnormalities

21

111

27.0

heart defect

60

defect of the
digestive system

35

hearing disorders

63

cerebral palsy

27.2**

6

other skeletal defects
Condition requiring
special education or care

46

122

* per 10,000 live births
** polydactyly and syndactyly

OTHER REPRODUCTIVE PROBLEMS
Problem

Number

%

Loss of libido

487

32.4%

Infertility

330

22.0%

Infertility and saw physician

246

16.4%

low birth weight children

162

8.1%

(under 5.5 Ibs.)

�10

TABLE 5
NEUROBEHAVIORAL DYSFUNCTION

Problem

Number

%

persistent tiredness
(saw physician)

957
270

63.7%
18.0%

persistent headaches
(saw physician)

773
338

51.5%
22.5%

nervous disorders
(saw physician)

684
356

45.5%
23.7%

difficulty with memory
or concentration
(saw physician)

786
165

52.3%
11.0%

mental illness or breakdown
(receiving some disability)

275
132

18.3%
8.8%

1233
1015

82.1%
67.6%

321

21.4%

regularly depressed, get into a
violent rage, anxious or irritable
(more than one behavioral problem)
Sensory symptoms of early stage
peripheral neuropathy
asthenia (need hands to rise from
chair, can't climb stairs without
holding onto railing, unable to do
tasks requiring holding arms at
shoulder level, difficulty grasping
tools)

775

51.6%

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24255">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24257">
              <text>1861</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24260">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24254">
                <text>Bangert, Joseph V.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24256">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Commonwealth of Massachusetts Agent Orange Program</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24258">
                <text>1986-06-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24259">
                <text>Health Survey of Massachusetts Vietnam Veterans, Summary</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24261">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24262">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24263">
                <text>congenital birth defects</text>
              </elementText>
              <elementText elementTextId="24264">
                <text>industrial exposure</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3280" public="1" featured="0">
    <fileContainer>
      <file fileId="1693">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/a453917f7a51f0f18267e95ca0786ef8.pdf</src>
        <authentication>61a90fa0c03be0e01424397a4b0e757f</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63642">
                    <text>Item ID Number

018GO

Author

Newell, John

Corporate Author
Report/Article Title New Research Links Agent Orange With Cancers

JOUmal/BOOk Title

New Scientist

Year

1985

Month/Day

February?

Color

n

Number of Images

'

DOSCrlpton Notes

Article refers to the Massachusetts Department of
Health Study. Handwritten notes on back.

Wednesday, July 11, 2001

Page 1861 of 1870

�/PH Saenvs; 7 Februaiy 1985

New research links Agent Orange with cancers
DEFOLIANT Agent
THL veteransthe the Vietnam war.Orange
could be
major cause of cancer
among
of
This is

absorbs large volumes of liquid, which
makes it vulnerable to dissolved carcinoJohn Constable, of the Massachusetts gens.
the conclusion of a study by the Massachu- General Hospital, said: "The study is
A research programme, headed by
setts Department of Health, published last significant because it compares veterans Professor Kenneth Newell, was set up to
week. The study contradicts three earlier who were in Vietnam with those who were study the sheep cancers, and to see if it was
studies which had found no increase in not. In this case there was not much differ- related to human cancers. Newell now
cancers among Vietnam veterans.
ence between the two groups except that works at the School of Tropical Medicine,
Last week's announcement follows a they were exposed to defoliants."
in Liverpool.
separate investigation in New Zealand
New Zealand has the world's highest
The research revealed a strong conwhich linked the two herbicides in Agent incidence of cancer of the large-bowel nection between the incidence of smallOrange with cancer of the small bowel among humans, but there is considerable bowel cancer in sheep and the intensity oi
in sheep. This study clears dioxin, a variations across the country. In 1977, a the use of herbicides that are based on
common contaminant of Agent Orange, of conference on large-bowel cancer was told phenoxy or picplinic acid. The variation in
causing the cancers. The main constituents that similar variations existed in cancer of the use of herbicides explained 98 per cent
of Agent Orange are the herbicides the small bowel among sheep. The small of the cases of small-bowel cancer in sheep.
2,4,5-trichlorophenoxyacetic acid and 2,4- bowel in sheep performs much the same Farms which had recently sprayed the
dichlorophenoxyacelic acid. The Tesults function as the large bowel in humans. It herbicides had more cases of cancer than
from New Zealand point to the
those farms where the spraying
herbicides and not the conhappened some time ago.
taminants as being carcinogenic.
Both types of herbicide arc
The researchers from Massaliable to become contaminated
chusetts analysed the death
with dioxin during manufaccertificates of 800 Vietnam
ture. Because dioxin was
veterans. They compared the
suspected as being the cause of
cause of death with a similar
cancers in Vietnam, Newell
control sample
of 2500
compared the likely dioxin
servicemen, all of whom had
content of the herbicides with
been in the armed forces, but
the incidence of cancer, and was
had not served in Vietnam.
surprised to discover that there
was no link. The research does
Nine of the Vietnam veterans
had died of tumours in the
not prove any connection
muscles, fat or other soft tissue,
between human bowel cancer
compared -with an expected
and the herbicide. Nonetheless,
death rale of 1 -9. Although the
the results are causing considnumbers of cancer deaths are
erable interest among lawyers in
small, the probability of such a
the United Stales, where several
result occurring by chance is one
cases are pending against the US
in 10000.
Victims of Agent Orange: now there is a link with cancer
Air Force.
n
John Newell

Reagan's budget squeezes America's civil science
HONEYMOON between
THE community has come to anReagan's
administration and America's civil
science
end this
year. For the first time, Reagan has cut into
funding for basic civil research, allowing it
to grow by only one per cent (against
inflation's four per cent) during the next
financial year.
Delivering the 1986 federal budget last
Monday, Reagan's science advisor Dr
George Kcyworlh repeatedly cited the
"extreme austerity" caused by the record
deficit of $ 180 billion. He noted thai during
Reagan's first four years, basic research
thrived while most other government
services were cut. Basic military research,
however, still grows, this year by 16 per
cent.
That growth is at the expense of items
such as: fusion research, which is cut by
over 10 per cent, while "key scientific
questions" arc resolved and internalional
collaboration can be negotiated; oceanographic research; and agricultural research
other lhan biotechnology, one of Keyworth's sacred cows. Biomedicine also fares
poorly. The government plans to support
only 5000, rather than the 6500, research
grants expected for the nexl financial year
(which begins on October 1) from the
National Institutes of Health.
The space programme is left relatively
intact, although the space station will be
put back a couple of years. As for the environmental sciences, Reagan has increased

aid for cleaning up toxic wastes and study- basic, the Department of Defense's profile
ing acid rain.
stands even taller. The government spendThe budget for the National Science ing on R&amp;D is $58 billion (up 12 per cent),
Foundation, the ally of American univer- ' with defence accounting for almost $40
sities, will jusl keep pace with inflation. The billion (up 22 per cent). The budget for
foundation will continue to support the research on "star wars" and other missile
funding for computers and other scientific systems is tripled, to $3-7 billion. Binary
instruments at universities, while favouring nerve gas is high on Reagan's agenda for
physical, mathematical and engineering financial support.
sciences.
Congress has yet to decide on Reagan's
When applied science is folded in with package.
Q

Australia injects money into space
AUSTRALIAN government is
THE scientific communitylocalthe develbacking demands from
industry
and Ihe
for

It is hoping for A$7 million from the
government this year, and plans to spend at
least 70 per cent on contracted work to
opment of an indigenous commercial space industry. The remainder will be spent on
industry. Money has been promised, and a consolidating CSIRO's own in-house space
study from ihe Australian Academy of research, which is currently spread across a
Technological Sciences is expected lo number of laboratories.
recommend the establishment of an
The aim is to improve the quality of
Auslralian research authority in space communications, remote sensing, meteortechnology.
ological surveillance and radar satellites.
The government realised belatedly that CSIRO wants to participate in a number of
the country was almost totally dependent overseas projects, such as the Internalional
on imported space technology, and that its Polar Orbiting Meteorological Satellite.
own industry was rundown.
Already a conlracl has been signed for
As a first move, Australia's Common- Australian industry to build the digital
wealth Scientific and Industrial Research package for a British long-track scanning
Organisation (CSIRO), a government radiometer, which is to be flown on board
agency, has set up an office of space science the European Remote Sensing Satellite.
and applications. Its express purpose is to The package will be built by British Aerobuild up skills in space research and space in Adelaide, and ihe federal government will contribute A$ 1 million.
rj
development in Australia's own industry.

��</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24236">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24237">
              <text>1860</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24241">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24235">
                <text>Newell, John</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="24238">
                <text>New Scientist</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24239">
                <text>February 7 1985</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24240">
                <text>New Research Links Agent Orange With Cancers</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24242">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24243">
                <text>popular press</text>
              </elementText>
              <elementText elementTextId="24244">
                <text>dioxin</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3278" public="1" featured="0">
    <fileContainer>
      <file fileId="1691">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/f2c540321d7fff75fbd4b41bf057c04c.pdf</src>
        <authentication>a6ba1af182f3b53496f94f69023ab06e</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63640">
                    <text>Item ID Number

01359

Author

Kogan, Michael D.

Corporate Author

Massachusetts Office of Commissioner of Veterans Ser

Ronnrt/ArtldB Tltta Mortality Among Vietnam Veterans in Massachusetts,
^
1972-1983

Journal/Book Tltte
Year

1985

MOUth/Day

January 18

Color

°

Number of Imagos

33

DBSCrlptOD NotOS

Duplicate does not include cover.

Wednesday, July 11, 2001

Page 1860 of 1870

�Mortality
among Vietnam veterans
in Massachusetts,
1972-1983
The Commonwealth of Massachusetts
Michael S. Dukakis, Governor
Office of the Commissioner of Veterans' Services
Agent Orange Program
January 18, 1985

�FOREWORD

The Office of the Commissioner of Veterans' Services was provided funding by
the 1983 Massachusetts Legislature for the purpose of conducting "medical and
scientific testing related to Agent Orange."
In January of 1984, the Agent Orange Program of the Office of the Commissioner of
Veterans' Services was implemented to survey programmatic, medical and scientific
options. The Agent Orange Program instituted an Agent Orange Medical Scientific
Advisory Board to provide technical recommendations, oversight and review of
proposal and implemented medical and scientific programs and studies.
As recommended by the Agent Orange Program and the Agent Orange Medical and
Scientific Advisory Board, the attached study, "Mortality Among Vietnam Veterans
in Massachusetts, 1972-1983" compiled by Michael Kogan, M.A., and Richard Clapp,
M.P.H., was contacted as the first step in the Conroonwealth's attempt to find
some answers to the complex questions surrounding the issue of Agent Orange.
This mortality study provides a stable foundation for our continued ongoing
efforts to provide scientific, technical, verifiable data regarding the effects
of Agent Orange where none has been previously available.
As highlighted in the study summary, "Deaths due to motor vehicle accidents,
suicides and kidney cancer were significantly elevated among Vietnam Veterans
compared to non-veteran males for the study period 1972-1983." As further
stated, "Elevated risk of death due to motor vehicle accidents and suicide lends
support to the hypothesis that Vietnam Veterans have had a greater incidence of
traumatic death since the end of the conflict than other non-veteran males."
This office is designing, preparing and directing this mortality study equally
emphasizing the preparation of an administrative and program response to all
study findings. Relative to the significant findings of elevated death due to
cancer and traumatic-stress related death, I feel strongly that the Office of
the Comnissioner of Veterans' Services response to the study focus primarily on
the incidence of traumatic-stress related death among Vietnam veterans. Further
study and research regarding cancer incidence and cancer death among Vietnam
Veterans will be aggressively pursued by this office.
In an attempt to appropriately respond to the traumatic-stress related deaths
highlighted by the study, it is necessary to assess the needs of those living
Vietnam Veterans who display stressed behavior. For this reason, the Office
of the Commissioner of Veterans' Services through the Agent Orange Program has
engaged McLean Hospital to provide a behavioral study of Vietnam Veterans. The
purpose of the study is to examine the possible behavioral consequences of exposure
to Agent Orange and to determine whether this exposure is responsible for any of
the symptoms that are often referred to as Post-Traumatic-Stress-Disorder.
The Office of the Commissioner of Veterans' Services feels most strongly that
the priority in dealing with the Vietnam Veterans is in researching, defining
and treating Post-Traumatic-Stress. It is my fear that Post-Traumatic-StressDisorder is the root of a host of problems facing not only the Vietnam Veteran
but also their families, spouses, children, neighbors and employers.

�ACKNOWLEDGMENTS

The Massachusetts Agent Orange Program, directed by Chris Gregory, was
substantially responsible for assembling a blue ribbon Medical/Scientific
Advisory Board. The credentials of the board members are consistent with
the highest standards of medical services found in the Boston area.
Because of his sincere and unrelenting drive to seek the answers to the health
predicament caused by Agent Orange, State Representative Thomas Vallely, a
Vietnam Veteran himself, provided the board with his own personal experience
as well as the need for public awareness of the perils of exposure to Agent
Orange.
This study would not have been possible without the wisdom and commitment of
the General Court of Massachusetts, and, in particular, the dedicated efforts
of State Senator Francis D. Doris, Chairman of the Special Commission on the
Concerns of the Vietnam Veteran. The Senator's sympathetic efforts have been
the bench mark for legislative support.
The support of the Department of Public Health and its personnel under the
direction of Commissioner Bailus Walker was significant. Dr. Walker's commitment
to public issues is consistent with his concern for the potential for harm
to humans exposed to Agent Orange.
Many staff members of the Office of the Commissioner of Veterans' Services
worked diligently in the publication of the mortality study and developed a
program to generate public awareness. They are: Joe Bangert, Research Assistant
for the Agent Orange Program; Martin Burke, Public Information Specialist;
Linda Wiggins, Administrative Assistant, for the long and arduous hours of
secretarial duties; the sound counsel of Maryann Argento, and last, but not least,
Dennis O'Brien, for whatever else needed to be done.
The Office of the Commissioner of Veterans' Services will continue to work to
uncover the complexities of exposure to Agent Orange and its harmful effects
upon Veterans of Vietnam and their families in the areas of behavior, birth defects
and mortality. Expanded mortality studies to address any new hypotheses brought
by this study will be forthcoming.

�MORTALITY AMONG VIETNAM VETERANS
IN MASSACHUSETTS, 1972-1983

MICHAEL D. KOGAN, M.A.
RICHARD W. CLAPP, M.P.H.

January 18, 1985

Massachusetts Office of Commissioner of Veterans Services
Agent Orange Program
Massachusetts Department of Public Health
Division of Health Statistics and Research

�Summary
The patterns of death among Vietnam veterans, other veterans who did not
serve 1n Vietnam, and non-veteran males from Massachusetts were studied by
compiling death certificate Information.

Veteran status was based on

whether or not the decedent's name appeared on a 11st of Massachusetts
veterans who served from 1958-1973 and received a bonus.

This bonus 11st was

supplied by the Office of the Commissioner of Veterans Services.

Only those

with an honorable discharge were eligible for the bonus. Persons whose name
on the death certificate matched that on the bonus 11st were Identified as
Vietnam veterans if they received a $300 bonus, or as non-Vietnam veterans if
they received a $200 bonus.
to be a non-veteran.

If there was no match, the decedent was presumed

Analyses of the mortality patterns of Vietnam veterans

compared to non-Vietnam veterans and to other males who died during the time
period (1972-1983) of the study were conducted.
Deaths due to motor vehicle accidents, suicides, and kidney cancer were
significantly elevated among Vietnam veterans compared to non-veteran males
for the study period 1972-1983.

Deaths due to stroke and connective tissue

cancer were significantly elevated among Vietnam veterans compared to both
non-Vietnam veterans and non-veteran males.

Deaths due to circulatory system

diseases, other than stroke, were lower among the Vietnam veterans compared to
non-Vietnam veterans.

Elevated risk of death due to motor vehicle accidents

and suicide lends support to the hypothesis that Vietnam veterans have had a
greater incidence of traumatic death since the end of the conflict than other
non-veteran males.

The excess cancers of connective tissue and kidney are

based on only nine death's from each type.

More years of follow-up would be

�Introduction
The Agent Orange Program 1n the Office of the Commissioner of Veterans
Services (OCVS) requested that a mortality study be conducted comparing the
causes of death among Vietnam veterans to those of
non-veteran Massachusetts residents.

non-Vietnam veterans and

This study was motivated by a concern

that Vietnam veterans may be at increased risk of dying from violent, preventable causes, such as motor vehicle accidents, homicide, and suicide.
The list of Massachusetts veterans whose mortality experience was evaluated was supplied on computer tape by the OCVS.

In August 1984, the study

.was initiated using mortality information from the statewide data base
collected by the Massachusetts Department of Public Health, Division of Health
Statistics and Research.

Using computer-record linkage techniques and manual

matching, the study group and two comparison groups were assembled.

The pro-

portionate mortality and mortality odds ratio were chosen as the methods for
comparing the mortality experience among the three groups because information
on the number of years since Vietnam service was not available for the Vietnam
veterans on the OCVS computer tape.
were not available.

In addition, the ages of the veterans

This study is a first step in analyzing Vietnam

veterans' experience of one particular health outcome (mortality). Therefore,
it can be used only to draw very general conclusions and to develop hypotheses
for further studies.

�necessary to adequately assess these findings, and further Investigation,
using other sources of Information, 1s recommended.
These results are based on the limited Information available from death
certificates.

Information on such potential confounding factors as smoking

and drinking habits, and complete histories of occupational exposures, was
unavailable and therefore could not be controlled for 1n the analysis.
Nevertheless, the results justify Intensified efforts to reduce deaths due to
stress-related or self-destructive behavior among Vietnam veterans.

�Methods
The mortality experience of Vietnam veterans was compared to that of
Vietnam-Era veterans who did not serve In Vietnam and to the general
Massachusetts white male population during the period 1972-83.
A computerized file of Massachusetts mortality data 1s available from the
Division of Health Statistics and Research of the Massachusetts Department of
Public Health (MDPH). The mortality data for Vietnam and non-Vietnam veterans
was obtained by linking the statewide computerized mortality files with the
computerized list of veterans who applied for a military service bonus,
available from the Massachusetts Office of Veterans Services. Eligibility for
the bonus was based on the following criteria:

(1) veterans must have served

for at least six months between July 1, 1958 and April 1, 1973; (2) they must
have been Massachusetts residents for at least six months Immediately prior to
entering the service; (3) they must have applied for the bonus; and (4) they
must have been honorably discharged.

Veterans received a bonus of $300 if

they went to Vietnam, or $200 If they did not.

It has been estimated that 95%

of all eligible Massachusetts residents received the bonus.(l)
The mortality and veterans files were linked by matching social security
numbers for the years 1972-76 and 1980-83.

For the years 1977-79, social

security numbers were not entered on the MDPH computerized files, although
they continued to be recorded on death certificates. For these three years,
the computer files were linked by matching names.

The resulting output was

then verified by hand-checking social security numbers on death certificates
with those from the veterans file.

�The computer linkage provided Information on age at death, sex, race,
cause of death, year of death, and Vietnam service.
classified

Cause of death was

according to the appropriate revisions of the

International

Classification of Diseases and converted to the Ninth Revision Codes.(2)
Systematic validation procedures were used to assess the accuracy of the computerized information on cause of death and veteran status, compared to the
information from the veterans bonus applications and the death certificates.
The cause of death codes on the mortality file were found to be more than 99%
accurate when compared to death certificates, as were the veteran status codes
on the veterans file.
Because white males accounted for about 98% of the veteran decedents,
cause of death data for non-whites or female veterans would be very sparse.
This report, therefore, is restricted to an analysis of white male mortality
patterns, although information on other groups may be pursued in further
studies.1
The number of deaths from specific causes among Vietnam veterans was
compared with the expected number of deaths based upon the actual mortality
experience of both non-Vietnam veterans and all other males in Massachusetts.
Veteran deaths were not Included in the Massachusetts white male comparison
group.

These numbers were derived from calculations of time-cause-specific

proportionate mortality within 10-year age groups.

The ratios of observed to

*Appendix A lists the non-white deaths by age at death, cause of death and
year of death.

�expected numbers of deaths were summarized using the standardized proportionate mortality ratio (sPMR).(3)

The statistical significance of the dif-

ferences was assessed using the Mantel-Haenszel Chi test with one degree of
freedom.(4) For cases in which the observed number of deaths was greater than
five, but the expected number of deaths was less than five, the Poisson
distribution was used to determine statistical significance.

SPMRs were

calculated for both the entire study period (1972-83) and the last six or
eight years of the study period, depending upon which time frame offered sufficient numbers for statistical stability. Also, the last half of the study
period was analyzed separately because any significant effect in the last six
or eight years might have been diluted by looking at the whole study period
only.
For causes of death for which the sPMR was statistically significant, the
standardized mortality odds ratio (sMOR) was also calculated according to the
method described by Miettinen.(B)

The sMOR was used to confirm the results

of, and to correct for biases Inherent in, the sPMR method. The sMOR compares
the odds for the exposed population—the number of deaths from the cause of
interest

compared

with

the

number

(auxiliary) causes—with

the

expected

(nonexposed) population.(6)

of deaths
odds

from

derived

selected
from

reference

a comparison

The sMOR approach 1s essentially equivalent to

the case-control approach, in which cases are all deaths from the disease of
interest, controls are all deaths from the auxiliary causes, and the exposure
of interest is Vietnam service. (7)
The sMOR analysis was carried out using all circulatory disease, except
rheumatic heart disease (ICDA 390-459), as the auxiliary cause.

All cir-

�dilatory disease was chosen on the assumption that 1t was unrelated to the
exposure of Interest (Vietnam service).

There were sufficient numbers of

deaths due to this auxiliary cause that statistically stable results could be
calculated.
Although accidents and violent deaths comprised the largest cause of death
category (e800-e999), they were not chosen as the auxiliary causes of death
because they had previously been found to be higher for Vietnam veterans compared to other males.

Including these causes of death would have Introduced

bias Into the sMOR analysis.

The differences between the two ratios of

observed and expected deaths were assessed by using the Mantel-Haenszel Chi
test with one degree of freedom.
The standardized mortality ratio (SMR) 1s another method for calculating
the ratio of observed to expected deaths.

It 1s sometimes viewed as a pre-

ferable method to the sPMR or the sMOR because the SMR 1s calculated by taking
the ratio of the mortality rate in the exposed group to the mortality rate in
the nonexposed group for a comparable follow-up per1od.(3) However, in this
study it was not possible to calculate SMRs because neither the calendar years
of Vietnam service nor the ages of the veterans were recorded on the veterans
file.

Date of birth was available for approximately 67% of the veterans on

the veterans file.

This Information was added to the original veterans file

by the Massachusetts Registry of Motor Vehicles, which matched the veterans
files with a computerized 11st of Massachusetts driver's license holders in
1983.

An estimated death rate using only those veterans where a date of birth

was listed would have been subject to selection bias, because it would have

�8

excluded veterans who died, moved out of state, or did not hold a driver's
license.

Therefore, age-specific mortality rates for the veterans could not

be calculated from the information available on the computerized files.

�Results

The numbers of deaths that occurred during the study period (1972-83)
among both Vietnam veterans and non-Vietnam veterans are presented, by age
group and calendar year, 1n Tables 1 and 2.

The distribution of deaths

suggests that Vietnam veterans, as a group, are probably younger than the
non-Vietnam veterans.

Tables 3 and 4 present the results of the standardized

proportionate mortality ratio (sPMR) analysis comparing Vietnam veterans to
non-Vietnam veterans and to all other non-veteran Massachusetts white males
for specified causes of death.

The sPMRs and their chi values are included in

the tables, and p-values are given for all statistically significant findings
(p£.05).

Uncommon causes of death for Vietnam veterans are not presented

because statistically stable comparisons could not be made.

A minimum of

seven observed Vietnam veteran deaths was used as a criterion for calculating
an sPMR.

Two methods of accounting for suicide deaths are used. The first

method includes only those deaths that were recorded as suicides on death certificates.

However, it has been estimated that the actual suicide rate is

three times the reported rate.(8) Therefore, a second calculation, known as
an "estimated suicide rate," was used which includes all poisonings (ICDA
codes e850-e869, e980-e982), recorded suicides (ICDA codes e950-e958), and
unknown causes of death (ICDA code 799.9).(9) The analyses presented were
carried out on 766 deaths from specific causes out of the total 840 deaths in
the Vietnam veterans group.

�10

TABLE 1
DISTRIBUTION OF DEATHS BY AGE AND CALENDAR YEAR
FOR WHITE MALE VIETNAM VETERANS. 1972-1983
AGE AT
DEATH

YEAR OF DEATH
1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 TOTAL

20-29

49

40

48

48

41

22

18

17

8

1

2

0

294

30-39

6

6

8

14

8

18

22

34

57

57

52

53

335

40-49

8

8

9

15

12

4

4

9

6

13

10

8

106

50-59

1

2

5

3

4

2

8

8

11

7

12

16

79

60+

1

0

1

1

1

3

1

2

0

3

4

9

26

TOTAL

65

56

71

81

66

49

53

70

82

81

80

86

840

TABLE 2
DISTRIBUTION OF DEATHS BY AGE AND CALENDAR YEAR
FOR WHITE MALE NON-VIETNAM VETERANS, 1972-1983
AGE AT
DEATH

YEAR OF DEATH
1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1932 1983 TOTAL

20-29

52

52

42

51

60

24

14

17

20

17

7

6

362

30-39

37

68

73

83

94

52

70

59

77

66

64

67

810

40-49

19

24

24

36

40

31

26

49

75

95 105 112

636

50-59

26

22

40

39

34

30

29

37

43

38

36

46

420

60+

3

14

12

16

15

3

11

22

36

40

55

60

287

TOTAL

137 180 191 225 243 140 150 184 251 256 267 291 2515

�11
TABLE 3
OBSERVED AND EXPECTED NUMBERS, STANDARDIZED PROPORTIONATE MORTALITY RATIOS
AND CHI VALUES COMPARING VIETNAM VETERANS TO NON-VIETNAM VETERANS
BY SPECIFIC CAUSES OF DEATH FOR PERIODS 1972-83 AND 1976-83 OR 1978-83*
CAUSE OF DEATH
ANALYSIS OBSERVED EXPECTED SPMR
CHI VALUES
(ICDA CODES, 9th REV.) PERIOD
DEATHS DEATHS
ALL CAUSES

840

ALL NEOPLASMS (140-239) 1972-83

129

136.15

95

-.52

1972-83

8

7.07

113

.34

1972-83
1976-83

25
21

25.49
22.44

98
94

-.10
-.30

CONNECTIVE TISSUE (171) 1972-83

9

1.02

880

7.89 (p&lt;.0001)

KIDNEY CANCER (189)

1972-83

9

4.91

183

1.84

CIRCULATORY SYSTEM (EXCEPT CEREBROVASCULAR) 1972-83
(390-429, 439-459) - 1978-83

139
85

158.54
106.54

88
80

-1.55
-2.08

(p-.03)

CEREBROVASCULAR DISEASE 1972-83
1978-83
(430-438)

28
19

25.17
11.56

111
164

.56
2.19

(p«.02)

CIRRHOSIS OF LIVER
(571)

1972-83
1976-83

29
24

30.81
19.03

94
126

-.33
1.15

ALL EXTERNAL CAUSES
(6800-6999)

1972-83
1978-83

428
202

396.09
181.51

108
111

1.60
1.52

MOTOR VEHICLE ACCIDENTS 1972-83
(e810-e825)
1978-83

169
74

153.17
61.38

110
121

1.27
1.61

1972-83
1978-83

102
55

109.92
55.65

93
99

-.75
-.09

(ESTIMATED SUICIDES***
(799.9, e850-e869,
6950-6958, e980-e982)

1972-83
1978-83

163
94

144.75
76.01

113
124

1.51
2.06

HOMICIDE (6960-6969)

1972-83
1976-83

31
20

38.73
18.82

80
106

-1.24
.27

153-154)
LUNG, BRONCHUS (162)

RECORDED SUICIDES
( e950-e958)

(P-.03)

*SEE PAGE 6 FOR FURTHER EXPLANATION OF STUDY PERIOD ANALYSIS.
**SIGNIFICANCE BASED ON POISSON DISTRIBUTION.
***ESTIMATED SUICIDES BASED ON UNKNOWN CAUSES OF DEATH, RECORDED SUICIDES,
AND POISONINGS. (9)

�12

TABLE 4
OBSERVED AND EXPECTED NUMBERS, STANDARDIZED PROPORTIONATE MORTALITY RATIOS
AND CHI VALUES COMPARING VIETNAM VETERANS TO THE MASSACHUSETTS WHITE
MALE POPULATION BY CAUSE OF DEATH FOR PERIODS 1972-83 AND 1976-83 OR 1978-83*
CAUSE OF DEATH
ANALYSIS OBSERVED EXPECTED SPMR
CHI VALUES
(ICDA CODES, 9th REV.) PERIOD
DEATHS
DEATHS
ALL CAUSES

840

ALL NEOPLASMS (140-239) 1972-83
1976-83

129
102

115.69
87.57

112
116

1.24
1.54

COLO-RECTAL (153-154)

1972-83

8

9.38

85

-.45

LUNG, BRONCHUS (162)

1972-83
1976-83

25
21

24.44
19.79

102
106

.11
.27

CONNECTIVE TISSUE (171) 1972-83

9

1.90

473

5.14(p«.0001)**

KIDNEY CANCER (189)

1972-83

9

2.55

353

4.04 (p-.OOl)**

CIRCULATORY SYSTEM (EXCEPT CEREBROVASCULAR)
1972-83
(390-429, 439-459)
1978-83

139
85

159.98
104.43

87
81

CEREBROVASCULAR DISEASE 1972-83
(430-438)
1978-83

28
19

20.25
10.95

138
174

1.72
2.43 (p».015)

CIRRHOSIS OF LIVER
(571)

1972-83
1976-83

29
24

32.07
23.61

90
102

-.54
.8
0

i ALL EXTERNAL CAUSES
\(e800-e999)

1972-83
1978-83

428
202

377.66
166.11

113
122

2.59 (p-.OlO)
2.78 (p«.005)

MOTOR VEHICLE ACCIDENTS 1972-83
(e8 10-e825)
1978-83

169
67

133.26
50.98

127
131

3.10 (p&lt;.003)
2.24 (p-.025)

RECORDED SUICIDES
Ke950-e958)

1972-83
1978-83

102
55

86.16
41.80

118
132

1.71
2.04

(p«.041)

ESTIMATED SUICIDES***
(799.9, e850-e869,
e950-e958, e980-e982)

1972-83
1978-83

163
94

116.21
59.56

140
158

4.34
4.46

(p&lt;.001)
(p&lt;.001)

1972-83
1976-83

31
20

46.71
28.09

66
71

HOMICIDE (e960-e969)
. '. ..

-1.66
-1.90

-2.30 (p«.021)
-1.52

*SEE PAGE 6 FOR FURTHER EXPLANATION OF STUDY PERIOD ANALYSIS.
**SIGNIFICANCE BASED ON POISSON DISTRIBUTION.
***ESTIMATED SUICIDES BASED ON UNKNOWN CAUSES OF DEATH, RECORDED SUICIDES,
AND POISONINGS. (9)

�13

Table 3 focuses on the proportionate mortality experience of Vietnam
veterans compared to non-Vietnam veterans.

Although the proportion of deaths

from all neoplasms was not unusual, the sPMR for connective and other softtissue neoplasms was significantly elevated (sPMR-880). All of the nine connective tissue neoplasms were sarcomas of five different types. This finding
for this cause of death had the most significant p-value in the study.
There was significantly less circulatory system disease among Vietnam
veterans for the six years from 1978-1983 (sPMR«80) compared to non-Vietnam
veterans.

Conversely, cerebrovascular disease among Vietnam veterans was

significantly elevated during the same time period ($PMR«164). The sPNR for
estimated suicides was significantly higher than expected for the final six
years of the study period (sPMR«124).
Table 4 displays the proportionate mortality ratios of Vietnam veterans
compared to the non-veteran Massachusetts white male population.
there were no significant differences

Once again,

In the proportion of all neoplasms.

However, the sPMR for connective and other soft-tissue neoplasms was significantly elevated (sPMR«473), as was the sPMR for kidney cancer (sPMR*353).
The patterns for causes of death found 1n Table 4 are similar to those in
Table 3.

There was a greater than expected proportion of cerebrovascular

disease among Vietnam veterans compared to the state's white male population
as a whole during the second half of the study period (sPMR»174). All major
categories of violent death were significantly elevated for Vietnam veterans,
with the exception of homicides (sPMR«66).

These categories included motor

�14

vehicle accidents (sPMR*127), estimated suicides (sPMR«140), and all external
causes (sPMR-113). Recorded suicides were elevated for the final six years of
the study period (sPMR»132).
The standardized mortality odds ratio (sNOR) was computed for each cause of
death for which the sPNR was statistically significant. The sMOR results are
presented In Table 5. The sMOR for circulatory system disease was not computed
because circulatory disease was used as the auxiliary cause of death for the
sMOR analysis.
Instances.

The sMOR findings differed from the sPMR findings 1n only two

Homicide was not found to be significantly lower for Vietnam

veterans compared to the state's white males (sMOR«.82), and estimated suicide
was not significantly
(sMOR*1.46).

elevated

when

compared

to non-Vietnam

veterans

Table 6 summarizes the causes of death for which the findings

were significant using both analytic methods.

�15

TABLE 5
STANDARDIZED MORTALITY ODDS RATIOS AND CHI VALUES
COMPARING VIETNAM VETERANS TO EITHER NON-VIETNAM VETERANS OR
THE MASSACHUSETTS WHITE MALE POPULATION BY SPECIFIC CAUSES OF DEATH
FOR 1972-83 AND 1976-83 OR 1978-83*
CAUSE OF DEATH
ANALYSIS COMPARISON
SMOR
CHI VALUES
(ICDA CODES, 9th REV.)
GROUP
PERIOD
CONNECTIVE TISSUE CANCER 1972-83 NON-VIETNAM
5.16
4.18(p&lt;.001)
VETERANS
(171)
MASSACHUSETTS
WHITE MALES
MASSACHUSETTS
WHITE MALES
MASSACHUSETTS
WHITE MALES

5.87

4.98(p&lt;.001)

4.04

4.27(p&lt;.001)

1.44

2.52(p».012)

1978-83

MASSACHUSETTS
WHITE MALES

1.29

1.96(p-.05)

1972-83

MASSACHUSETTS
WHITE MALES

1.65

3.85(p&lt;.001)

1978-83

MASSACHUSETTS
WHITE MALES
MASSACHUSETTS
WHITE MALES

1.39

3.10(p-.002)

1.46

2.09(p=.037)

1.40

1.50

1972-83

MASSACHUSETTS
WHITE MALES
NON-VIETNAM
VETERANS

1.46

1.53

1978-83

NON-VIETNAM
VETERANS

1.46

1.06

1972-83

MASSACHUSETTS
WHITE MALES

1.73

3.11(p-.002)

1978-83

1.69

2.43(p-.015)

1972-83

MASSACHUSETTS
WHITE MALES
MASSACHUSETTS
WHITE MALES

1976-83

MASSACHUSETTS
WHITE MALES

1972-83
KIDNEY CANCER (189)

1972-83

ALL EXTERNAL CAUSES
(e800-e999)

1972-83

MOTOR VEHICLE ACCIDENTS
( 6810-6825)

RECORDED SUICIDES
(e950-e958)

1972-83
1978-83

ESTIMATED SUICIDES**
(799.9, e850-e869,
6950-6958, e980-e982)

HOMICIDES
(e960-e969)

.82

-1.62

.78

-.75

*SEE PAGE 6 FOR FURTHER EXPLANATION OF STUDY PERIOD ANALYSIS.
**ESTIMATED SUICIDES BASED ON UNKNOWN CAUSES OF DEATH , RECORDED SUICIDES,
' AND POISONINGS. (9)

�16

TABLE 6
SUMMARY TABLE FOR STATISTICALLY SIGNIFICANT CAUSES OF DEATH FOR PERIODS
1972-83 AND 1976-83 OR 1978-83*
STANDARDIZED MORTALITY ODDS RATIOS AND STANDARDIZED PROPORTIONATE
MORTALITY RATIOS COMPARING VIETNAM VETERANS TO EITHER NON-VIETNAM VETERANS
OR THE MASSACHUSETTS WHITE MALE POPULATION
CAUSE OF DEATH
ANALYSIS COMPARISON GROUP
SMOR
SPMR
(ICDA CODES, 9th REV.)
PERIOD
(xlOO)
CONNECTIVE TISSUE CANCER 1972-83 NON-VIETNAM
516
880
VETERANS
(171)
1972-83
MASSACHUSETTS
587
473
WHITE MALES
KIDNEY CANCER
404
1972-83 MASSACHUSETTS
353
(189)
WHITE MALES
CIRCULATORY SYSTEM
1972-83 NON-VIETNAM
88
(EXCEPT CEREBROVASCUVETERANS
LAR)**( 390-429, 439-459) 1978-83 NON-VIETNAM
80
VETERANS
CEREBROVASCULAR DIS1972-83 NON-VIETNAM
111
VETERANS
EASES** (430-4 38)
164
1976-83 NON-VIETNAM
VETERANS
138
1972-83
MASSACHUSETTS
WHITE MALES
174
1976-83
MASSACHUSETTS
WHITE MALES
144
ALL EXTERNAL CAUSES
113
1972-83 MASSACHUSETTS
(e800-e999)
WHITE MALES
129
1978-83 MASSACHUSETTS
122
WHITE MALES
127
MOTOR VEHICLE ACCIDENTS 1972-83
165
MASSACHUSETTS
(e81 0-e999)
WHITE MALES
131
1978-83
MASSACHUSETTS
139
WHITE MALES
146
118
RECORDED SUICIDES
1972-83 MASSACHUSETTS
( e950-e958)
WHITE MALES
140
132
1978-83
MASSACHUSETTS
WHITE MALES
140
ESTIMATED SUICIDES***
1972-83 MASSACHUSETTS
173
(799.9, 6850-6869,
WHITE MALES
158
169
6950-6958, 6980-6982)
1978-83
MASSACHUSETTS
WHITE MALES
*SEE PAGE 6 FOR FURTHER EXPLANATION OF STUDY PERIOD ANALYSIS.
**SMORs NOT CALCULATED FOR CIRCULATORY DISEASE SINCE IT WAS USED AS
AUXILIARY CAUSE.
***ESTIMATED SUICIDES BASED ON UNKNOWN CAUSES OF DEATH , RECORDED
SUICIDES AND POISONING. (9)

�17

Discussion
This study was carried out using death certificates as the source of the
health outcome Information.
Information.

There are Inherent problems 1n relying on such

Other studies have assessed the accuracy of death certificate

Information by comparing the stated cause of death on the death certificate to
either clinical data or autopsy findings.(10,11) The accuracy of death certificates has generally been about 90%.
approximately 85-90% reliable

Death certificates seem to be

for the general

diagnosis

of malignant

neoplasms, although there may be underreporting of malignant neoplasms of
about 10%.(11)

This study did not attempt to confirm cause of death using

hospital or other records.

However, the effect of misclassifying cause of

death due to inaccuracies on the death certificate would most likely be one of
diluting the magnitude of the effects seen in the comparisons.
Further problems with death certificate studies Involve lack of knowledge
about other factors related to the cause of death.

For example, there is no

information on death certificates concerning potential confounding factors
such as smoking, alcohol consumption, and dietary habits. In addition, death
certificate studies may be biased due to differential access to good quality
medical care.

In this study, Vietnam veterans may not have had as good access

to medical care as the non-veteran white males to whom they were compared. On
the other hand, the non-veteran comparison group includes some individuals who
were unable to serve in the military because of health problems. This potential bias, referred to as the "healthy veteran effect," would tend to dilute
the magnitude of the associations between veterans and non-veterans.(12)

�18

The method of Identifying deceased veterans by computer file-linking
represents a potential source of bias.

The primary Unking method (social

security number) has been found 1n other mortality studies to be more than
90% accurate in Identifying deaths In a study population.(13) However, some
studies have found a 20% false negative rate (missing deaths) when matching was
done using names, as 1t was In this study for the years 1977-79.(14)
Nevertheless, there 1s no reason to suspect that there 1s any systematic bias
between the study group and the non-Vietnam

veteran

comparison

group.

However, m1sclass1f1ed social security numbers, names, or veterans who died
out of state would only reduce the magnitude of the excess mortality seen 1n
the Vietnam veterans compared to the Massachusetts male population.
Another potential source of bias Is that only honorably discharged
veterans were Included 1n the study population.
veterans were

more

non-Vietnam veterans.

likely to

It Is not known 1f Vietnam

have been dishonorably discharged than

Once again, this potential bias would tend to dilute

the magnitude of the associations between Vietnam service and specific causes
of death.
The standardized proportionate mortality ratio (sPMR) as a method of
analysis has been criticized by various authors.(3,5,15) The major criticisms
of the sPMR approach concern the summary nature of the statistic. Because the
sPMR for all causes must equal 100, the statistic cannot give any Information
about the total force of mortality.(15) Secondly, the sPMRs for two or more
causes are Interdependent, since the sum of the expected numbers must equal
the sum of the observed numbers.(3) Therefore, any sPMR greater than the null

�19

may be an underestimate If more than one specific cause of death 1s estimated.
It has also been pointed out that sPMRs tend to be more easily Interpreted for
uncommon causes of death, because they are less dependent upon how common are
the other causes, relative to the cause of Interest.(3,5)
The sMOR has certain advantages relative to the sPNR. When the auxiliary
cause(s) of death 1s unrelated to the exposure, the mortality odds ratio 1s
Interpretable as the observed-to-expected

ratio.

When standardized for age

and time, the mortality odds ratio becomes the standardized mortality odds
ratio and the observed-to-expected ratio becomes the standardized mortality
ratio.

In contrast, the sPMR can be quantitatively Interpreted as the stan-

dardized mortality ratio only when the sum of the mortality rate(s) of
Interest and the rate for the auxiliary cause(s) of death 1s the same for both
the exposed and nonexposed.(6)
In this study, the sPMR analysis Identified specific causes of death
for which there were significant differences between Vietnam veterans and the
comparison groups. The sMOR analysis was used to confirm these findings. The
results of the study are strengthened by the fact that the sMOR analysis,
using a specific auxiliary cause, differed from the sPMR analysis in only two
Instances.
In order to Interpret the meaning of the findings 1n this study, it Is
necessary to keep two other factors 1n mind.

First, the study group of

Vietnam veterans was assembled from a 11st of those who received a bonus after
they had presented proof of Vietnam service and honorable discharge.

No

�20

Information about length of service (beyond the six month required minimum),
precise location of service, or specific exposures to toxic substances, such
as Agent Orange, was available from these records. Furthermore, no correction
was made for possible social class differences between the Vietnam veterans
and the two comparison groups.

However, the Vietnam veterans findings for

three causes of death which are highly correlated with social class—lung
cancer, colo-rectal cancer, and cirrhosis of the liver—did not, 1n this
Instance, differ significantly from those of the comparison groups.
Three significant findings presented In Table 6, specifically suicides,
estimated suicides, and motor vehicle accidents, are all similar In that the
causal factor may be a behavioral one.

It may be that social stress, which

could not be directly measured 1n this study, was higher for Vietnam veterans
compared to non-Vietnam veterans and other non-veteran white males. Depression
1s a major risk factor for suicide (8),

and previous studies of Vietnam

veterans

stress disorder

have documented

post-traumatic

and

associated

depression, as well as elevated rates of suicide, among those who served in
combat.(16,17,18)

It 1s certainly plausible that the findings in this study

may be due, at least in part, to Increased stress experienced by Vietnam
veterans.
No significant differences were found between Vietnam veterans and the
two comparison groups with respect to death due to malignant neoplasms as a
whole (ICDA 140-239).

The significant elevation of connective tissue cancer

was based on only nine deaths; all of these were sarcomas of five different
types. Table 7 lists the nine cases by hlstologlcal type. Previous studies

�21

have reported that soft-tissue sarcomas were associated with exposure to phenoxyacetic

acids such

Orange.(19,20)

as 2,4-D and 2,4,5-T, the components of Agent

For all of the cases with the possible exception of case 9,

occupational exposure as obtained from the death certificate did not seem to
be significant.

A more recent study of upstate New York Vietnam veterans

reported no excess of soft-tissue sarcomas diagnosed through 1980.(21)

The

present study was not based on either adequate numbers of deaths or adequate
exposure Information to help resolve this Important Issue.

Nevertheless, the

highly significant excess of this rare malignancy in Vietnam veterans 1s
important new Information.

The latency period for soft-tissue sarcoma in

adults is probably sufficiently long that several more years of observation
will be necessary before any conclusive findings can be made.

�22

TABLE 7
CASE-SPECIFIC INFORMATION FOR CONNECTIVE TISSUE CANCER DEATHS
AMONG VIETNAM VETERANS BY HISTOLOGIC TYPE AND OCCUPATION
YEAR
CASE AGE AT YEAR
YEAR OF HISTOLOGIC
OCCUPATION ON
DEATH INDUCTED DISCHARGED DEATH
DEATH CERTIF.
TYPE

1

30

1969

1971

1975

FIBROSARCOMA

DATA PROCESSING

2

28

1967

1970

1976

SYNOVIAL
SARCOMA

MANAGER

3

30

1965

1967

1976

LIPOSARCOMA

MENTAL HEALTH
ASSISTANT

4

32

1967

1972

1977

FIBROSARCOMA

MANAGER

5

30

1964

1967

1977

FIBROSARCOMA

ENGINEER'S AIDE

6

32

1970

1971

1978

FIBROSARCOMA

CIVIL ENGINEER

7

32

1970

1971

1982

EPITHELIOID
SARCOMA

GRAPHICS

8

29

1971

1974

1982

SARCOMA, NOS

FIREFIGHTER

9

39

1961

1966

1983

HEMANGIOPERI- PICKER
CYTOMA

Kidney cancer 1s less rare than soft-tissue sarcomas and was found to be
significantly
males.

elevated 1n Vietnam veterans compared to

non-veteran white

Possible confounding due to cigarette smoking, analgesic use or other

known risk factors among veterans should be considered, but Information on
those risk factors was unavailable In this study.

Further studies may also

shed light on this finding.
Finally, the significantly lower number of deaths among Vietnam veterans
due to circulatory system disease (excluding stroke)

for

the time period

1978-83 may be a reflection of the "healthy veteran effect."(12)

�23

Conclusions
The findings in this study support the hypothesis that white male Vietnam
veterans are at greater risk of death due to self-Inflicted or stress-related
conditions than the non-veteran white male population in Massachusetts.

The

results would support an effort to reduce early or untimely deaths among
Vietnam veterans due to suicide or motor vehicle accidents, which are largely
preventable.

Although the numbers of cancer deaths are small, the finding of

excess deaths due to connective tissue sarcoma and kidney cancer warrants
further study using the cancer incidence records from the Massachusetts Cancer
Registry, and, if available, Information on possible exposures to Agent
Orange, as reflected

in detailed military service histories, as well as

histories of other exposures to potential carcinogens.

�24

Acknow!edgements
We would like to acknowledge the following people for their Invaluable
assistance 1n various aspects of the study:
Sharon L. Rosen, Ph.D.; David N. Gute, Ph.D.; Christopher Gregory; the
Medical-Scientific

Advisory

Board

of

the

Agent

Orange

Program

(Louis

Bartoshesky, M.D.; John McCahan, M.D.; John Cutler, M.D., Ph.D.; Robert
Weiss, Ph.D.; John Constable, M.D.; Ralph Timperi, M.P.H.); Gall Grady; Lynne
Whitton; Pam English; Shelley J. Allison, M.P.H.; Linda Wiggins; Susan Mullen;
and Masahiru Takeuchi. Special thanks to George A. Lareau for word processing
the manuscript.
Drs. Harris Pastides, Letitla Davis, James Robins, Robert Dubrow and
Adrian Ostfeld reviewed or commented on drafts of the report.

�25

References
1.

Feeney R: Personal communication. Military Archivist, Massachusetts.

2.

Manual of the International Statistical Classification of Disease,
Injuries and Causes of Death, Ninth Revision. Geneva: WHO, 1975.

'3.

Monson RR: Occupational Epidemiology. Boca Raton, FL: CRC Press, 1980.

4.

Mantel N, Haenszel W: Statistical aspects of the analysis of data from
retrospective studies of disease.
Journal of the National Cancer
Institute 1959; 22:719-748.

5.

Miettlnen OS, Wang J: An alternative to the proportionate mortality
ratio. American Journal of Epidemiology 1981; 114:144-148.

6.

Splegelman D, Wang J, Wegman D: Interactive electronic computing of the
mortality odds ratio.
American Journal of Epidemiology 1983;
118:599-607.

7.

Dubrow R, Wegman D:
Occupational characteristics of white male
Massachusetts state cancer victims, 1971-73. NIOSH Pub No 84-109, 1984.

8.

Healthy People: The surgeon general's report on health promotion and
disease prevention. DHEW (PHS) Publication No 79-55071, 1979.

9.

McClure GMG: Trends In suicide rates for England and Wales, 1975-80.
British Journal of Psychiatry 1984; 144:119-126.

10. Alderson MR, Meade TW: Accuracy of diagnosis on death certificates compared with that in hospital records. British Journal of Preventive and
Social Medicine 1967; 21:22-29.
11. Engel L, Strauchen J, et al: Accuracy of death certification in an
autopsied population with specific attention to malignant neoplasms and
vascular diseases. American Journal of Epidemiology 1980; 111:99-112.
12. Seltzer CC, Jablon S: Effects of selection on mortality.
Journal of Epidemiology 1974; 100:367-72.

American

13. Alvey W, Aziz F: Quality of mortality reporting in SSA linked data:
some preliminary results. Proceedings of the Section on Survey Research
Methods, American Statistical Association, Washington, DC, 1979; 275-279.
14. Roget E, Feinlelb M, et al: On the feasibility of linking census samples
to the National Death Index for epidemiologic studies:
a progress
report. American Journal of Public Health 1983; 73:1265-1269.
15. Mil ham S:
Methods in occupational mortality studies.
Occupational Medicine 1975; 17:581-585.

Journal of

�26
16.

levy C:

Spoils of War. Boston, MA: Houghton-Mifflin, 1974.

17.

Shatan C: The grief of soldiers.
1973; 43(4).

18.

U.S. Congress, House Committee on Veteran Affairs.
Presidential review
memorandum on Vietnam-era veterans, H.R. 38, 10 October 1978.

19.

Hardell L and Sandstrom A: Case-control study: soft-tissue sarcomas and
exposure to phenoxyacetic adds on chlorophenols.
British Journal of
Cancer 1978; 39:711-717.

20.

Eriksson M, Hardell L, et al: Soft-tissue sarcomas and exposure to chemical substances: a case-referent study. British Journal of Industrial
Medicine 1981; 38:27-33.

21.

Greenwald P, Kovasznay B, et al: Sarcomas of soft tissue after Vietnam
service. Journal of the National Cancer Institute 1984; 73:1107-1109.

American Journal of Ortho-psychiatry

�27
APPENDIX A
NON-WHITE VE TERAN DEATHS BY YEAR OF DEATH, VETERAN STATUS,
YEAR OF
DEATH
1972

1973

1974

1975

1976

1977

1978

VETERAN
STATUS

Vietnam
Vietnam
Non-Vietnam
Non-Vi etnam
Non-Vietnam
Non-Vi etnam
Non-Vietnam
Non-Vi etnam
Vietnam
Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non- Vietnam
Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Vietnam
Vietnam
Non-Vietnam
Non- Vietnam
Non- Vietnam
Non-Vi etnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Vietnam
Non-Vietnam
Non-Vietnam
Non-Vietnam
Non- VI etnam
Vietnam
Vietnam
Vietnam
Non-Vietnam

CAUSE OF DEATH AND AGE AT DEATH
CAUSE OF DEATH
(ICDA CODES. 9th REV.)

AGE AT DEATH

Motor vehicle collision (e812.0)
Suicide by hanging (e953.0)
Metastatic cancer without
specification (199.0)
Disease of aortic valve (395.9)
Acute myocardlal Infarction (410)
Cardlomyopathy (425)
Fall out of building (e882)
Homicide by knife (e966)
Lymphosarcoma (200.1)
Accidental drowning (e910.9)
Rectal cancer (154.1)
Myocardlal Insufficiency (428)
Cirrhosis of liver, unspecified (571 .9)
Suicide by firearms (e955.4)
Homicide by firearms (e965.4)
Homicide by firearms (e965.4)
Legal Intervention by firearms (e970 i
Sigmoid colon cancer (153.3)
Brain cancer (191)
Acute myocardlal Infarction (410)
Motor vehicle traffic accident (e815,,0)
Watercraft accident (e830.0)
Motor vehicle collision (e812.0)
Motor vehicle collision (e812.0)
Acute myocardlal infarction (410)
NoncolHslon traffic accident (e816.0)
Accident by electric current (e925.9)
Homicide by firearms (e965.4)
Stomach cancer (151.9)
Stomach cancer (151.9)
Disease of mitral valve, rheumatic (394.0)
Acute myocardial Infarction (410)
Accidental poisoning, opiates 1.853.6,
Bronchus and lung cancer (162.9)
Essential hypertension (401)
Atherosclerotic heart disease (414.0)
Subarachnoid hemorrhage (430)
Chronic nephritis (582)
Unknown and unspecified
cause of death (799.9)
Homicide by knife (e966)
Bronchus and lung cancer (162.9)

31
28
33
45
43
43
47
32
22
24
31
21
57
32
25
27
27
53
36
56
41
27
29
24

41
31
36
31
33
56
29
40
25

53
52
42
37
29
27
27

32

�28
APPENDIX A (continued)
NON-WHITE VETERAN DEATHS BY YEAR OF DEATH, VETERAN STATUS.
CAUSE OF DEATH AND AGE AT DEATH
YEAR OF VETERAN
CAUSE OF DEATH
AGE AT DEATH
DEATH
(ICDA CODES, 9th REV.)
STATUS
1979
Vietnam
Volume depletion (276.5)
52
Vietnam
Ischemic heart disease (414.9)
53
Non-Vietnam Chronic monocytic leukemia (206.1)
40
Non-Vietnam Pneumonitis due to Inhalation
54
of food (507.0)
Non-Vietnam Passenger 1n motor vehicle
collision (e812.1)
36
Vietnam
Colon cancer (153.9)
42
1980
Vietnam
36
Intracerebral hemorrhage (431)
Vietnam
Motor vehicle collision (e812.0)
36
Non-Vietnam Bronchus and lung cancer (162.9)
45
Non-Vietnam Diabetes mellltus (250.0)
66
Non-Vietnam Epilepsy (345.9)
46
Non-Vi etnam Acute myocardial Infarction (410)
45
Non-Vietnam Chronic renal failure (585)
53
Vietnam
Rectal cancer (154.1)
53
1981
Acute edema of lung (518.4)
Vietnam
38
Motor vehicle collision (e812.0)
Vietnam
32
43
Non-Vietnam Palate cancer (145.5)
Non-Vietnam Larynx cancer (161.9)
57
56
Non-Vietnam Bronchus and lung cancer (162.9)
63
Non-Vietnam Bronchus and lung cancer (162.9)
Non-Vietnam Alcohol dependence syndrome (303)
38
Non-Vietnam Acute myocardial Infarction (410)
52
37
Non-Vietnam Intracerebral hemorrhage (431)
27
Non-Vietnam Accidental drowning (e910.1)
28
Non-Vietnam Suicide due to firearms (e955.4)
Atherosclerotic heart disease (414.0)
42
1982 .- Vietnam
38
Alcohol cirrhosis of the liver (571.2)
Vietnam
Drowning, undetermined 1f
Vietnam
33
accidental (e984)
64
Non-Vietnam Bronchus and lung cancer (162.9)
45
Non-Vietnam Volume depletion (276.5)
36
Non-Vietnam Atherosclerotic heart disease (414.0)
64
Non-Vietnam Cardlomyopathy (425)
32
Non-Vietnam Acute edema of lung (518.4)
Cardiomyopathy (425)
33
Vietnam
1983
35
Myocarditis (429)
Vietnam
49
Non-Vietnam Acute myocardial infarction (410)
52
Non-Vietnam Acute myocardial Infarction (410)
52
Non-Vietnam Cerebral Infarction (434.9)
32
Non-Vietnam Suicide by firearms (e955.4)
40
Non-Vietnam Homicide by firearms (e965.4)

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24217">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24219">
              <text>1859</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24222">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24215">
                <text>Kogan, Michael D.</text>
              </elementText>
              <elementText elementTextId="24216">
                <text>Richard W. Clapp</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24218">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Massachusetts Office of Commissioner of Veterans Services, Agent Orange Program; Massachusetts Department of Public Health, Division of Health Statistics and Research</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24220">
                <text>January 18 1985</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24221">
                <text>Mortality Among Vietnam Veterans in Massachusetts, 1972-1983</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24223">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24224">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24225">
                <text>suicide</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="3276" public="1" featured="0">
    <fileContainer>
      <file fileId="1689">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/252560d2f96615aedef84b0d2d86d088.pdf</src>
        <authentication>f39caa3a4fda966f6b7e7d82bf31410b</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63638">
                    <text>Item ID Number

01858

Author

McKinley, Thomas W.

Corporate Author

Georgia Department of Human Resources

ROpOTt/ArtlGto HUB

Geor

9'a Agent Orange Survey of Vietnam Veterans:
Summary

Journal/Book Title
Year

1983

Month/Day

Ju|

Color
Number of Images

v

||
:

11

Descrlpton Notes

Wednesday, July 11, 2001

Page 1859 of 1870

�v.v$?

--•••£•*'*

Georgia Survey
of Vietnam
Veterans

-"'&amp;:.:

• IT: &amp;*

;•«?»

•SSfei

4^

•S"

s^si^s
stA^

�SUMMARY

Published by

GEORGIA DEPARTMENT
James G. Ledbetter, PhD, Commissioner
47 Trinity Avenu® , S.W.
Atlanta, Georgia 30334

JULY 1983

Prepared by
Thomas W. McKintey, MPH
Epidemiologist

th&amp; Direction of
R. Keith Sikes, DVM, MPH
Director, Office of Epidemiology

James W. Alley, MD, MPH
Director, Division of Public Health

�flCKNQWLEDGEMENTS

The Office of Epidemiology expresses grateful appreciation
for the suggestions and guidance provided by the following
persons who comprised an ad hoc fldvisory Committee for the
Georgia ftgent Orange Study:
Committee* Members
Thomas W. McKinley, MPH (Chairman)

Office of Epidemiology, DHR

R. Keith Sikes, DVM, MPH

Office of Epidemiology, DHR

Douglas Huber, MD
John Brady

Nam Vets of Georgia
•*»
^a. Dept. of Vet. Services

D. S. Wilkerson

Ga. D^nt. of Vet. Services

Julian ft. Jarman, MD

Decatur Vft Hor-p:'tal

James R. Bishop

Decatur VO Hosoitai

Observers
John D. Humphreys

Division of Pub. Health,DHR

Don Barrish

Office of
Community
Inte*—Gov. Relations,

and
DHR

�GEORGIA SURVEY

The 198£ Georgia General ftssernbly passed House B i l l
1£00*
entitled "Reports of Veterans Exposed to Agent Orange." ft sum of
$67,525 was appropriated for the Department of Human Resources to
conduct a questionnaire survey of Vietnam veterans exposed to
flgent Orange during the Vietnam conflict.
Recording
to
Veterans ndrr,inistrat ion (VO)
estimates,
approximately 58,008 Georgians Served in Vietnam.
ft
list of
Vietnam veterans was not available from the Georgia Department of
Veterans Services to use as a basis for the survey.
Therefore,
it was necess-ary to use registers of veterans who took the ficent
Orange physical examination being offered by Vft hospitals and
membership lists from organisations such as Nam Vets of Georgia.
In addition, veterans were reached oy publicity campaigns and by
placing posters,
brochures.
and Questionnaires in Georgia
Department of Veterans Services Offices and other locations
freauented by veterans throughout the state. firrancsments were
also made with Ti.el.ine, the state telephone information and
referral system, to allow Vietnam veterans to call toll free from
anywhere in the state and request a questionnaire. ftpproximately
£6, 030' questionnaires were distributed; 9.6% by direct mailing
and 90.4% by placement in locations freauented by veterans.
Participation was limited to Vietnam veterans residing in
the state at the time of the survey. General objectives were to:
1.

Obtain completed questionnaires by Marcn 31, 1383, from
the largest possible number of veterans in Georgia who:
(a)
(b)

currently reside in Georgia,

(c)

had known or presumed exposure to flgent Orange,
and

(d)
£.

served in Vietnam,
period 196E-1974,

Laos,

or Cambodia during

the

have seen a physician for a health problem
believed to be related to Agent Orange Exposure.'

Verify medical histories given by veterans by querying
physicians
and/or hospitals identified on
veteran
questionnaires.

*Sponsored by Representatives Eleanor L. Richardson, Joe T. Wood,
Forest Hayes, Jr., Joe Frank Harris, and Paul S. Branch, Jr.

�3. Analyse and summarize data from veterans, physicians, and
hospitals.
4. Report
findings to
General flssembly.

the 1384 session

of

the

Georgia

Results
fls of June 30, 1983,
quest ionnaires were received form 1905
veterans. These quest ionnaTres form the basis for a regTsTfry of~
Vietnam veterans in Georgia whose illnesses are allegedly due to
flgent Orange exposure or who have health concerns about flgent
Orange exposure.
Of the total questionnaires received,
1£6S _
(67.6%) were e 1 i g i big for i &gt;^gjLusjLon__i n the survey based on
the
abov"e~cr i t erTa".
Questionnaires were received from 1£4 . o
^ f Georgia's 159«
counties (Figure 1). " flpproxirnately 97% of the survey group were'
males; 65"/« were white and 30"/. black. ftge ranged from £3-77
years; mean 39.4 years.
Major findings of the survey are contained in the following
statemants.
Interpretation of these findings must take into
consideration the fact that 1) the survey targeted veterans
who
had one or more health conditions which they believe to be
related to flgent Orange exposure, £) a. subst ant_ial proport ion of
Jnejalth conditions r^^£Il^JigL__by veterans^were not confirmed by
'thjnTr bhysi'cians^ and may have been reported on the basTsoTsUTf^
diagnosis, and 3) information regarding exposure to flgent Orange
is totally dependent uoon recall of sometimes uncertain- events
which occurred 10-15 years ago.
1.
1£88 Vietnam veterans in the State of Georgia reported
having one or more health conditions which .they believe to be
related to exposure to flgent Orange.
Health conditions r_e_p_ortgd__
by more than half the veterans include s k in cond i t i ons (other
than acne),
emotional/adjustment
problems,
nervous
system
problems, and sleeplessness.
£. Only 52?t of 'survey participants had taken
Orange physical examination offered by Vfl.

the

flgent

3. fl substantial proportion of veterans (£9% during their
first tour of duty) reported being sprayed with flgent Orange by
aircraft.
4. Veterans reported 205 cases of acne with onset
after
service in Vietnam.
Physicians confirmed £9 cases in 119 of
these reports (£4. 4"/i), but there was no indication that the cases
were chloracne
(a specific type of acne caused by exposure to
dioxin and other chlorinated biphenyls).
.Vfl has acknowledged
only two or three cases of chloracne
in Georgia veterans.

�5. Veterans who participated in Operation Ranch Hand
(code
name for the group who sprayed flgent Orange) reported
a
significantly higher prevalence of cancer,
liver problems,
respiratory problems, sexual dysfunction, and chronic pain than
other veterans.
6. Veterans who remembered developing sorna type of illness
within
43 hours of exposure to flgent Orange, reported
a
significantly higher prevalence of 12 of 30 medical conditions.
7. Veterans reported 99 cases of cancer, but physicians
completing questionnaires on 47 of these confirmed only 13
(£1.3%).
Theoretically, all Georgia Vietnam veterans (est.
58,000) could have participated in the survey if they have a
health problem, including cancer, which they believe to be
related to flgent Orange exposure.
There are at least two ways to
analyze the cancer data:
(a)
The first method of analysis involves a comparison
of observed to expected cases.
Using cancer surveillance
data and assuming that the total population of Georgia
Vietnam
veterans has the same race,
sex,
and
ace
distribution as the survey group, Jbh_e expected number, ._._..Q.f_
cases i n . JLJlg_t ^!^gL'-!^QJ[li-ia ^ i'ietTvam^veFe'r an population
_
- - .
^ 37
7.
If the actual number of "cases ir\~t h e sorVey groTTp""
is 10^ this would only be three percent of the expected. If
the actual number
is 21, this would be six percent of
expected.
If the actual total is 99, this would be £3* of
expected.
(b)
0 second method of analysis consists of comparing
the observed prevalence rate of living cancer cases in the
survey group to the expected prevalence rate estimated for
all Georgia Vietnam veterans.
The expected prevalence rate
of living cancer cases in the total population of Georgia
Vietnam veterans was derived using cancer surveillance data
arid the assumptions indicated in (a) above.
If the actual
number of cancer cases in the survey group is only 10, this
would give a prevalence rate of 77S per 130,000 which is not
significantly different from the expected prevalence rate of
613 per 100,000.
If the actual number of cases is £1, the
observed prevalence rate would be sigificantly higher than
expected (p&lt;.01; Chi-square test). However, these data must
be interpreted with caution since the survey design tended
to inflate the number of cases of illness in the survey
group..
JJia—Sj^yjey^jdesigji,_ ijo_jHa.c_tJL__doGs not al low for a
determination of whjstjier cancer rjat e s are higher i n~vTetnarn
vc?tt?rans
exposed to
_
~
unex posed
popUIatjjgru
This and similar determinations"
"musTE await completion
of the large population
based
study being conducted by the Centers for Disease Control.

�8. Negative pregnancy outcomes reported by veterans were
less than 6.5^ of the number expected for any negative pregnancy
outcome among families of all 58,000 Georgia Vietnam veterans.
Pregnancy outcomes were not confirmed by physician questionnaires
or other means.
9,
The rate of cancer, other than leukemia, for progeny of
Vietnam veterans was not significantly different between those
children born before and those born after the father's Vietnam
service.
Veterans reported two cases of leukemia in children
born after Vietnam service, but meaningful comparisons were not
possible since physician confirmation of these cases was not•
obtained.

0 MORE DETAILED REPORT OF THE STUDY IS WftlLftBLE ON REQUEST

�Figure

STATE

:

.r&gt;?st-&gt;:*zvfiv/
^^^S

iift,"

^1

i

*:'?i'5?!:''''"'&gt;:''"1''';&gt;'''"ViiJii;!!i&gt;;

CAL**OW*

! - «*&lt;«.«» -'

i

/»

v

'-j '- ,•'

/•,'--""/&gt;" ' "

vr«g^s;.sss.s«8;r'
»«" ^^^^Ix ""*"'

/;

�RECOMMENDRTIONS

This report completes the charge to conduct an flgent Orange
survey which was given to the Department of Human Resources by
the 1982 Georgia General assembly. The following recommendations
are made as a result of that survey:
1.

£.

Consideration should be given to setting up an flgent Orange
clearinghouse or phone center which would receive inquiries
and complaints from veterans,
dependents and others, and
would transmit to interested persons information
with
resoect to flgent Orange or dioxin-related matters.
•*•
Veterans who have not taken.the Vfl flgent Orange physical
examination should be encouraged to take the examination at
the earliest time.

3.

The list of veterans who indicated they participated in
Operation Ranch Hand should be checked against military
study records to determine whether all these veterans are
enrol led in the Ranch Hand Study.

4.

The Vfl should be asked to evaluate or re-evaluate, as the
case may be, veterans whase physicians confirmed a diagnosis
of acne after age 18 to determine whether they may have
ch lor acne..

5. figent Orange questionnaires, computer tapes' containing data
on health conditions, and other pertinent files and records
should be transferred to the Georgia Department of Veterans
Service for safe keeping and possible use when results arc
completed on the CDC epidemiologic study.
S.

Odditional studies regarding the question of Ogent Orange
exposure and health of Vietnam veterans in Georgia should
await the results of the CDC epideniiolog ical cohort study.

�SUKMflRY OF HEflLTH EFFECTS OF DIOXIN EXPOSURE
figent Orange consisted of an approximately equal mixture of
two common herbicides, 2,4-D (£, 4-dichlorophenoxy acetic acid)
and 2,4,5-T (2,4,S-trichlorophenoxy acetic acid).
The latter
herbicide contained a small amount (average 2 parts per million)
of
a
chemical
contaminant
known
as
TCDD
(2,3,7,8tetrachlorodibenzo-para-dioxin), also commonly referred to as
"dioxin."
This contaminant, which is formed if the reaction
temperature becomes too high during synthesis of 2,4,5-T, has
been called the "most toxic man made substance known" because of
its highly lethal effects on certain strains of guinea pigs.
To date__t_here ^rg__np conclusive studies which causal 1 y link
TCDjD_ or 'fl"ge_nt Q*"anJe_j!JiP-gj?ure with_j?xcessive mortality or long
term health effects___i-Ki—huwajas...—
Information on'TfeaTth
effects
comes almostentirely from animal studies, which are not directly
predictive of effects in hurnans, and from human occupational
exposures to herbicides and other chemicals contaminated with
TCDD.
What is known regarding health effects is briefly
summarized in the following paragraphs.
Persons exposed to high concentrations of TCDD by reason of
occupation or industrial accident were commonly observed to
develop a painful skin, condition
called chloracne.
This
condition usually appeared within weeks to months following
exposure and persisted for one to several years, depending on the
severity of exposure.
Other health effects have also been
observed in severely exposed persons.
For example, a condition
known as porphyria cutanea tarda, which is characterized by large
blisters of the skin and liver involvement, was reported among at
least two groups of exposed workers.
In addition, Swedish
investigators have recently suggested that there may be a
relationship
between exposure to TCDD containing herbicides and
a form of cancer known as soft tissue sarcoma.
However,
information to date is not sufficiently completed to establish a
cause and effect relationship.
Birth defects were reported among children born to south
Vietnamese refugees who sought sanctuary in north Vietnam. Pi
higher rate of birth defects was also reported among infants born
to women whose husbands fought in south Vietnam compared to
those born to women whose husbands stayed in north Vietnam.
Results of these observations are in doubt, however, "due to
methodological
problems
attendant
with
ascertainment
of
information in a war-torn area.
Increased abortion rates were
also reported among women living in the PUsea, Oregon area where
2,4,5-T had been used for forest management. fln EPPt study tended
to confirm this report, but the EPft study was later found to have
serious problems with incomplete ascertainment of data.

�flnimal studies have shown that rabbits and monkeys develop
chloracne when exposed to subacute doses of TCDD.
Subacute
exposure has also been shown to produce severe weight loss and
porphyria (a disorder of hemoglobin metabolism) in certain animal
species.
Carcinogenicity testing of TCDD in rats and mice has yielded
results that are difficult to interpret. Increases were observed
in cancerous tumors but only at doses which produced other toxic
effects.
There was a general lack of both organ specificity and
linear dose response usually observed with cancer causing agents.
In one study a certain strain of mice fed combinations of TCDD
and S,4,5-trichlorophenoxyethanol showed a significantly higher
incidence of liver cancer than controls.
These observations led
investigators to hypothesize that'TCDD may be a tumor
promoter
rather than a primary carcinogen.
However, —in actual trials in
rats and mice, TCDD was not shown, to be a tumor promoter.
In
test systems which employed TCDD and a carcinogenic polyaromatic
hydrocarbon, TCDD was observed to inhibit tumor formation by
inducing
the
production of enzymes which
converted
the
polyarornatic hydrocarbons into non-cancer causing metabolites.
In other animal studies, certain strains of pregnant mice
showed fetatoxicity and birth defects in their offspring after
TCDD exposure; however, exposed male mice were not shown to
produce deformed offspring.

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24195">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24197">
              <text>1858</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24200">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24194">
                <text>McKinley, Thomas W.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24196">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Georgia Department of Human Resources</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24198">
                <text>1983-07-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24199">
                <text>Georgia Agent Orange Survey of Vietnam Veterans: Summary</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24201">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24202">
                <text>questionnaire</text>
              </elementText>
              <elementText elementTextId="24203">
                <text>morbidity trends</text>
              </elementText>
              <elementText elementTextId="24204">
                <text>dioxin</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2534" public="1" featured="0">
    <fileContainer>
      <file fileId="1366">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/e60d6e0915a2c041b9cb88f357f1c009.pdf</src>
        <authentication>c26923e4beba70ccf43ac8c3d4b04e26</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63315">
                    <text>Item ID Number

01496

Author

Shepard, B. M.

Corporate Author
Roport/Arttehj TltlO Typescript: Chapter 6: The Risk of Soft Tissue
Sarcoma in Veterans of the Vietnam Conflict

Journal/Book Title
°00°

Year
Month/Day
Color

n

Numberoflmae.es

25

DOSCriptOD NOtflS

This manuscript is a draft version of a chapter or section
from the following book: Agent Orange and its
Associated Dioxin: Assessment of a Controversy,
Young, A. L. and G. M. Reggiani, eds. New York:
Elsevier, 1988. This book is available in the NAL
collection, call no.: RA1242 T44 A3.

Tuesday, May 15, 2001

Page 1496 of 1514

�CHAPTER 6
"Perhaps the greatest fear held by veterans of the Vietnam
conflict was the fear of Cancer because they had been exposed to
Agent Orange"
THE RISK OF SOFT TISSUE SARCOMA IN VETERANS
OF THE VIETNAM CONFLICT
B.M. Shepard, H.K. Rang, F.M. Enzinger, L.B. Hobson

Ever since the reports by Hardell and Sandstrom (1979) ,
Eriksson et al. (1981) and others began to appear in Sweden
in the late 1970's, the concern that exposure to the phenoxy
acid herbicides increases the risk of developing one of ,.the
soft tissue cancers has persisted in the minds of scientists
and non-scientists alike.

This concern coincided with the

growing fear among many veterans of the Vietnam conflict that
service in that country and especially exposure to the
phenoxy herbicides used for strategic purposes during that
military action posed a major risk for developing a wide
variety of serious health problems.

It was inevitable,

therefore, that soft tissue sarcomas quickly joined the
growing list of adverse health effects attributed to exposure
to the phenoxj? -herbicides used in Vietnam.

By far the

predominant Herbicide used was code named Agency Orange.

It

was a 50:50 mixture of 2,4-D and 2,4,5-T, the latter
containing trace amounts of 2,3,7,,8-TCDD ranging between 1
and 47 parts-per-million (ppm).

The average concentration

was estimated to be approximately 2 ppm.

The distinction

�between the active herbicidal ingredients and the dioxin
contaminant as being the "causative" agent of these various
health problems including the soft tissue sarcomas has
remained clouded, although there is little evidence to
implicate 2,4-D or 2,4,5-T alone as human carcinogens.
The reports of. Hardell and his associates linking phenoxy
herbicide exposure with soft tissue sarcomas and related
concerns among Vietnam veterans have stimulated a series of
studies in the United States designed to shed more light on
this perplexing and troublesome issue.

Meanwhile the

concerns of Vietnam veterans in this area drew considerable
attention in the U.S. Congress where the issue was
heatedly debated and became the subject of a number of
legislative initiatives designed to mandate additional
research in this area as well as to provide compensation and
special medical care eligibility for Vietnam veterans who
developed one of these rare types of cancer.
This chapter will provide an overview of what is known
generally about this group of tumors and will summarize the
results of some of the studies designed to determine if
service in "'y
Vietnam and herbicide exposure have increased the
'
5,

risk for developing soft tissue sarcomas.
"V

INCIDENCE, DEFINITION AND DISTRIBUTION
Soft tissue sarcomas, compared to carcinomas and other
neoplasms are relatively rare tumors.

It is estimated that

�they account for about 1% of all cancers and are responsible
for about 2% of all cancer deaths.

Between 5000 and 7500 new

cases are diagnosed each year in the United States.

It has

been suggested that there is an upward trend in the incidence
of soft tissue sarcomas, but it is not clear whether this
represents a true increase or whether it reflects merely
better diagnostic capabilities and greater interest in this
type of tumor.

The average annual age-adjusted incidence

rate is 2.0 to 3.5 per 100,000 population, but the rate
varies not only in different age groups, but also depends
upon the definition of soft tissue sarcomas and the types of
neoplasms that are included among these tumors.

For example,

in the National Cancer Survey, retroperitoneal, mesenteric
and omental sarcomas are counted among the neoplasms of the
digestive system and pleural sarcomas (malignant mesotheliomas) are included among the tumors of the respiratory
system.

Judging from the available data, incidence and

distribution of soft tissue sarcomas seem to be similar in
different geographic regions of the world (Tucker and
Franmeni, 1982).
As the name indicates soft tissue sarcomas are usually
*'"''
defined as extra-skeletal, non-epithelial sarcomas that arise
chie.fXy in musple, fat or fibrous connective tissue such as
tendons or ligaments and less frequently in blood vessels and
nerves that serve these tissues. Consequently, soft tissue
sarcomas may occur anywhere in the body, but the majority

�originate in the large muscles of the extremities, the chest
wall, mediastinum and retroperitoneum.

Excluded are sarcomas

of the brain and other major organs, such as the heart,
lungs, kidneys, liver and intestinal tract.

Excluded also

are the tumors of the hematopoietic system, such as leukemias
as well as malignant lymphomas and Hodgkin's disease
(Enzinger et al. 1969; Enzinger and Weiss, 1983).
Soft tissue sarcomas may occur at any age: about 15% affect
persons younger than 15 years old and about 35% occur in
persons 55 years or older.

In general they are somewhat more

common in males than in females.

The age and sex incidence,

however, varies among different histologic types.

There is

no proven racial variation, even though the annual age-

:

adjusted incidence rates have been reported in some cases to
be higher for blacks than whites.

CATION AND DIAGNOSIS
On clinical examination, as well as direct visualization and
palpation during surgery, soft tissue sarcomas as a group
tend to display a fairly uniform picture.

When examined

under the microscope, however, they vary greatly in
appearance and actually comprise an extremely varied and
highly complex group of neoplasms rather than a single
entity.

At present, the classification recognizes 25 major

types of soft tissue sarcoma, many of which can be further
divided into one or more subtypes on the basis of their

4

�histologic characteristics.
Classification and diagnosis by subtypes are essential
because the clinical behavior and response to therapy
frequently depend not only upon the histogenetic type but
also upon the degree of cellular differentiation or grade of
the tumor.

The various types are named according to the

predominant cellular elements and the resemblance of the
tumor to normal tissue or its embryonal counterpart.
Malignant fibrous histiocytoma, liposarcoma and fibrosarcoma
are the most common soft tissue sarcomas of adult life;
together they account for more than 50% of all cases.
Rhabdomyosarcoma, neuroblastoma and extra-skeletal Swings
sarcoma are the most frequent types of soft tissue sarcoma in
children.
Correct diagnosis of these tumors is still largely dependent
on incisional or excisional biopsy in order to provide the
pathologist with a specimen of sufficient size for an
accurate description and identification.

In recent years

percutaneuous needed biopsy and aspiration have become
increasingly popular as a means of diagnosing many types of
neoplasms.

Reliance on these techniques when dealing with

this group of tumors, however, should be approached with
great caution, since they provide only a minute specimen which
may not be representative of the entire tumor.

But even with

adequate material many soft tissue sarcomas present a
diagnostic dilemma, and an accurate diagnosis often requires

�examination with the transmission or scanning electron
microscope.
techniques

More recently the use of immunohistochemical
in the study of soft tissue sarcomas has

profoundly changed the approach to the diagnosis of these
tumors and has permitted an accuracy of diagnosis unheard of
only a few years ago.

BEHAVIOR AND THERAPY
The various types of soft tissue sarcoma differ considerably
in their degree of malignancy, and identification and
diagnosis of the exact histologic type and subtype are
essential for predicting the clinical course of the tumor as
well as selecting the best method and plan for treatment
(Costa et al. 1984; Mandard et al. 1981).

Despite a wide

variety of therapeutic modalities, it is generally agreed
that surgical resection, when possible, is still the
treatment of choice for primary soft tissue sarcomas.
Chemotherapy and radiotherapy serve as adjunctive forms of
treatment, especially in highly malignant sarcomas.

When

planning definitive surgery, it is important to know as much
as possible about the extent of the lesion as well as the
&gt;• •'•

type and grade of the tumor.

Since the extent of the tumor

is not always evident microscopically, it is most important
that the margins of the resection be checked by the pathologist during the operative procedure.

The best chance of cure

is achieved with total excision during the initial surgical

�procedure.

Since many sarcomas develop microscopic met-

astases early in the course of the disease, the ultimate
outcome of these tumors must be assessed with considerable
caution and long term follow-up is essential, especially in
the case of high grade soft tissue sarcomas.

The outcome is

much less favorable with recurrent tumors and with large
unresectable tumors such as many sarcomas in the retroperitoneum (Eilber et al, 1984; Enneking, 1983; Rosenberg,

1982) .
Soft tissue sarcomas occurring in childhood often respond
extremely well to combination therapy with some reported cure
rates as high as 80%.

For this reason surgery in this age

group can usually be less radical when combined with

•-

radiation and chemotherapy.

PATHOGENESIS
As with other types of malignant neoplasms, the causative
factors of soft tissue sarcomas, are still for the most part
unknown. The development of sarcomas from benign soft tissue
tumors is rare.

A notable exception to this rule is the

appearaftce pf malignant neural tumors arising in
neurof ibromas... .In this instance it is nearly always seen in
T
patients with previously determined manifestations of
neurofibromas. A few causative agents and predisposing
factors have been clearly established and include various
physical and chemical exposures such as ionizing radiation

�and asbestos as well as various inherited or acquired
immunologic defects.

Determination of the exact cause is

often extremely difficult, because of the long latent period
between the time of exposure and appearance of the sarcoma.
The possible effect of multiple environmental and hereditary
factors during the induction period further complicates any
attempt to establish the causative agent or other
circumstances (Enzinger and Weiss, 1983).
Considering the extensive use of radiotherapy, radiation
induced sarcomas are extremely rare and therefore the benefit
of radiation in the treatment of malignant neoplasms, far
outweighs the risk of developing such a sarcoma.

It has been

estimated that only about 1% of patients who survive 5 years
following intensive radiation therapy for breast carcinoma,
malignant lymphoma or other types of malignant neoplasm,
develop a soft tissue sarcoma in the area of radiotherapy.
Almost any type of soft tissue sarcoma may arise following
radiation, but the two most common types are malignant
fibrous histiocytoma and extra-skeletal osteosarcoma.

There

is a close relationship between the total radiation dosage
and the risk' of developing a sarcoma (Halperin, et al, 1984;
Kim, 1978).
In addition to radiation, immunodeficiency and therapeutic
immunosuppression are known to be associated with the
development of soft tissue sarcomas.

For example virus-

induced immunodeficiency such as in the case of acquired

8

�immune deficiency syndrome (AIDS) has been recognized as
causing Kaposi's sarcoma in almost 1/3 of the affected
patients. The profound depression of cell-mediated immunity
in these patients is the result of a defect in the T-4
inducer or helper subset of T-lymphocytes.

Kaposi's sarcoma

carries a high mortality rate with a median survival of 18 to
20 months.
Aside from their role in the development of Kaposi's sarcoma,
there is no evidence that human transmissible viral agents
constitute a major risk factor in the development of soft
tissue sarcomas.

However, using the electron microscope,

particulate material, which may represent viral fragments,;
has been found repeatedly in soft tissue sarcomas.

The

origin and significance of this material, however, have not
yet been conclusively established.
Various types of sarcomas also occur secondary to therapeutic
immunosuppression associated with organ transplantation,
especially in renal transplant recipients.

Acquired immune

deficiency may also be the underlying mechanism in the
development of the relatively rare angiosarcomas or
lymphangiosarcomas that arise in the edematous extremity,
•M ,
'

either secondary to radical mastectomy (Stewart-Treves
Syndrome) or as a consequence of other forms of chronic
lymphedema.
There are only a few environmental factors that are
associated with the development of soft tissue sarcomas.

�About 80% of patients with pleural or peritoneal mesothelioma
give a history of asbestos exposure, usually 25 years or more
prior to the first appearance of this tumor.

As increased

incidence is found in asbestos miners as well as shipyard and
other industrial workers engaged in the process of
manufacturing, installing or repairing asbestos containing
products such as thermal and electrical insulation, brake
linings and cement tiles and pipes.

Important risk factors

include the intensity and duration of asbestos exposure as
well as the type and submicroscopic diameter of the asbestos
fiber (Selikoff et al 1964; Selikoff and Hammond, 1979).
Soft tissue sarcomas have also been reported as arising in
scar tissue following surgical procedures or thermal burns,
in fracture sites and rarely in the vicinity of plastic or
metal implants.

Whether trauma per se ever leads to a

sarcoma has not been clearly established, but in most
instances the association with mechanical trauma appears to
be coincidental rather than causative.

EPIDEMIOLOGICAL TECHNIQUES USED TO STUDY THE SOFT TISSUE SARCOMA ISSI
Research efforts designed and conducted to shed more light on
•

&lt; •'

^ * ^*St&gt;%,

• the relationship between adverse health effects in humans and
'exposure to the phenoxy herbicides and trace amounts of the
'•A '•
dioxin contaminant found in 2,4,5-T have usually been in one
of two general categories or types of epidemiological study
design.

These are case/control studies and cohort studies.
10

�Each of these types has its own strengths and weaknesses, but
when taken in combination they can provide a convincing body
of evidence.

The case/control design is well suited for the

study of rare events such as soft tissue sarcomas. Two
features of such a study, however, are of paramount
importance:

accurate diagnosis of the disease in question

and assurance of non-bias in the selection of the controls.
The cohort study is probably the most widely used method to
determine the relationship between exposure to a particular
chemical or other environmental factor (s) and a disease or
group of diseases.

Using this study design, however, the

rarer the outcome being studied, the larger the cohort,.must
be.

In this type of study the accuracy of exposure data for

each member of the cohort of interest is of key importance.
Again, the selection of the comparison or control cohort must
be carried out with great care.
The mortality experience of a group can be used to look for
possible cause-and-effeet relationships between an exposure
of concern and adverse health outcomes.

The two commonly

used analytical techniques are known as the proportionate
m r a i y * ' ! ' (PMR) and the standardized mortality ratio
otlt^*!?
i.
"•
• ,-,*&gt;:'/•?*
'^'
(SMR) . In general, when using the SMR one determines and
r'tiSj "^. .'
-

-Jf
•"»!* ** "

compares the numbers and causes of death in a particular
study group and a comparison group.

This method has the

potential for and the advantage of providing death rates if
sufficiently large cohorts are used.
11

As with the cohort

�morbidity study, the rarer the outcome, the larger the cohort
must be.

The PMR on the other hand cannot generally provide

death rates, but can provide relative frequencies by cause of
death.

These relative frequencies in the group of interest,

as for example a group of deceased Vietnam veterans, can be
compared to those in a comparison group, i.e., veterans of
the same age and sex who served elsewhere.

In addition the

frequencies may be compared to those known to exist for age
and sex specific segments of the general population.

In the

case of veterans, however, the latter method of comparison is
generally considered less valid since veterans represent a
highly selected group of individuals and their patterns of
death, especially in the first half of life are somewhat

,-

different from those seen in the general civilian population.

12

�REVIEW OF STUDIES OF SOFT TISSUE SARCOMAS
IN VIETNAM VETERANS

VETERANS ADMINISTRATION STUDY
In view of the concern raised by this issue among Vietnam
veterans, a case comparison group analysis of patients
treated in Veterans Administration hospitals was undertaken
to determine the association between previous military
service in Vietnam and soft tissue sarcomas (Rang et al.
1986).

A total of 418 cases with International

Classification of Disease

(ICD) 171 diagnosis, i.e.,

malignant neoplasms of connective and other soft tissues,;;
were identified by computer search of the Veterans

...

Administration Patient Treatment File (PTF) for Vietnam era
veterans who were hospitalized between 1969 and 1983.

The

PTF is a large computerized hospital data base of in-patient
records which includes diagnostic and demographic
information.

A pathology report for each of theses 418 cases

was requested from the appropriate VA hospital and a total of
394 pathology reports were received.
reports were reviewed by a single VA
pathologist With particular expertise in this area of cancer
diagnosis.

He;had no knowledge of the Vietnam service status

of any of the cases.

A total of 234 of these cases were

determined to meet the World Health Organization (WHO)
classification system for soft tissue sarcoma.

13

The

�comparison group consisted of 14,931 VA hospital patients who
were systematically sampled from the same Vietnam era veteran
patient population from which the cases were identified.
Military service information, in particular the Vietnam
service status, for each STS case and control patient was
obtained from a comprehensive review of the military
personnel records at the National Personnel Records Center
(NPRC) in St. Louis Missouri.

Military personnel records

were located and abstracted for all of the 234 STS cases and
13,496 of the 14,931 (90%) control patients.
V

Eighty six of the 234 STS cases (36.8%) had served in Vietnam.
':- 5# .

whereas of the sample of 13,496 Vietnam era patients who's^t
''."*• * f
personnel records were located and reviewed, 5544 (41%) had
served in Vietnam.

On the basis of this comparison it was

concluded that no significant association of soft tissue
sarcomas and previous military service in Vietnam exists
among Vietnam era veterans who come to the VA hospital for
inpatient medical care.

The odds ratio was 0.83 with a 95%

confidence interval of 0.63-1.09.
In order to further strengthen the study, the tissue slides
• '•; -iS1

from/all the&lt;?a$es originally coded as ICD 171 in the PTF
•«' if,
were requested^$rom the VA Medical Centers. The tissue
specimens f.0r 1 8 cases were located and sent to Dr. Franz
'1
Enzinger at the Armed Forces Institute of Pathology for his
review.

During the review, Dr.Enzinger knew neither the

Vietnam service status of the cases nor the VA's diagnoses.
14

�Following his review a comparison was made between his
diagnosis and that of the VA Pathologist who had reviewed the
pathology reports.

Among the 181 cases he reviewed, he

concurred with the VA diagnosis in 171 cases (94.5%):
cases, STS; 73 cases, non-STS.

98

However, for 10 cases he

disagreed with the VA's diagnosis:

4 cases that VA

classified as non-STS, he classified as STS; 6 cases that VA
determined as STS, he reclassified as non-STS.

Military

service information was available for 96 of the 98 ICD 171
cases that both VA and AFIP agreed to be STS cases.

A record

of Vietnam service was indicated on 33 of the 96 STS cases
(34.4%).
Comparing this proportion to the proportion of Vietnam
veterans in the comparison group, no significant association
of soft tissue sarcoma and previous military service in
Vietnam was observed. (The odds ratio was 0.75 with a 95%
confidence interval of 0.49-1.15.)

U.S. Air Force Health Study
A group of approximately 1260 men who conducted the Ranch
Hand fixed wing, aerial herbicide spraying missions in Vietnam
from 1962 through 1971 is being studied for their mortality
patterns and the current health status.

Cumulative mortality

as of December 31, 1984, in Ranch Hand personnel revealed no
death from soft tissue sarcoma (Wolf et al., 1985).

Although

the study did not indicate any increased mortality or any
15

�unusual patterns of death, it should not be regarded as final
because of the small number of study subjects and the
relatively short follow-up period.

STATE STUDIES OF SOFT TISSUE SARCOMA IN VIETNAM VETERANS
In four states-New York, Massachusetts, West Virginia, and
Wisconsin-investigators have conducted mortality studies that
include soft-tiss.ue sarcomas among the causes of death.

In

each study there have been relatively few cases of soft
tissue sarcoma and the results in this area have not been
: £

consistent.

In addition to the mortality studies, a case

control study of soft tissue sarcoma was conducted in New
York.

New York
Greenwald et al. (1984) conducted a case-control study in
which he identified 281 soft-tissue sarcoma cases in the New
York State Cancer Registry among men who were between the
ages of 18 and 29 during the period 1962-1971 and who were
diagnosed between 1962 and 1980.
y

At the time of the study,

. '•*

151 of the 281 cases were still alive and 130 had died.
Using the'driver's license registration files of the N.Y.
State Department of Motor Vehicles, a living male control was
selected to match each of the 281 cases by being within 5years of the birth date and within the same ZIP code of

16

�residence.

In addition, a deceased control was selected for

each of the deceased cases.

The deceased cases and the

deceased controls were also matched for race, sex, the year
of death, 5-year age group, year of education and health
system area.

Of 281 cases, 10 men had served in Vietnam as

had 18 men of 281 living controls and 9 of 129 deceased
controls.

This carefully conducted case-control study

demonstrates "no statistically significant positive
association between sarcomas of soft-tissues and either
service in Vietnam or military service in general."
Lawrence et al. (1985) undertook a mortality study involving
1,496 male Vietnam-era veterans of whom 555 or 37% served.:
'
I
Vietnam and all of whom died in New York State (but outsid£
New York City) during 1965-1967 or 1970-80.

Among the 555

Vietnam veterans, 2 died of cancer of connective and soft
tissues and 3 of the 941 non-Vietnam veterans died from this
same category of cancer.

This resulted in an adjusted

mortality odds ratio (MOR) for connective and soft-tissue
cancers of 1.09; 95% CI of 0.18 - 6.70.

In addition, the

study included a comparison of mortality patterns between
4558 deceased v&amp;terans of the Vietnam era and 17,936 nonveteran males of the same age group who had died in New York
State.

There were 12 connective and soft tissue cancers

among the veterans and 47 among the non-veterans
95% CI 0.61 - 2.17).

These

(MOR=1.15:

data suggest that there was no

significant difference in deaths due to soft tissue sarcomas
17

�between Vietnam veterans and non-Vietnam veterans as well as
between veterans and non-veterans.

The small number of

cases, however, make the results relating to soft tissue
sarcoma of limited value.

Massachusetts
Kogan and Clapp (1985) in the report of a mortality study
conducted in Massachusetts described their results as showing
"a statistically highly significant excess of soft tissue
sarcoma mortality in Massachusetts Vietnam veterans."

The

two veteran groups, those with service in Vietnam and those
who served elsewhere were identified from a list of honorably
discharged service men who applied for a state bonus and whose names appeared in the Massachusetts death registry.
Vietnam service status was determined from the fact that in
granting the bonus a larger amount was paid to those who
served in Vietnam.

The cause of death was obtained from

death certificates.

No verification of military service

beyond the discharge certificate (DD214) was attempted.
Among the 840 deceased Vietnam veterans nine deaths were
believed tf&amp;JtyidLdue to soft tissue sarcoma.

Statistical

calculations found that 1.02 deaths from connective and softtissue cancerrwould have been expected among Vietnam-era
veterans and 1.90 deaths among non-veterans.

Such

differences are striking.
The validity of the Massachusetts study is somewhat in
18

�question however, because verification of Vietnam service
status was not attempted.

The DD214 often does not show the

specific place of service as Vietnam. In addition when dealing with such relatively rare causes of death as soft tissue
sarcoma where the diagnosis can be difficult to make it is
generally agreed that verification of the diagnosis by a
pathologist with expertise in this area is necessary in order
to draw valid conclusions regarding this type of cancer.
West Virginia
The fact that reliance on the DD214 to determine service in
Vietnam may be misleading is illustrated in a mortality study
of West Virginia veterans conducted by Holmes, et al. (1986).
The study groups were compiled from a list of 83,730 bonusfe
applicants of whom 41,059 qualified as Vietnam veterans and
41,782 as non-Vietnam veterans.

The DD214 was used to

determine whether or not the veteran had served in Vietnam
and the cause of death was obtained from death certificates.
Comparison of the bonus roster with the death register
revealed that 615 Vietnam and 610 non-Vietnam male veterans
had died.

Among these were 3 deaths attributed to soft-

tissue sarcoma.;5 and all were among veterans classified as
having served in Vietnam.

No soft tissue sarcoma deaths were

found among the non-Vietnam veterans.
Subsequent to publishing the report, the military service
records of the three veterans who died of soft-tissue sarcoma
were examined.

One veteran was in the Navy and had served
19

�aboard ship off the coast of Vietnam, a second was stationed
in Thailand, and the third served with an Army combat unit in
Vietnam.

Thus, only one soft-tissue sarcoma death occurred

in a Vietnam veteran with actual in-country service.

Wisconsin
Anderson et al. (1986) issued a report of a study of
Wisconsin veterans in which Vietnam service status was
determined from the DD214 and the cause of death from the
death certificate.

Two epidemiological techniques were used:

"proportionate mortality ratio" (PMR) comparing the relative
number of deaths from that cause expected on the basis of
experience in another, e.g., Vietnam-era veterans, or

.,

"standardized mortality ratio" (SMR) comparing the causespecific death rates in the two groups.
A comparison of the proportion of STS deaths in 923 deceased
Vietnam veterans with the same proportion in 1,571 deceased
non-Vietnam veterans showed no statistically significant
increase in the proportion of soft-tissue sarcoma (PMR, 147;
95% CI, 62-350).

There were, however, only 5 deaths

tabulated £ra»J8oft-tissue sarcoma among Vietnam veterans and
the tabulated information about these cases indicated that
one&gt;man;had a,"wide-spread carcinoma", apparently
misclassified as a soft-tissue sarcoma.

This reduces to 4

the number of soft-tissue sarcoma deaths and further
diminishes the significance of any differences.
20

�An SMR analysis comparing the deaths among Vietnam veterans
with the deaths among Wisconsin, non Vietnam veterans, was
based on 4 STS deaths among 43,398 Vietnam veterans and 5 STS
deaths among 78,840 non Vietnam veterans.

Both groups had

less risk of dying from soft-tissue sarcoma when compared to
the entire state of Wisconsin.

Vietnam veterans had a

somewhat greater risk than non Vietnam veterans but the
observed elevation was not statistically significant.
Discussion
The absence of a consistently positive association between
soft tissue sarcoma and Vietnam service might be a result of
insufficient observation time since Agent Orange exposure in
Vietnam.

In general, it takes more than a decade for cancer

to manifest itself if it is induced by a chemical carcinogen.
Another possibility it that even if Agent Orange or dioxin
has the potential for including STS in humans, Vietnam
veterans as a group, were exposed to such small amounts that
the conventional epidemiologic study cannot detect the excess
risk resulting from Agent Orange exposure in Vietnam.
Alternatively, there is the possibility that neither Agent
Orange nor clioxin has the potential for inducing STS in
humans.
In conclusion, studies of STS in Vietnam veterans, in
general,have not revealed a statistically significant
positive association between STS and previous military
service in Vietnam.
21

�SUMMARY OF SOFT TISSUE SARCOMA STUDIES OF
VIETNAM VETERANS
AUTHORS

STUDY DESIGN

STUDY POPULATION

Greenwald, et al
(1984)

Case/Control

281 STS cases, 18-29 years
old anytime between
1962-1971 in NY State
Cancer Registry

Odds ratio = 0.53
(95% CI 0.21-1.31)

Lawrence, et al.
(1985)

PMR

555 NY State Vietnam
veteran deaths between
1965 and 1980, exclusive
1968 and 1969

Vietnam: 2 STS/555 deaths
Non Vietnam: 3 STS/941
deaths, Mortality odds
ratio= 1.09 (95% CI
0.18-6.70)

Kogan &amp; Clapp
(1985)

PMR

840 Massachusetts State
Vietnam veteran deaths

9 STS deaths vs. 1.02
expected, PMR=880 (P&lt;0.0001)

Anderson, et al
(1986)

PMR

923 Wisconsin State
Vietnam veterans deaths

5 STS death vs. 3.40
expected, PMR= 147
(95% CI 62-350)

SMR

43,398 Wisconsin State
Vietnam veterans, of which
927 were dead as of December,
1984

Vietnam:

615 West Virginia State
Vietnam veteran deaths
between 1968 and 1983

Vietnam: 3 STS/615 deaths
Non Vietnam: 0 STS/610
deaths

Holmes, et al.
(1986)

PMR

22

RESULTS

4 STS/927 deaths

Non Vietnam: 5 STS/1663
deaths

�AUTHORS

STUDY DESIGN

STUDY POPULATION

Wolf et al
(1985)

SMR

1260 Ranch Hand Personnel
who conducted aerial herbicide
spraying missions in Vietnam
from 1962 through 1971

0 STS/55 deaths

University of
Sydney
(1984)

SMR

10,205 Australian Vietnam
veterans, of which 260 were
dead as of January, 1982

Vietnam: 2 STS/260 deaths
Non Vietnam = STS/263
deaths

Rang, et al

Case Control

234 STS cases in the Patient
Treatment File

Odds ratio = 0.83 (95%
CI 0.63-1.09)

96 STS cases reviewed by the
AFIP

Odds ratio = 0.75
(95% CI 0.49-1.15)

RESULTS

SMR = Standardized Mortality Ratio; PMR = Proportionate Mortality Ratio; CI = Confidence Interval

23

�REFERENCES
1.

Anderson, H.A., Hanrahan, L.P., Jensen, M., et al.: 1986.
Wisconsin Vietnam veteran mortality study. Wisconsin Health
Department.

2.

Bailey, C., Baron, R.C., Basanac, E. et al.: 1986. West
Virginia Vietnam-era veterans mortality study. West
Virginia Health Department.

3.

Costa, J., Wesley, R.A., Rosenberg, S.A.: 1984. The
grading of soft tissue sarcomas. Results of a
clinicohistopathologic correlation in a series of 163 cases.
Cancer 53:530.

4.

Eilber, F.R., Morton, D.L., Eckhardt, J., et al.: 1984.
Limb salvage for skeletal and soft tissue sarcomas. Cancer
53:2579.

5.

Enneking, W.F.: 1983. Musculoskeletal Tumor Surgery,
Churchill Livingstone, New York, London.

6.

Enzinger, F.M., Lattes, R., Torloni, R.: 1969. Histological
typing of soft tissue tumors. International Histologicalj
Classification of Tumors No. 3., World Health Organization.

7.

Enzinger, F.M., Weiss, S.W.: 1983.
The C.V. Mosby Company, St. Louis.

8.

Eriksson, M., Hardell, L., Berg, N.O., et al.: 1981. Soft
tissue sarcomas and exposure to chemical substances: A
case-referent study. Br. J. Ind. Med. 38:27-33.

9.

Greenwald, P., Kovasznay, B.,Collins, D.N. et al.:
1984.
Sarcomas of soft tissues after Vietnam service. JNCI 73(5):
1107-1109.

10.

Halperin, E.C., Greenberg, M.S., Suit, H.D.: 1984. Sarcoma
of bone and soft tissue following treatment of Hodgkin's
disease.
Cancer 53:232.

11.

Hardell, L., Sandstrom, A.: 1979.
Case-control study:
tissue sarcoma and exposure to phenoxyacetic acids or
chlorophenols. Br. J. Cancer 39:711-717.

12.

Rang-, H.K., Weatherbee, L., Breslin, P.P.: 1986 Soft tissue
sarcomas and military service in Vietnam: A case comparison
group analysis of hospital patients. J. Occup. Med. 28(12):
1215-1218.

13.

Kim, J.H.:, Chu, F.C., Woodard, H.Q., et al.: 1978.
Radiation-induced soft tissue sarcoma and bone sarcoma.

24

Soft Tissue Tumors.

Soft

�Radiology 129:501.
14.

Kogan, M.D. and Clapp, R.W.: 1985. Mortality among Vietnam
veterans in Massachusetts, 1972-1983. Massachusetts
Department of Public Health.

15.

Lattes, R.: 1983. Tumors of soft tissues. Atlas of Tumor
Pathology, Second Series, Fascicle 1 (Revised), Armed Forces
Institute of Pathology.

16.

Lawrence, C.E., Reilly, A.A., Quickenton, P., et al.: 1985.
Mortality patterns of New York State Vietnam veterans. AJPH
75(3); 277-279.

17.

Mandard, A.M., Chasley, J., Mandard, J.C.: 1981. The
pathologist's role in a multidisciplinary approach for soft
tissue sarcoma. A reappraisal. J. Surg. Oncol. 1.69.

18.

Rosenberg, S.A., Tepper, J., Glatstein, E., et al.:
1982.
The treatment of soft tissue sarcomas of the extremities.
Ann Surg 196:305.

19.

Russell, W.O., Cohen, J., Enzinger, F.M., et al.: 1977.
clinical and pathological staging system for soft tissue
sarcomas. Cancer 40: 1562.

20.

Selikoff, I.J., Churg, J., Hammond, E.G.:
exposure and neoplasia. JAMA 188:22.

21.

Selikoff, I.J., Hammond, B.C.: 1979. Health hazards of
asbestos exposure. Ann NY Acad. Sci. 330:1.

22.

Tucker, M.A., Fraumeni, J.F.: 1982. Soft Tissue, in Cancer
Epidemiology and Prevention; Schottenfeld, D. and Fraumeni,
J.F.,: W.B. Saunders Co.

23.

Wolfe, W.H., Michalek, J.E., Miner, J.C., et al. 1985. An
epidemiologic investigation of health effects in Air Force
personnel following exposure to herbicides. Mortality
update-1985. Epidemiology Division, USAF School of
Aerospace Medicine, Brooks AFB, Texas.

25

1964.

A

Asbestos

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17853">
              <text>056</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17854">
              <text>1496</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17856">
              <text>Series III Subseries II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17849">
                <text>Shepard, Barclay M.</text>
              </elementText>
              <elementText elementTextId="17850">
                <text>H. K. Kang</text>
              </elementText>
              <elementText elementTextId="17851">
                <text>F. M. Enziger</text>
              </elementText>
              <elementText elementTextId="17852">
                <text>L. B. Hobson</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17855">
                <text>Typescript: Chapter 6: The Risk of Soft Tissue Sarcoma in Veterans of the Vietnam Conflict</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17857">
                <text>VA/AFIP STSS</text>
              </elementText>
              <elementText elementTextId="17858">
                <text>Air Force Health Study</text>
              </elementText>
              <elementText elementTextId="17859">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
